<?xml version="1.0" encoding="utf-8"?>
<items><item><CGlande><value>Pituitary</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Reassure and discharge&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If clinical review is reassuring and GH and IGF-I are normal, acromegaly can be &lt;a href="http://jcem.endojournals.org/cgi/content/full/87/8/3534" target="_blank"&gt;excluded&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Proceed to OGTT&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is a strong clinical suspicion, or if either screening tests are elevated, a formal GH suppression test should be undertaken.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Acromegaly confirmed, proceed to further investigations&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Failure of GH suppression on an OGTT confirms biochemical acromegaly, and so disease localisation and severity then need to be assessed. MRI pituitary, formal visual perimetry and baseline pituitary function are required urgently. Dynamic pituitary function testing should be performed if baseline cortisol is suboptimal.&lt;/p&gt;
&lt;p&gt;Arrange CXR, ECG, echocardiogram, and offer a baseline colonoscopy.&lt;/p&gt;
&lt;p&gt;Consider cardiology review if cardiomyopathy, valve disease or rhythm disturbance have been detected.&lt;/p&gt;
&lt;p&gt;Consider referral to sleep specialist if there is clinical suspicion of obstructive sleep apnoea.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review results and MRI scan at multidisciplinary meeting&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;The management of acromegaly is &lt;a href="http://jcem.endojournals.org/cgi/content/abstract/jc.2008-2421v1" target="_blank"&gt;complex&lt;/a&gt; and a multidisciplinary approach is optimal.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Surgical cure is most likely to be achieved with microadenomas.&lt;/p&gt;
&lt;p&gt;Surgical referral is mandatory if there is visual field loss or chiasmal compression on MRI scan.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Surgical cure is unlikely to be achieved with macroadenomas, and good tumour shrinkage as well as biochemical control may be achieved with somatostatin analogue therapy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dopamine agonists may be used as an alternative or adjunctive treatment to somatostatin analogues, and particularly if serum prolactin is elevated. These are effective only in a small proportion of patients, but are cheap, given orally, and are generally well tolerated, so a trial of therapy may be appropriate in various situations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is not a first line treatment and does not control local disease but is highly effective at controlling severe biochemical disease. Its role is largely confined to patients not acheiving biochemical control despite dual therapy with somatostatin and dopamine agonists after non curative surgery.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is not generally considered a first line treatment but is useful in cases where the disease is not cured surgically. It is also useful where the patient cannot tolerate, or responds poorly to medical treatments.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Timing of repeat MRI should be determined after discussion at multidisciplinary meeting.&lt;/p&gt;
&lt;p&gt;It is standard practise to repeat an OGTT three months post surgery to determine response. Cure is defined by suppression of GH&amp;lt;0.4ng/ml with a normal age and gender related IGF-I.&lt;/p&gt;
&lt;p&gt;For patients not acheiving a primary cure, medical treatment should be started, and treatment titrated upwards if necessary. Although previously OGTT was used to assess control, latest &lt;a href="http://jcem.endojournals.org/content/95/7/3141.full" target="_blank"&gt;guidance&lt;/a&gt; suggests that normalised life expectancy is acheived if a random GH is below 1ng/ml. Biochemical control is therefore now defined as a random GH &amp;lt;1ng/ml on a modern ultrasensitive assay with a normalised age and gender related IGF-I. Further assessment on medical treatment may be performed using a GH day curve combined with an IGF-I. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Uptitrate treatment whenever necessary to achieve normalisation of IGF-I and GH &amp;lt;1ng/ml. OGTT is required to diagnose acromegaly, and to define cure post surgery. However, response to treatment with somatostatin analogues and dopamine agonists is best determined by &lt;a href="http://jcem.endojournals.org/content/95/7/3141.full" target="_blank"&gt;GH and IGF-I&lt;/a&gt;, and response to GH receptor antagonists with IGF-I alone.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Somatostatin analogue dose may be uptitrated, or dopamine agonists added.&lt;/p&gt;
&lt;p&gt;Patients not responding or not fully controlled by standard treatments may be considered for pegvisomant treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Conventional radiotherapy or repeat surgery may also be considered if the patient is not biochemically controlled or if there is poor tumour shrinkage post primary surgery.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider gamma knife radiosurgery in patients more than 24 months post conventional radiotherapy, who are not biochemically controlled or are poorly tolerating medical treatment. Radiosurgery is also considered as an alternative to conventional radiotherapy in some centres.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients with acromegaly require lifelong follow up. Cardiovascular risk assessment, investigation and treatment of complications such as obstructive sleep apnoea, osteoarthritis, diabetes and cardiomyopathy, and screening for colon, prostate and other cancers should all be considered annually.&lt;/p&gt;
&lt;p&gt;MRI should typically be repeated three to six months post surgery or treatment initiation, and subsequently at 12 months in all patients. Selected cases with extensive residual disease will require further scanning at two years, then every three years if stable, depending on multidisciplinary discussion. Cases with good biochemical control and minimal residual disease may not require ongoing imaging.&lt;/p&gt;
&lt;p&gt;Biochemical reassessment with repeat IGF-I and OGTT should initially be performed pre-clinic annually to confirm cure. Long term, annual assessment with IGF-I and random GH will usually be sufficient to confirm on going biochemical control or to assess response to on going medical treatment.&lt;/p&gt;
&lt;p&gt;Basal pituitary function and existing pituitary replacement therapy should also be reveiwed annually, and dynamic pituitary function should be repeated every two years post radiotherapy in patients who are not panhypopituitary.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Prolactinoma and Hyperprolactinaemia</value></CCondName><CQueMgt><value>Random GH and IGF-I normal 
				</value><value>Clinically suspicious or elevated GH or IGF-I 
				</value><value>OGTT shows failure of GH suppression 
				</value><value>Consider immediate surgical referral 
				</value><value>Consider starting depot somatostatin analogue 
				</value><value>Consider trial of dopamine agonist 
				</value><value>Consider pegvisomant in resistant cases 
				</value><value>Conventional radiotherapy 
				</value><value>Clinical review with repeat IGF-I and OGTT at three months 
				</value><value>Further clinical review with repeat IGF-I and GH every six months until GH controlled, then annually life long 
				</value><value>Medical treatment 
				</value><value>Surgery and radiotherapy 
				</value><value>Radiosurgery 
				</value><value>Lifelong follow up 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/diabetes-insipidus/</value><value>http://www.endobible.com/condition/diabetes-insipidus/examination</value><value>http://www.endobible.com/condition/diabetes-insipidus/investigation</value><value>http://www.endobible.com/condition/diabetes-insipidus/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/acromegaly/management</CURLMgt><CURLTop>http://www.endobible.com/condition/diabetes-insipidus/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Pituitary</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Withdraw drug if possible &lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the hyperprolactinaemia occurs in the presence of a drug known to elevate prolactin, for example risperidone, discuss whether it is possible to withdraw this with the patient with the responsible psychiatrist.&lt;/p&gt;
&lt;p&gt;Any interfering agents should be withdrawn for at least six weeks prior to retesting prolactin on at least two occasions.&lt;/p&gt;
&lt;p&gt;Psychotropic agents must be withdrawn under close psychiatric supervision only whereas other agents, for example contraceptive pills, may be stopped abruptly.&lt;/p&gt;
&lt;p&gt;If it is not possible to withdraw potentially offending drugs, latest &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/21296991" target="_blank"&gt;guidelines&lt;/a&gt; suggest imaging the pituitary gland.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Serum levels normalise&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If serum levels normalise after drug withdrawal, the patient should be reassured that no further investigation or treatment should be necessary.&lt;/p&gt;
&lt;p&gt;If the patient requires resumption of treatment, estrogen or testosterone therapy may be considered for symptom control.&lt;/p&gt;
&lt;p&gt;Severe symptoms, for example galactorrhoea, may necessitate switching to an alternative psychotropic agent under supervision.&lt;/p&gt;
&lt;p&gt;Dopamine agonists should be used with extreme caution in this instance.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin remains elevated&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the prolactin does not normalise on drug withdrawal, or if the agent cannot be stopped for other reasons, proceed to MRI scan and management as below.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;MRI pituitary&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is performed to rule out a large non functioning pituitary tumour particularly in patients using interfering medications, or to assess the pre-treatment size of a prolactinoma.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Baseline pituitary function&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ensure that thyroid function is normal and assess whether the patient has PCOS before treating elevated prolactin.&lt;/p&gt;
&lt;p&gt;Other abnormalities of pituitary function, for example hypopituitarism or elevation of IGF-I, will require formal assessment and treatment as appropriate.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;No symptoms&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the patient does not complain of galactorrhoea and is menstruating regularly or is post menopausal, treatment &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/21296991" target="_blank"&gt;may not be necessary&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider dopamine agonist therapy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Cabergoline is the &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/21296991" target="_blank"&gt;first line&lt;/a&gt; dopamine agonist, as it has the highest efficacy in terms of biochemical control and tumour shrinkage. Very low doses, for example cabergoline 0.25mg once or twice a week, should be enough to control symptoms in the majority of cases with microprolactinomas.&lt;/p&gt;
&lt;p&gt;Warn patients of possible psychiatric, fibrotic and gastrointestinal side effects and advise them to take medication during the main meal of the day.&lt;/p&gt;
&lt;p&gt;Aim to use the minimum dose to achieve regular menses and control galactorrhoea. Absolute normalisation of prolactin may not be necessary. &lt;/p&gt;
&lt;p&gt;Treatment should be started after the MRI scan is performed since tumour shrinkage may be rapid.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider the combined oral contraceptive pill&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the patient with a microadenoma is amenorrhoeic but has no other symptoms, the contraceptive pill may be used as an alternative to a dopamine agonist. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Monitoring for patients on dopamine agonists&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Baseline chest radiograph, electrocardiogram, echocardiogram and renal function should all be performed within three months of starting ergot derived dopamine agonists in view of recent &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.mhra.gov.uk/Publications/Safetyguidance/DrugSafetyUpdate/CON2031802"&gt;guidance&lt;/a&gt;. Further monitoring tends to be on an annual basis, though should depend on the cumulative dose exposure, underlying conditions and results of previous screens.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Clinical review after three months is mandatory to review the scans with the patient, ensure resolution of symptoms and to recheck serum prolactin.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Long term treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;With a confirmed microadenoma, aim to &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/21296991" target="_blank"&gt;withdraw&lt;/a&gt; treatment every two years or at the time of natural menopause if the patient is well controlled: normalised serum prolactin with no visible tumour on MRI scanning. &lt;/p&gt;
&lt;p&gt;Treatment should resume if the patient develops amenorrhoea, or if there was a large initial lesion on MRI scan and the prolactin rises dramatically post treatment cessation. &lt;/p&gt;
&lt;p&gt;Generally, there is no indication to repeat MRI scans if the initial pre-treatment MRI was normal or showed a microadenoma.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual perimetry and acuity&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If visual fields are abnormal on examination, or a macroadenoma is suspected, this must be performed at baseline and repeated during treatment to confirm response. With non functioning pituitary adenomas, serum prolactin will fall but tumour shrinkage will not be observed and so surgery should be considered.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider starting dopamine agonist therapy immediately after the MRI scan is performed&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If visual loss is confirmed or the optic chiasm compromised on the MRI scan, higher doses of dopamine agonists may be used for urgent decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Warn patients of possible psychiatric, fibrotic and gastrointestinal side effects and advise them to take medication during the main meal of the day.&lt;/p&gt;
&lt;p&gt;Warn patients with very large macroadenomas of the symptoms of a cerebrospinal fluid leak, as this can occassionally occur on shrinkage of macroprolactnimoas on medical therapy.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Repeat prolactin within one week, then at one month&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Serum prolactin levels are expected to fall smoothly but dramatically in response to dopamine agonist therapy.&lt;/p&gt;
&lt;p&gt;A very rapid response, for example complete normalisation within a week, may indicate that the prolactin is elevated due to disinhibition from a &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/non-functioning-pituitary-adenoma/management"&gt;non functioning tumour&lt;/a&gt;. In this case, there will be no visual field or MRI response and urgent surgery should in stead be considered.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Clinical review with repeat visual fields, serum prolactin and ideally repeat MRI scanning at six weeks.&lt;/p&gt;
&lt;p&gt;If serum prolactin levels have not responded, consider alternative dopamine agonist.&lt;/p&gt;
&lt;p&gt;If the prolactin has responded dramatically, but there is no improvement in vision arrange a repeat MRI scan and consider urgent surgery, as this may represent disinhibition of prolactin secretion due to a nonfunctioning pituitary tumour.&lt;/p&gt;
&lt;p&gt;If prolactin is falling, and the patient is clinically improving, continue treatment and arrange routine rescanning (timing depends on initial clinical and MRI features and clinical response).&lt;/p&gt;
&lt;p&gt;If the prolactin has not fallen satisfactorily, switch patients on bromocriptine to cabergoline, or increase the dose of cabergoline as tolerated. &lt;/p&gt;
&lt;p&gt;Patients not controlled or intolerant of higher doses of dopamine agonist should be discussed at a pituitary MDT and offered surgery or radiotherapy.&lt;/p&gt;
&lt;p&gt;Vaginal bromocryptine may also be used in patients unable to tolerate oral dopamine agonists.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Monitoring for patients on dopamine agonists&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Baseline chest radiograph, electrocardiogram, echocardiogram and renal function should all be performed within three months of starting ergot derived dopamine agonists in view of recent &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.mhra.gov.uk/Publications/Safetyguidance/DrugSafetyUpdate/CON2031802"&gt;guidance&lt;/a&gt;. Further monitoring depends on initial results, underlying conditions, and cumulative dose exposure, but is generally repeated on an annual basis.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Clinical review at three months&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Aim to use the minimum dose necessary to restore vision and to control tumour size and symptoms, rather than aiming for a 'normal' serum prolactin.&lt;/p&gt;
&lt;p&gt;Retest baseline pituitary function at three months.&lt;/p&gt;
&lt;p&gt;Menses will usually be restored in female patients. However, with long standing macroprolactinomas, gonadotropin function may not return. Testosterone replacement is thus frequently required in male patients despite good control of serum prolactin.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Long term follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients with sight threatening macroadenomas should be seen at six weeks, then three, six and 12 months, then annually lifelong for monitoring of their treatment, tumour size and pituitary function.&lt;/p&gt;
&lt;p&gt;Aim to reduce doses wherever possible while maintaining disease control.&lt;/p&gt;
&lt;p&gt;Attempt to withdraw treatment every two years if the patient is well controlled with a normal serum prolactin and no visible remnant on MRI scanning.&lt;/p&gt;
&lt;p&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/21296991" target="_blank"&gt;Consider&lt;/a&gt; surgery or conventional radiotherapy if ongoing dopamine agonist requirements are high, dopamine agonists are not tolerated, or ifi the tumour is not well controlled on scanning.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Cabergoline is not licensed for use in pregnancy. Therefore patients seeking &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/21296991" target="_blank"&gt;fertility&lt;/a&gt; should be maintained on the lowest dose of bromocriptine that controls their prolactin and on which they have normal menstrual cycles. &lt;/p&gt;
&lt;p&gt;Patients should generally discontinue dopamine agonist therapy as soon as they are pregnant. In exceptional cases with large tumours abutting the chiasm a decision to continue therapy through pregnancy may be made.&lt;/p&gt;
&lt;p&gt;Regular clinical review and visual field testing should be performed throughout pregnancy (at least once per trimester) though monitoring of prolactin is not recommended and MRI scanning (without gadolinem) is only indicated in pregnancy if the patient develops a new field defect or severe headache indicating possible apoplexy. &lt;/p&gt;
&lt;p&gt;If there is significant and symptomatic growth in pregnancy, bromocriptine should be restarted.&lt;/p&gt;
&lt;p&gt;Patients with macroadenomas who have not acheived tumour control should be offered surgery prior to planning pregnancy.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Prolactinoma and Hyperprolactinaemia</value></CCondName><CQueMgt><value>Interfering drugs 
				</value><value>No offending drugs 
				</value><value>Microprolactinoma 
				</value><value>Macroprolactinoma 
				</value><value>Patients who are pregnant or actively seeking fertility 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/diabetes-insipidus/</value><value>http://www.endobible.com/condition/diabetes-insipidus/examination</value><value>http://www.endobible.com/condition/diabetes-insipidus/investigation</value><value>http://www.endobible.com/condition/diabetes-insipidus/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/hyperprolactinaemia/management</CURLMgt><CURLTop>http://www.endobible.com/condition/diabetes-insipidus/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Thyroid</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Any patient with a &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/thyroid-nodule/"&gt;solitary nodule&lt;/a&gt;, a dominant nodule within the gland, with palpable lymph nodes or with any other suspicious features, requires urgent ultrasound guided aspiration.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Smoking increases the risk of developing new ophthalmopathy, increases the severity of existing ophthalmopathy, reduces the efficacy of treatment for ophthalmopathy, and increases the risk of ophthalmopathy deteriorating or developing de novo following radioactive iodine treatment.&lt;/p&gt;
&lt;p&gt;General advice must be given and referral to a formal smoking cessation clinic discussed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with suspected eye disease require evaluation by an endocrinologist or ophthalmologist experienced in Graves' ophthalmopathy - see below. Patients should be reassured that treatment is available and is highly effective, and a detailed patient &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/info-for-patients/Docs/ptinfo-TED.pdf"&gt;information sheet&lt;/a&gt; is available. Simple lubricants, avoidance of smoky environments, and avoidance of bright sunlight and strong winds by wearing sunglasses should be advised in all patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;No symptoms or signs present&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;&lt;span style="font-size: 8pt; line-height: 115%; "&gt;Patients with a history of Graves’ disease, but with no symptoms nor signs of GO do not require referral. There is now excellent &lt;a href="http://eje-online.org/content/158/3/273.long" target="_blank"&gt;international guidance&lt;/a&gt; on best practise for all other categories of patients as below.&lt;br&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Unilateral eye involvement and euthyroid ophthalmopathy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;&lt;span style="font-size: 11.111111640930176px; line-height: 12.222222328186035px; "&gt;Patients with unusual presentations eg unilateral eye involvement or euthyroid GO should be referred to an ophthalmologist or combined thyroid-eye clinic, however mild their symptoms or signs, in order to make an accurate diagnosis.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Mild Graves' ophthalmopathy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;&lt;span style="font-size: 11.111111640930176px; line-height: 12.222222328186035px; "&gt;Patients with very mild symptoms of Graves' ophthalmopathy with confirmed hyperthyroidism and with no unusual feautres do not necessarily require ophthalmological assessment. These patients should recieve smoking cessation advice, advice on occular lubricants. Supplements of&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed?term=EUGOGO%20selenium" target="_blank"&gt; selenium&lt;/a&gt; 100mcg bd have also been shown to reduce severity in one series.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Routine referral to an ophthalmologist or combined thyroid-eye clinic&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p class="MsoNormal"&gt;&lt;span style="font-size: 8pt; line-height: 115%; "&gt;All patients with suspected eye involvement should be given smoking cessation advice. Patients should also be advised to use occular lubricants liberally, to avoid smokey environments, and to wear sunglasses in very bright sunshine or wind.Patients with very mild involvement eg grittiness only may not require any further assessment or treatment. &lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size: 8pt; line-height: 115%; "&gt;The presence of any more severe occular involvement including any of the symptoms or signs listed below should prompt referral to a specialist clinic:&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size: 8pt; line-height: 115%; "&gt;Eyes abnormally sensitive to light: troublesome or deteriorating over the past 1–2 months&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Eyes excessively gritty and not improving after 1 week of topical lubricants&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Pain in or behind the eyes: troublesome or deteriorating over the past 1–2 months&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Progressive change in appearance of the eyes and=or eyelids over the past 1–2 months&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Appearance of the eyes has changed causing concern to the patient&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Seeing two separate images when there should only be one&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size: 8pt; line-height: 115%; "&gt;Troublesome eyelid retraction&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Abnormal swelling or redness of eyelid(s) or conjunctiva&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Restriction of eye movements or manifest strabismus&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Tilting of the head to avoid double vision&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cases requiring urgent referral to an ophthalmologist or combined thyroid-eye clinic&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;The presence of any of these symptoms or signs mandates urgent referral according to latest &lt;a href="http://eje-online.org/content/158/3/273.long" target="_blank"&gt;guidelines&lt;/a&gt;:&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Unexplained deterioration in vision&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Awareness of change in intensity or quality of colour vision in one or both eyes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;History of eye(s) suddenly ‘popping out’ (Globe subluxation)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Obvious corneal opacity&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Cornea still visible when the eyelids are closed&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;Optic disc swelling on fundoscopy&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:8.0pt;line-height:115%"&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Classification of disease severity&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should be assessed by an ophthalmologist. &lt;a href="http://eje-online.org/content/158/3/273.long" target="_blank"&gt;EUGOGO&lt;/a&gt; recommends the following categories of disease severity:&lt;/p&gt;
&lt;p&gt;&lt;span style="font-size: 9pt; line-height: 115%; "&gt;Sight-threatening GO: patients with dysthyroid optic neuropathy (DON) and=or corneal breakdown. This category warrants immediate intervention.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Moderate to severe GO: patients without sight-threatening GO whose eye disease has sufﬁcient impact on daily life to justify the risks of immunosuppression (if active) or surgical intervention (if inactive). Patients with moderate to severe GO usually have any one or more of the following: lid retraction $ 2 mm, moderate or severe soft tissue involvement, exophthalmos $ 3 mm above normal for race and gender, inconstant or constant diplopia.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Mild GO: patients whose features of GO have only a minor impact on daily life insufﬁcient to justify immunosuppressive or surgical treatment. They usually only have one or more of the following: minor lid retraction (&amp;lt;2mm), mild soft tissue involvement, exophthalmos &amp;lt; 3 mm above normal for race and gender, transient or no diplopia, corneal exposure responsive to lubricants.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt; &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Assessment of disease activity&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;&lt;span style="font-size: 9pt; line-height: 115%; "&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;The clinical activity score (CAS) is based on the clinical indicators of inflammation and is calculated as the sum of all items present scoring 1 for each symptom or sign. A CAS above 3/7 indicates active Graves' orbitopathy. MRI scanning may also be helpful to assess disease activity.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Spontaneous retrobulbar pain&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Pain on attempted up- or down gaze&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Redness of the eyelids&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Redness of the conjunctiva&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Swelling of the eyelids&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Inﬂammation of the caruncle and=or plica&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;line-height:115%"&gt;Conjunctival oedema&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Incomplete lid closure and lid retraction&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These may be helped in the inactive phase by botulinum toxin or by corrective lid surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Persisting diplopia&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Prisms may alleviate this distressing symptom.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Pulsed methyl prednisolone should be considered in patients with active severe disease&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the CAS is above 3 and the disease is moderate to severe or sight threatening, iv glucocorticoids are indicated though must only be prescribed by an experienced thyroid eye specialist. Pulsed iv treatment has been shown to be more effective and cause less side effects than oral therapy.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Orbital decompression&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This radical treatment should be considered in sight threatening ophthalmopathy which has not responded within 2 weeks of iv glucocorticoids. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Orbital radiotherapy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should be considered for moderate to severe disease not responding to iv glucocorticoids.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Rehabilitative surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is generally only used in stable disease which is inactive, and should only be performed by highly experienced surgeons.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offspring of women with high TSH receptor antibodies (TRABs) are at risk of foetal and neonatal thyroid dysfunction. It is therefore useful to test TRABs prior to pregnancy or before the end of the second trimester. Women with negative antibodies require no special monitoring. Women with positive antibodies should be considered at risk of complications. Obstetricians should therefore consider ultrasound monitoring to seek evidence of foetal thyroid dysfunction eg for foetal growth retardation,hydrops, goitre or cardiac failure. TSH testing of cord blood may also be performed and neonatalogists warned at the time of delivery. &lt;/p&gt;
&lt;p&gt;It is standard practise to use propylthiouracil rather than carbimazole in patients who may be or are planning &lt;a href="http://www.endo-society.org/guidelines/final/upload/Clinical-Guideline-Management-of-Thyroid-Dysfunction-during-Pregnancy-Postpartum.pdf" target="_blank"&gt;pregnancy&lt;/a&gt;, due to small but real concerns regarding teratogenicity from carbimazole. Treatment may frequently be stopped by the second trimester as the disease often spontaneously improves until the post partum period. Monitoring should continue throughout pregnancy and breastfeeding, and carbimazole substituted for propylthiouracil if required during the second trimester (since organogenesis is complete, and the risk of liver failure from propyl thiouracil outweighs the risks of carbimazole during this stage of the pregnancy). &lt;/p&gt;
&lt;p&gt;Patients with uncontrolled thyrotoxicosis should be advised to avoid pregnancy until biochemical control is achieved due to the risk of miscarriage. Treatment during pregnancy requires close monitoring typically every six weeks.&lt;/p&gt;
&lt;p&gt;Radioactive iodine is contraindicated in pregnant or breast feeding individuals. Women should be advised to avoid conception for six months and men should avoid fathering children for four months following radioactive iodine treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Any patient with severe clinical or biochemical thyrotoxicosis requires immediate medical treatment, before long term decisions are taken, in line with national &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.bmj.com/cgi/content/full/313/7056/539"&gt;guidelines&lt;/a&gt;. However, the options of medical treatment, radioactive iodine and surgery should all be introduced at this stage.&lt;/p&gt;
&lt;p&gt;All patients must receive verbal and written &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/carbimazole-warning-sheet/"&gt;safety warnings&lt;/a&gt; regarding drug therapy.&lt;/p&gt;
&lt;p&gt;Usual treatment starts with high dose carbimazole, for example 40-60mg daily, though lower doses may be appropriate in those with milder disease. Propyl thiouracil may be substituted in patients intolerant of carbimazole, using an approximate dose equivalence of 50mg propyl thiouracil for 5mg carbimazole.&lt;/p&gt;
&lt;p&gt;Patients with tachycardia or other severe symptoms are also usually treated with beta blockade, for example propranolol 120-240mg daily in divided doses.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients should receive instructions as to the timing of dose reduction and firm arrangements made for serial monitoring. Typical monitoring intervals are every six weeks initially. There should be rapid dose reduction through 20mg, 15mg, 10mg to a maintenance therapy of 5mg, according to the early fall in T4 levels.&lt;/p&gt;
&lt;p&gt;Once on maintenance doses, monitoring of TSH only is necessary, aiming for a detectable, normal TSH with complete resolution of symptoms. This is typically repeated every three months until the end of the treatment course.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Typical treatment course for Graves' thyrotoxicosis is 18 months. Monitoring is typically required every six weeks initially, and three monthly once patients are on a stable maintenance dose. &lt;/p&gt;
&lt;p&gt;All patients with auto-immune hyperthyroidism should be warned of a 50% chance of disease recurrence after their initial treatment course. Male patients, older patients, those with high antibody titres, those with previous episodes and those with severe biochemical disease are at the highest risk of future recurrence.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dose titration may be inappropriate in certain circumstances, in which case high dose carbimazole is continued, with thyroxine added once the serum thyroxine falls to within the normal range.&lt;/p&gt;
&lt;p&gt;Thyroxine dose should then be adjusted according to symptoms and aiming for a normal serum TSH level.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Agranulocytosis is an uncommon but important side effect of all anti-thyroid drugs. Patients should receive written and verbal &lt;a href="http://www.endobible.com/investigation/carbimazole-warning-sheet/" target="_blank"&gt;warnings&lt;/a&gt; to discontinue the drug until they have had a blood count checked if they develop a severe sore throat or mouth ulcers.&lt;/p&gt;
&lt;p&gt;Mild neutropaenia &amp;lt;1.5x10*9 is commonly observed in people with Graves disease, some racial groups and with anti-thyroid drugs.&lt;/p&gt;
&lt;p&gt;Neutrophil count 1-1.5 - continue drug but institute close monitoring of blood count. &lt;/p&gt;
&lt;p&gt;Neutrophil count &amp;lt;1 - stop antithyroid drug and monitor blood count daily.&lt;/p&gt;
&lt;p&gt;Neutrophil count &amp;lt;1 with suspected sepsis or in the unwell patient - stop antithyroid drug and arrange urgent admission. Treat as for neutropaenic sepsis, remembering that pseudomonas is a common infective organism in this group. Monitor blood count every 12 hours initially and take haematological advice. Bone marrow biopsy may be helpful to determine response. Granulocyte-colony stimulating factor (GCSF) should be considered after haematology review of the patient's response to drug cessation. DO NOT RECHALLENGE THE PATIENT WITH AN ALTERNATIVE ANTI-THYROID DRUG.&lt;/p&gt;
&lt;p&gt;Rash is common and usually controlled by antihistamines. Alternatively switch to alternative anti-thyroid drug.&lt;/p&gt;
&lt;p&gt;Arthralgia and arthritis are uncommon with carbimazole but more common with PTU. Stop the drug. Check antibody screen including ANCA for drug induced lupus and discuss wtih rheumatologist. &lt;/p&gt;
&lt;p&gt;Mild abnormalities of liver function are common with thyrotoxicosis and do not require treatment. Mild transaminitis (&amp;lt;1.6x upper limit of normal) is also common after 3 months therapy with PTU and does not require treatment or monitoring unless baseline liver function was abnormal.&lt;/p&gt;
&lt;p&gt;Allergic hepatitis with submassive necrosis occurs in 0.1-0.2% of patients receiving PTU. Stop PTU and involve a hepatologist immediately if this is suspected.&lt;/p&gt;
&lt;p&gt;Carbimazole is not associated with this condition, but may cause a cholestatic picture of abnormal liver function. Stop the drug and inform hepatology if this is suspected, though complete resolution is normal on drug withdrawal. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;It is usual to start medical treatment at presentation particularly in those with severe biochemical disease in order to allow them to make an informed decision regarding long term management. Written &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/info-for-patients/Docs/bta_patient_hyperthyroidism.pdf%20"&gt;information&lt;/a&gt; about radioactive iodine and other treatments should also be given to the patient to consider before making a decision.&lt;/p&gt;
&lt;p&gt;Radioactive iodine is highly effective at rendering patients euthyroid, usually after one treatment of 370-600MBq, and offers the advantage of preventing future recurrence. It is therefore particularly suitable for patients with relapsed Graves' disease, or those at high risk of recurrence for example male patients, those with severe biochemical disease, or those with high antibody titres. The dose should be determined by the responsible ARSAC licence holder in line with local results and policies&lt;/p&gt;
&lt;p&gt;Patients must be warned about standard &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.rcplondon.ac.uk/Pubs/contents/0621b67a-4880-4a1b-9942-57a666efee4a.pdf"&gt;radioactive iodine&lt;/a&gt; precautions. Patients should also be warned that transient thyroid swelling may occur, that repeat applications may be necessary, that long term monitoring is required, and that hypothyroidism requiring thyroxine replacement therapy is likely to ensue. Long term studies confirm that weight gain follows all treatments of thyrotoxicosis though this may be more frequently observed wtih radioactive iodine. However, radioactive iodine treatment is associated with the lowest all cause mortality compared to other treatments of thyrotoxicosis. &lt;/p&gt;
&lt;p&gt;Radioactive iodine is absolutely contraindicated in pregnancy. Women should also be advised to avoid conception for six months, and men should avoid fathering children for four months following radioactive iodine treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.rcplondon.ac.uk/Pubs/contents/0621b67a-4880-4a1b-9942-57a666efee4a.pdf"&gt;Radioactive iodine&lt;/a&gt; should be discussed with an experienced ophthalmologist in the case of suspected eye disease, as 15% patients may experience new or worsened ophthalmopathy within 6 months of treatment, though it is usually mild. Mild to moderate eye disease does not preclude the use of radioactive iodine, but it is standard practise to render the patient euthyroid medically, ensure the patient has given up smoking if relevant, and confirm that their eye disease is inactive before treatment.  The ophthalmologist will also advise whether an individual patient will require &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18299459" target="_blank"&gt;prophylactic treatment&lt;/a&gt; to reduce this risk. If so, a course of ,3 months prednisolone is usually given. In our institution, we have adopted a low dose regimen: 1 day before radioactive iodine is administered, patients start on 0.3mg/kg prednisolone for one week, with the dose reduced gradually over a six week course (eg 25mg then 20mg, 15mg, 10mg, 5mg, 2,5mg for one week each). Bisphosphonate cover is only given if the course is anticipated to last for more than three months. Proton pump inhibitors are considered in patients at high risk of gastrointestingal bleeding (previous ulcer, or taking concomitant aspirin, clopidogrel, warfarin, bisphosphonate or selective serotonin reuptake inhibitor) but are not given routinely.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid function should be assessed at 6 and 12 weeks, and then at least every three months for the first year after radioactive iodine, and then annually thereafter for emerging hypothyroidism or for recurrent thyrotoxicosis. Hypothyroidism must be avoided in patients with ophthalmopathy.&lt;/p&gt;
&lt;p&gt;Subsequent &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypothyroidism/management"&gt;hypothyroidism&lt;/a&gt; should be treated conventionally.&lt;/p&gt;
&lt;p&gt;Subsequent recurrence, more than 6 months following radioactive iodine should be treated with a repeat application of radioactive iodine.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Annual monitoring of serum TSH levels is usually all that is required after treatment for Graves' disease. Patients should also be warned to report any symptoms suggestive of thyroid dysfuntion before this routine monitoring. Patients are also at increased risk of developing auto-immune conditions, however, routine surveillance is not usually required if all other baseline investigations were normal.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Surgery is no longer considered a first line treatment for Graves' disease as most patients prefer either a course of medical treatment or a one off treatment with radioactive iodine. However, in patients intolerant or unresponsive to medical treatments, and who decline or are unsuitable for radioactive iodine, surgery can provide an alternative highly effective treatment.&lt;/p&gt;
&lt;p&gt;Generally, it is a straight forward and effective procedure, with a very low risk of complications such as hypoparathyroidism or recurrent laryngeal nerve damage. However, all patients must be warned that surgery does not offer a guaranteed cure of their thyrotoxicosis, that relapse is possible, and that they will usually require life long thyroxine replacement therapy which is unfortunately associated with long term weight gain in a large proportion of patients. &lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Thyrotoxicosis or hyperthyroidism</value></CCondName><CQueMgt><value>Suspicious characteristics 
				</value><value>All patients should be advised to stop smoking 
				</value><value>Suspected eye disease 
				</value><value>Graves' ophthalmopathy 
				</value><value>Pregnancy and fertility plans should be discussed with all patients 
				</value><value>Medical treatment for thyrotoxicosis 
				</value><value>Dose reduction and treatment monitoring 
				</value><value>Treatment duration and likelihood of relapse should be discussed with all patients 
				</value><value>A block and replace regimen may be appropriate in exceptional cases 
				</value><value>Common side effects of anti-thyroid drugs 
				</value><value>Discuss radioactive iodine treatment 
				</value><value>Graves' ophthalmopathy may be exacerbated by radioactive iodine therapy 
				</value><value>Post radioactive iodine monitoring and treatment 
				</value><value>Long term follow up 
				</value><value>Discuss thyroid surgery 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/</value><value>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/examination</value><value>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/investigation</value><value>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/graves-disease/management</CURLMgt><CURLTop>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Pituitary</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Urgent serum prolactin and urgent 9am cortisol must be assessed immediately in all patients, and hydrocortisone replacement therapy instituted immediately if rapid assessment is not possible.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hormone replacement therapy should be started immediately.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specific education regarding steroid replacement therapy, a steroid instructions card and emergency identification need to be discussed with all patients.&lt;/p&gt;
&lt;p&gt;Cortisone acetate has been largely superseded by the biologically active hydrocortisone for glucocorticoid replacement.&lt;/p&gt;
&lt;p&gt;Typical modern doses of hydrocortisone are 10mg on waking, 5mg approximately five hours after waking, and 5mg approximately 10 hours after waking.&lt;/p&gt;
&lt;p&gt;Doses should then be adjusted according to clinical response, for example if the patient feels very tired at certain times of the day, the previous dose may be increased, or the next dose brought forward. A &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/hydrocortisone-day-curve/"&gt;hydrocortisone day curve&lt;/a&gt; may be useful during the initial period of dose adjustment as in &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/addisons-disease/"&gt;Addison's&lt;/a&gt; disease and post adrenalectomy patients.&lt;/p&gt;
&lt;p&gt;Patients with residual ACTH reserve as indicated by 9am cortisols &amp;gt;250nmol/l, or with a suboptimal response to insulin tolerance test, may require lower 'top-up' doses. Asymptomatic patients with suboptimal reserve may not require daily replacement therapy, though all need thorough education and will need hydrocortisone therapy in the case of intercurrent illness and emergencies.&lt;/p&gt;
&lt;p&gt;If the treatment dose appears to be excessive clinically, a hydrocortisone day curve may be repeated to confirm the safety of dose reduction, although routine repetition of a day curve is unlikely to alter management.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In most patients, a starting dose of 50mcg thyroxine is appropriate, with dose titrated according to serum thyroxine levels taken after approximately six weeks treatment.&lt;/p&gt;
&lt;p&gt;In patients with cardiac disease, and those with profound hypothyroidism, it may be appropriate to start with lower doses or in the presence of unstable cardiac disease with low doses of short acting liothyronine.&lt;/p&gt;
&lt;p&gt;Serum thyroxine should be monitored annually in patients taking stable doses. Dose adjustments should be made according to symptoms, aiming for levels between the median and the upper end of the reference range.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Estrogen deficiency should be treated in most women below 50, particularly those with a low bone mineral density.&lt;/p&gt;
&lt;p&gt;Patches, depot injections, and oral hormone replacement therapy should all be discussed.&lt;/p&gt;
&lt;p&gt;When GH is being considered, it is usual to switch to trans-dermal estrogen as this allows lower doses of GH to be administered to achieve the same serum IGF-I level.&lt;/p&gt;
&lt;p&gt;The presence or absence of a uterus, personal and family history of cardiovascular, cerebrovascular and thromboembolic disease and the desire or not for a withdrawal bleed should all inform treatment choice.&lt;/p&gt;
&lt;p&gt;Treatment is usually continued until the age of the natural menopause approximately 50 years.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Testosterone replacement should be discussed in all patients with profound biochemical deficiency and particularly those with a low bone mineral density.&lt;/p&gt;
&lt;p&gt;Intermittent intra-muscular, topical gel and depot preparations should be discussed in all patients.&lt;/p&gt;
&lt;p&gt;Potential effects on libido and mood must be discussed prior to treatment initiation, particularly in those with long standing and profound biochemical deficiency.&lt;/p&gt;
&lt;p&gt;Testosterone, SHBG, PSA, FBC and LFTs should be assessed annually in all patients to aid dose adjustment in conjunction with symptoms and to detect potential treatment complications.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dynamic testing of GH reserve with either &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;insulin tolerance&lt;/a&gt; or other appropriate testing is necessary to confirm the need for GH replacement. In the UK, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.nice.org.uk/Guidance/TA64"&gt;NICE guidelines&lt;/a&gt; also dictate that GH therapy should only be considered in patients with confirmed pituitary disease, and once all other axes of the pituitary have been assessed and treated if necessary. &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.nice.org.uk/nicemedia/pdf/AGHDA_questionnaire.pdf"&gt;AGHDA&lt;/a&gt; or other validated quality of life score should be then be assessed with a minimum score of &amp;gt;11/25 necessary for NICE approval of GH treatment.&lt;/p&gt;
&lt;p&gt;MRI scan, DEXA bone scan, waist hip ratio, fasting glucose and lipids and IGF-I should all be documented prior to starting treatment. It is also worth considering switching from oral to transdermal estrogen replacement therapy prior to treatment, to reduce GH dose requirements.&lt;/p&gt;
&lt;p&gt;The practicalities of GH replacement therapy should be discussed and the delivery methods demonstrated and then taught to the patient prior to treatment.&lt;/p&gt;
&lt;p&gt;IGF-I levels are initially tested monthly to guide treatment dose with dose adjustment according to symptoms, adverse effects and serum IGF-I level, aiming for a level between the median and the upper limit of the age and gender related reference range.&lt;/p&gt;
&lt;p&gt;IGF-I and AGHDA score should be reassessed after six months to determine whether it is appropriate to continue treatment - a drop of 6 points is deemed an appropriate response according to NICE guidelines.&lt;/p&gt;
&lt;p&gt;Hydrocortisone and thyroxine doses should also be assessed three months after starting GH as serum levels may fall requiring up-titration in a minority of cases.&lt;/p&gt;
&lt;p&gt;MRI scan should be repeated after one year of treatment, and then according to multidisciplinary team discussion. Further assessments of serum IGF-I should then be made after six months and then on an annual basis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Symptoms of DI are profound and require treatment immediately whenever this occurs, for example after the initiation of hydrocortisone therapy.&lt;/p&gt;
&lt;p&gt;Emergency &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/diabetes-insipidus/management"&gt;treatment&lt;/a&gt; of DI is with subcutaneous doses of desmopressin (typical dose 1mcg). Urea and electrolytes, and paired urine and serum osmolalities should be performed daily in the acute phase to confirm the need for ongoing treatment, and to prevent over-treatment.&lt;/p&gt;
&lt;p&gt;Long term treatment is usually given as an intranasal spray (typical dose 1 x 10mcg inhalation on retiring). Mild cases may be controlled with oral DDAVP (typical dose 100-300mcg on retiring), and top up oral doses may also be added during the day in those whose symptoms are not fully controlled with once daily treatment.&lt;/p&gt;
&lt;p&gt;In patients with a normal thirst mechanism, treatment aims to relieve nocturia and extreme thirst, while allowing a short period of polyuria and thirst just before a dose to prevent water overload developing, and maintain normal serum biochemistry. However, in patients with hypothalamic damage and loss of thirst, it may be necessary to calculate a fixed oral intake and desmopressin dose.&lt;/p&gt;
&lt;p&gt;Long term monitoring of urea and electrolytes is the usually all that is required according to symptoms. Hyponatraemia indicates excessive replacement, prompting discussion of dose reduction.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Clinical assessment of pituitary status should be performed annually to ensure that new deficiencies are not emerging and to detect clinical under or over-replacement. Blood pressure, weight, waist hip ratio and BMI should also be documented.&lt;/p&gt;
&lt;p&gt;Aggressive treatment of diabetes and cardiovascular risk should be undertaken.&lt;/p&gt;
&lt;p&gt;Bone mineral density should have been assessed at baseline and &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/osteoporosis/management"&gt;treatment &lt;/a&gt;considered accordingly. Repeat DEXA scans may then be considered in some cases.&lt;/p&gt;
&lt;p&gt;The minimum monitoring performed in all hypopituitary patients prior to annual review in our unit includes: full blood count, urea and electrolytes, liver function test, HbA1c, fasting glucose and lipid profile, HbA1c, thyroxine, 9am cortisol (unless on hydrocortisone replacement), IGF-I, LH and FSH. In male patients testosterone, SHBG and PSA are also performed, and in female patients estrodiol may also be checked in patients not already on replacement.&lt;/p&gt;
&lt;p&gt;AGHDA score is also completed in most patients, and MRI scanning is repeated when indicated by previous MDT discussion. &lt;/p&gt;
&lt;p&gt;Dynamic pituitary function is tested every two years in patients who have previously received pituitary irradiation, and who are not currently on replacement therapy, and according to baseline results in other patients.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Prolactinoma and Hyperprolactinaemia</value></CCondName><CQueMgt><value>Hypopituitarism suspected 
				</value><value>Pituitary dysfunction confirmed 
				</value><value>Glucocorticoid replacement therapy must take priority over all other treatments 
				</value><value>Thyroid hormone replacement therapy may then be started 
				</value><value>Female sex hormone replacement therapy 
				</value><value>Male sex hormone replacement therapy 
				</value><value>GH replacement therapy should then be considered 
				</value><value>Desmopressin therapy may be required at any time 
				</value><value>Annual life-long follow up is mandatory 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/diabetes-insipidus/</value><value>http://www.endobible.com/condition/diabetes-insipidus/examination</value><value>http://www.endobible.com/condition/diabetes-insipidus/investigation</value><value>http://www.endobible.com/condition/diabetes-insipidus/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/growth-hormone-deficiency/management</CURLMgt><CURLTop>http://www.endobible.com/condition/diabetes-insipidus/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Gonadal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;If hypogonadism has been identified as the cause of gynaecomastia, psychological as well as genetic counselling may be helpful. Fertility should also be discussed early with the patient and their family where appropriate.&lt;/p&gt;
&lt;p&gt;Discuss the likelihood of successful treatment in all cases. Discuss the natural history of physiological gynaecomastia at the outset, and explain that treatment is rarely required for this condition.&lt;/p&gt;
&lt;p&gt;Where other non endocrine causes such as malignancy have been identified, early referral is essential.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Gynaecomastia should reverse after withdrawal of the offending drug or dietary component. However, this should not preclude a full evaluation to ensure no other sinister pathology is missed, and patients should be warned that normalisation of the breast may take many months or years in some cases.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Physiological gynaecomastia occuring during puberty regresses spontaneously in the vast majority of cases.&lt;/p&gt;
&lt;p&gt;Idiopathic gynaecomastia will sometimes improve as pectoral muscle bulk increases. For this reason, some patients may find a high protein diet with isometric weight training improves symptoms.&lt;/p&gt;
&lt;p&gt;Medical therapy with clomiphene or tamoxifen are occasionally used for persistant severe idiopathic gynaecomastia, athough surgical treatment is usually preferable. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Elevated prolactin will require thorough evaluation to identify its cause and determine the most appropriate treatment - see &lt;a onclick="window.open(this.href,'','resizable=yes,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hyperprolactinaemia/"&gt;prolactinoma&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Gynaecomastia should respond rapidly to a fall in serum prolactin.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss treatment aims, timescales and outcomes&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Pubertal induction aims to replicate the natural process of puberty and should occur over approximately the same timescale - approximately two years. Late onset hypogonadism, and hypergonadotropic hypogonadism can often be treated much more quickly with typical adult doses from the outset.&lt;/p&gt;
&lt;p&gt;Patients should be warned that symptoms of gynaecomastia may be exacerbated at the start of testosterone replacement therapy.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate testosterone treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;In the case of absent puberty, initiate very low dose testosterone therapy, and warn patient of expected psychological and physical effects.&lt;/p&gt;
&lt;p&gt;Typical starting dose in a testosterone naive patient is approximately 20% of an adult dose. This has traditionally been given as 50mg testosterone undecanoate monthly.&lt;/p&gt;
&lt;p&gt;In late onset hypogonadism, it may be appropriate to start with adult doses.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Monthly testosterone treatment is then typically increased by a further 50mg every six months according to clinical response.&lt;/p&gt;
&lt;p&gt;Alternatives include low dose depot testosterone, or topical gel, again, starting with approximately 20% of the usual adult dose, increasing by the same amount every six months until adult doses are reached.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Treatment monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p&gt;Routine monitoring of serum testosterone levels is not necessary until the expected adult dose is reached.&lt;/p&gt;
&lt;p&gt;Peak and trough levels may then be useful to confirm the appropriateness of the final dose in patients taking monthly testosterone undecanoate. Peak 7 days post injection should typically be 25-30nmol/l, with a predose trough level of 8-12nmol/l. Subsequently, the dose should not be altered unless the clinical response is suboptimal, or in the light of changes in serum monitoring of prostate specific antigen, full blood count, liver function, or pre dose testosterone levels.&lt;/p&gt;
&lt;p&gt;In patients taking depot preparations, a random or pre dose level of 15-20nmol/l, and for patients taking daily topical preparations, a level of 15-20nmol/l 4-6 hours post application of the gel is usually suficient.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Warn patients that testicular volume is not likely to change&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Testicular volume may be enhanced during gonadotropin treatment used in the induction of spermatogenesis, however, this tends to reverse on treatment cessation.&lt;/p&gt;
&lt;p&gt;Synthetic implants can be considered to restore testicular volume where required.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Once the patient is virilised appropriately and established on a full adult dose, discuss alternative modes of treatment. Daily gel or depot preparations of testosterone are well tolerated and give a smooth serum profile which some patients find more acceptable.&lt;/p&gt;
&lt;p&gt;Optimise final dose and preparation, according to patient preference, symptoms and serum levels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Annual monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Testosterone levels are usually checked on an annual basis only after the dose has been optimised. This should be taken 4-6 hours after gel application, or generlaly pre dose in patients taking testosterone injections to ensure testosterone levels are not excessive.&lt;/p&gt;
&lt;p&gt;Prostate specific antigen, full blood count and liver function tests should also be performed annually. Consider dose reduction, treatment cessation and onward referral if abnormalities arise.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients, though patients with gonadal failure, and isolated hypogonadotropic hypogonadism may be discharged to their general practitioner.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry where indicated. Consider repeat basal and dynamic pituitary function in patients with suspected pituitary disease, and follow up as per underlying condition.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling.&lt;/p&gt;
&lt;p&gt;Ensure that an MRI scan of the pituitary and olfactory bulbs has been performed, and that pituitary function, karyotype and where necessary pelvic ultrasound scan have all been reviewed to exclude other diagnoses.&lt;/p&gt;
&lt;p&gt;Arrange a renal ultrasound scan, as abnormalities of the urogenital tract may be associated with this condition. &lt;/p&gt;
&lt;p&gt;Arrange an echocardiogram and cardiology review where indicated, as multiple congenital heart defects including ventricular and atrial septal defects and rhythm disturbances have been decribed in a small subset of patients with Kallmann's syndrome.&lt;/p&gt;
&lt;p&gt;Arrange neurology review in those patients with other neurological sequellae such as epilepsy.&lt;/p&gt;
&lt;p&gt;Treat with standard pubertal induction and long term testosterone replacement therapy as for other causes of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypogonadism/management"&gt;hypogonadism&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Offer life long follow up.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling to all patients diagnosed with this condition. Psychological counselling may also be beneficial in some cases, and other psychological, psychiatric, or learning difficulties should be treated on their own merits.&lt;/p&gt;
&lt;p&gt;Medical treatment is the same as for any other patient presenting with &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypogonadism/management"&gt;hypogonadism&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Follow up should be life long.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Turner syndrome</value></CCondName><CQueMgt><value>Discuss diagnosis, offer counselling 
				</value><value>Likely causative medications or diet identified 
				</value><value>Physiological, pubertal and idiopathic gynaecomastia 
				</value><value>Hyperprolacinaemia detected 
				</value><value>Hypogonadism confirmed 
				</value><value>Kallmann's syndrome 
				</value><value>Klinefelter's syndrome 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/gynaecomastia/</value><value>http://www.endobible.com/condition/gynaecomastia/examination</value><value>http://www.endobible.com/condition/gynaecomastia/investigation</value><value>http://www.endobible.com/condition/gynaecomastia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/gynaecomastia/management</CURLMgt><CURLTop>http://www.endobible.com/condition/gynaecomastia/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Pituitary</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Urgent serum prolactin and urgent 9am cortisol must be assessed immediately in all patients, and hydrocortisone replacement therapy instituted immediately if rapid assessment is not possible.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hormone replacement therapy should be started immediately.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specific education regarding steroid replacement therapy, a steroid instructions card and emergency identification need to be discussed with all patients.&lt;/p&gt;
&lt;p&gt;Cortisone acetate has been largely superseded by the biologically active hydrocortisone for glucocorticoid replacement.&lt;/p&gt;
&lt;p&gt;Typical modern doses of hydrocortisone are 10mg on waking, 5mg approximately five hours after waking, and 5mg approximately 10 hours after waking.&lt;/p&gt;
&lt;p&gt;Doses should then be adjusted according to clinical response, for example if the patient feels very tired at certain times of the day, the previous dose may be increased, or the next dose brought forward. A &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/hydrocortisone-day-curve/"&gt;hydrocortisone day curve&lt;/a&gt; may be useful during the initial period of dose adjustment as in &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/addisons-disease/"&gt;Addison's&lt;/a&gt; disease and post adrenalectomy patients.&lt;/p&gt;
&lt;p&gt;Patients with residual ACTH reserve as indicated by 9am cortisols &amp;gt;250nmol/l, or with a suboptimal response to insulin tolerance test, may require lower 'top-up' doses. Asymptomatic patients with suboptimal reserve may not require daily replacement therapy, though all need thorough education and will need hydrocortisone therapy in the case of intercurrent illness and emergencies.&lt;/p&gt;
&lt;p&gt;If the treatment dose appears to be excessive clinically, a hydrocortisone day curve may be repeated to confirm the safety of dose reduction, although routine repetition of a day curve is unlikely to alter management.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In most patients, a starting dose of 50mcg thyroxine is appropriate, with dose titrated according to serum thyroxine levels taken after approximately six weeks treatment.&lt;/p&gt;
&lt;p&gt;In patients with cardiac disease, and those with profound hypothyroidism, it may be appropriate to start with lower doses or in the presence of unstable cardiac disease with low doses of short acting liothyronine.&lt;/p&gt;
&lt;p&gt;Serum thyroxine should be monitored annually in patients taking stable doses. Dose adjustments should be made according to symptoms, aiming for levels between the median and the upper end of the reference range.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Estrogen deficiency should be treated in most women below 50, particularly those with a low bone mineral density.&lt;/p&gt;
&lt;p&gt;Patches, depot injections, and oral hormone replacement therapy should all be discussed.&lt;/p&gt;
&lt;p&gt;When GH is being considered, it is usual to switch to trans-dermal estrogen as this allows lower doses of GH to be administered to achieve the same serum IGF-I level.&lt;/p&gt;
&lt;p&gt;The presence or absence of a uterus, personal and family history of cardiovascular, cerebrovascular and thromboembolic disease and the desire or not for a withdrawal bleed should all inform treatment choice.&lt;/p&gt;
&lt;p&gt;Treatment is usually continued until the age of the natural menopause approximately 50 years.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Testosterone replacement should be discussed in all patients with profound biochemical deficiency and particularly those with a low bone mineral density.&lt;/p&gt;
&lt;p&gt;Intermittent intra-muscular, topical gel and depot preparations should be discussed in all patients.&lt;/p&gt;
&lt;p&gt;Potential effects on libido and mood must be discussed prior to treatment initiation, particularly in those with long standing and profound biochemical deficiency.&lt;/p&gt;
&lt;p&gt;Testosterone, SHBG, PSA, FBC and LFTs should be assessed annually in all patients to aid dose adjustment in conjunction with symptoms and to detect potential treatment complications.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dynamic testing of GH reserve with either &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;insulin tolerance&lt;/a&gt;, &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;arginine-GHRH&lt;/a&gt; or &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;glucagon&lt;/a&gt; testing is necessary to confirm the need for GH replacement. &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.nice.org.uk/Guidance/TA64"&gt;NICE guidelines&lt;/a&gt; also dictate that GH therapy should only be considered in patients with confirmed pituitary diseaase, and once all other axes of the pituitary have been assessed and treated if necessary. &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.nice.org.uk/nicemedia/pdf/AGHDA_questionnaire.pdf"&gt;AGHDA&lt;/a&gt; or other validated quality of life score should be then be assessed with a minimum score of &amp;gt;11/25 necessary for NICE approval of GH treatment in the UK.&lt;/p&gt;
&lt;p&gt;MRI scan, DEXA bone scan, waist hip ratio, fasting glucose and lipids and IGF-I should all be documented prior to starting treatment. It is also worth considering switching from oral to transdermal estrogen replacement therapy prior to treatment, to reduce GH dose requirements.&lt;/p&gt;
&lt;p&gt;The practicalities of GH replacement therapy should be discussed and the delivery methods demonstrated and then taught to the patient prior to treatment.&lt;/p&gt;
&lt;p&gt;IGF-I levels are initially tested monthly to guide treatment dose with dose adjustment according to symptoms, adverse effects and serum IGF-I level, aiming for a level between the median and the upper limit of the age and gender related reference range.&lt;/p&gt;
&lt;p&gt;IGF-I and AGHDA score should be reassessed after six months to determine whether it is appropriate to continue treatment - a drop of 6 points is deemed an appropriate response according to NICE guidelines.&lt;/p&gt;
&lt;p&gt;Hydrocortisone and thyroxine doses should also be assessed three months after starting GH as serum levels may fall requiring up-titration in a minority of cases.&lt;/p&gt;
&lt;p&gt;Repeat MRI scan after one year of treatment, and then according to multidisciplinary team discussion. Further assessments of serum IGF-I should then be made after six months and then on an annual basis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Symptoms of DI are profound and require treatment immediately whenever this occurs, for example after the initiation of hydrocortisone therapy.&lt;/p&gt;
&lt;p&gt;Emergency &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/diabetes-insipidus/management"&gt;treatment&lt;/a&gt; of DI is with subcutaneous doses of desmopressin (typical dose 1mcg). Urea and electrolytes, and paired urine and serum osmolalities should be performed daily in the acute phase to confirm the need for ongoing treatment, and to prevent over-treatment.&lt;/p&gt;
&lt;p&gt;Long term treatment is usually given as an intranasal spray (typical dose 1 x 10mcg inhalation on retiring). Mild cases may be controlled with oral DDAVP (typical dose 100-300mcg on retiring), and top up oral doses may also be added during the day in those whose symptoms are not fully controlled with once daily treatment.&lt;/p&gt;
&lt;p&gt;In patients with a normal thirst mechanism, treatment aims to relieve nocturia and extreme thirst, while allowing a short period of polyuria and thirst just before a dose to prevent water overload developing, and maintain normal serum biochemistry. However, in patients with hypothalamic damage and loss of thirst, it may be necessary to calculate a fixed oral intake and desmopressin dose.&lt;/p&gt;
&lt;p&gt;Long term monitoring of urea and electrolytes is the usually all that is required according to symptoms. Hyponatraemia indicates excessive replacement, prompting discussion of dose reduction.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Clinical assessment of pituitary status should be performed annually to ensure that new deficiencies are not emerging and to detect clinical under or over-replacement. Blood pressure, weight, waist hip ratio and BMI should also be documented.&lt;/p&gt;
&lt;p&gt;Aggressive treatment of diabetes and cardiovascular risk should be undertaken.&lt;/p&gt;
&lt;p&gt;Bone mineral density should have been assessed at baseline and &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/osteoporosis/management"&gt;treatment &lt;/a&gt;considered accordingly. Repeat DEXA scans may then be considered in some cases.&lt;/p&gt;
&lt;p&gt;The minimum monitoring performed in all hypopituitary patients prior to annual review in our unit includes: full blood count, urea and electrolytes, liver function test, HbA1c, fasting glucose and lipid profile, HbA1c, thyroxine, 9am cortisol (unless on hydrocortisone replacement), IGF-I, LH and FSH. In male patients testosterone, SHBG and PSA are also performed, and in female patients estrodiol may also be checked in patients not already on replacement.&lt;/p&gt;
&lt;p&gt;AGHDA score is also completed in most patients, and MRI scanning is repeated when indicated by previous MDT discussion. &lt;/p&gt;
&lt;p&gt;Dynamic pituitary function is tested every two years in patients who have previously received pituitary irradiation, and who are not currently on replacement therapy, and according to baseline results in other patients.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Prolactinoma and Hyperprolactinaemia</value></CCondName><CQueMgt><value>Hypopituitarism suspected 
				</value><value>Pituitary dysfunction confirmed 
				</value><value>Glucocorticoid replacement therapy must take priority over all other treatments 
				</value><value>Thyroid hormone replacement therapy may then be started 
				</value><value>Female sex hormone replacement therapy 
				</value><value>Male sex hormone replacement therapy 
				</value><value>GH replacement therapy should then be considered 
				</value><value>Desmopressin therapy may be required at any time 
				</value><value>Annual life-long follow up is mandatory 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/diabetes-insipidus/</value><value>http://www.endobible.com/condition/diabetes-insipidus/examination</value><value>http://www.endobible.com/condition/diabetes-insipidus/investigation</value><value>http://www.endobible.com/condition/diabetes-insipidus/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/hypopituitarism/management</CURLMgt><CURLTop>http://www.endobible.com/condition/diabetes-insipidus/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Pituitary</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Start appropriate therapy immediately if &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypopituitarism/management"&gt;hypopituitarism&lt;/a&gt; is confirmed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Arrange dynamic pituitary function testing with &lt;a href="http://www.endobible.com/investigation/insulin-stress-test/" target="_blank"&gt;insulin&lt;/a&gt; or &lt;a href="http://www.endobible.com/investigation/glucagon-test/" target="_blank"&gt;glucago&lt;/a&gt;n stress testing. &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;Arginine-GHRH&lt;/a&gt; testing is an appropriate alternative for GH deficiency if insulin testing is contraindicated. Similarly, &lt;a href="http://www.endobible.com/investigation/synacthen-test/" target="_blank"&gt;Synacthen&lt;/a&gt; testing is also occasionally used in patients with suspected chronic ACTH deficiency if the insulin stress test is contraindicated, though this may be unreliable in patients wtih pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;It is usually possible to differentiate between a NFPA and prolactinoma clinically. However, in certain difficult cases, consider instituting a trial of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hyperprolactinaemia/management"&gt;medical therapy&lt;/a&gt; with close monitoring of visual fields, serum prolactin and MRI appearance. &lt;/p&gt;
&lt;p&gt;Visual fields and MRI appearances should respond rapidly and dramatically in the case of a macroprolacinoma, with a smooth decline in serum prolactin.&lt;/p&gt;
&lt;p&gt;Visual fields and MRI appearance will not change but there may be a massive immediate fall in prolactin with a NFPA since the prolactin emanates from normal not tumourous cells in this case.&lt;/p&gt;
&lt;p&gt;If clinical doubt remains, and vision is threatened, early surgery should be considered.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If clinical features are unusual for example with a suprasellar or peripituitary mass on MRI scan, or with diabetes insipidus, consider other causes. Ensure that serum angiotensin converting enzyme, ESR, auto-antibody screen, alpha feto protein, human choriotropic hormone and chest radiograph have all been assessed before discussing at a multidisciplinary meeting to determine further management.&lt;/p&gt;
&lt;p&gt;Review MRI scan, visual field testing and other results before deciding on conservative management or surgery. Consider urgent surgical referral in all cases with visual field involvement.&lt;/p&gt;
&lt;p&gt;For &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/21474686" target="_blank"&gt;incidental &lt;/a&gt;pituitary lesions, a conservative approach is often appropriate. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All new non functioning pituitary tumours require discussion at a pituitary MDT.&lt;/p&gt;
&lt;p&gt;The presence of a visual field defect mandates the consideration of surgery in all cases. Impingement of the optic chiasm should also prompt consideration of early surgery, although patient factors must be considered, and conservative management with close monitoring of tumour size on serial MRI scan and of visual fields may be suitable in selected cases.&lt;/p&gt;
&lt;p&gt;However, conservative management is frequently suitable for small incidental lesions after discussion. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Repeat MRI at three to six months post-operatively according to multidisciplinary discussion.&lt;/p&gt;
&lt;p&gt;Consider further surgery or radiotherapy if a significant disease remnant is visible on the initial post operative MRI scan, if the histology has particularly concerning features eg a high Ki67 index, or for a growing tumour remnant during serial imaging post surgery.&lt;/p&gt;
&lt;p&gt;There is also some evidence for tumour stablisation with dopamine agonist use. This may be considered in aggressive or growing tumours following conventional treatment with surgery and or radiotherapy, or in patients unfit for surgery.&lt;/p&gt;
&lt;p&gt;Clinical review with repeat assessment of pituitary function (basal +/- dynamic if necessary), visual fields and optimisation of pituitary replacement therapy is necessary at three, six and 12 months post-operatively.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI scans tend to be repeated at three to six months post op, then at one year, then at three years and then at three-yearly intervals if surgical clearance is satisfactory.&lt;/p&gt;
&lt;p&gt;Always repeat MRI scan sooner if there is a clinical indication, for example a new headache, visual field or acuity loss.&lt;/p&gt;
&lt;p&gt;Patients who have responded well to surgery and radiotherapy may not need such regular scanning.&lt;/p&gt;
&lt;p&gt;Repeat basal pituitary function in all patients annually, with alternative year dynamic testing to seek GH and ACTH deficiency in patients who have undergone radiotherapy.&lt;/p&gt;
&lt;p&gt;Ensure thyroxine levels are between the middle and upper end of the reference range.&lt;/p&gt;
&lt;p&gt;Ensure patient is not clinically or biochemically over-replaced with glucocorticoid, and ensure that sex hormone and GH replacement therapy have been considered.&lt;/p&gt;
&lt;p&gt;Monitor and treat cardiovascular risk factors aggressively.&lt;/p&gt;
&lt;p&gt;Monitor and treat new cerebrovascular disease or new tumours.&lt;/p&gt;
&lt;p&gt;Consider repeat surgery, radiosurgery or radiotherapy if regrowth or recurrent tumour detected after initial surgery and radiotherapy. Dopamine agonist therapy may also be considered in this group as there is some evidence of tumour stabilisation, and the treatments are generally well tolerated.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Prolactinoma and Hyperprolactinaemia</value></CCondName><CQueMgt><value>Hormone replacement therapy 
				</value><value>Suspicion of GH or ACTH deficiency, but not proven 
				</value><value>Consider medical treatment for prolactinoma if clinical diagnosis is uncertain 
				</value><value>Review results to confirm diagnosis and determine optimum treatment 
				</value><value> Discuss all new diagnoses at the pituiary MDT 
				</value><value>Further management 
				</value><value>Annual life-long follow up 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/diabetes-insipidus/</value><value>http://www.endobible.com/condition/diabetes-insipidus/examination</value><value>http://www.endobible.com/condition/diabetes-insipidus/investigation</value><value>http://www.endobible.com/condition/diabetes-insipidus/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/non-functioning-pituitary-adenoma/management</CURLMgt><CURLTop>http://www.endobible.com/condition/diabetes-insipidus/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Adrenal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Conn's syndrome highly unlikely&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider investigating for other causes of secondary hypertension if indicated, for example with renal ultrasound scan or CT scan of the aorta for coarctation. Also consider investigating for other causes of hypokalaemia for example renal disease, Bartter's or Gitelman's syndromes.  &lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypertension and hypokalaemia may also be present in &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-disease/"&gt;Cushing's&lt;/a&gt; syndrome. If this is suspected on thorough history and examination, proceed to low dose &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/dexamethasone-suppression-test/"&gt;dexamethasone suppression testing&lt;/a&gt; and urinary free cortisol estimations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Ensure thorough medication history is documented. Advise patient and GP that they need to switch medications before tests can be performed&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Angiotensin converting enzyme inhibitors prevent angiotensin production, and angiotensin 2 receptor blockers prevent its action, such that both classes of drug may lead to falsely low ratios (increased renin and decreased aldosterone).&lt;/p&gt;
&lt;p&gt;Spironolactone and other aldosterone antagonists prevent its action and so potentially increase the ratio (by increasing aldosterone).&lt;/p&gt;
&lt;p&gt;Beta blockers prevent renin release and also lead to unreliably elevated ratios.&lt;/p&gt;
&lt;p&gt;Diuretics potentially reduce fluid delivery to renal tubules. This leads to increased renin production and so increased renin and aldosterone. This also makes interpretation of renin:aldosterone ratios difficult.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Stop angiotensin converting enzyme inhibitors, angiotensin 2 receptor blockers and spironolactone or eplerenone for at least four weeks, and beta blockers and any other diuretics for at least two weeks before proceeding with further investigations&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients may well need to start alternative agents to maintain safe blood pressure control. This requires careful involvement of the GP and patient in arranging safe BP and serum potassium monitoring before planning investigations.&lt;/p&gt;
&lt;p&gt;Although calcium channel blockers may also interfere with the renin-angiotensin-aldosterone pathway, in practise this is not clinically apparent. Alpha blockers such doxazosin and calcium channel blockers such as amlodipine are thus routinely recommended for blood pressure control during investigation of possible Conn's syndrome.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Check serum potassium one week prior to investigation&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Severe, uncorrected hypokalaemia may reduce aldosterone secretion.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Advise patients to follow a normal not low salt diet&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If patients habitually follow a low salt diet this may also lead to a fall in aldosterone levels.&lt;/p&gt;
&lt;p&gt;If clinically suspected, or in the case of borderline results, this can be prevented by giving NaCl 120mmol/24-hours orally for three days prior to further tests, or by suggesting the patient eats a high salt diet for three days, for example eating a shop bought pizza the day before any tests.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Repeat recumbent renin and aldosterone off all interfering medications and with a normal serum potassium&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;The &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/recumbent-renin-and-aldosterone/"&gt;protocol&lt;/a&gt; for this test usually requires the patient to lie recumbent and resting for 30 minutes, but can be taken at any time of day.&lt;/p&gt;
&lt;p&gt;Historically, renin and aldosterone assessments were repeated at various times of the day, with synchronous cortisol and ACTH measurements, and with or without prior ambulation or rest, to attempt to distinguish degrees of ACTH responsiveness. This was performed in an attempt to determine whether hyperaldosteronism was secondary to unilateral adenoma or bilateral hyperplasia.&lt;/p&gt;
&lt;p&gt;However, these are no longer performed in most centres as they are difficult to interpret, non specific and since adrenal imaging and selective venous catheterisation have improved and become more widely available.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Interpreting results&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;International &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://jcem.endojournals.org/cgi/reprint/93/9/3266"&gt;guidelines&lt;/a&gt; exist to aid in the diagnosis of Conn's syndrome.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Aldosterone/renin ratio:&lt;/strong&gt;&lt;/p&gt;
&lt;table border="1" cellspacing="1" cellpadding="1" width="273" style="width: 273px; height: 78px"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&amp;gt;2,000&lt;/td&gt;
            &lt;td&gt;Almost certainly Conn's&lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;800-2,000&lt;/td&gt;
            &lt;td&gt;Possibly Conn's, investigate further&lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;lt;800&lt;/td&gt;
            &lt;td&gt;Excludes Conn's&lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;strong&gt;Plasma renin: &lt;/strong&gt;typically &amp;lt;0.3 pmol/ml/hr (normal range 0.5-3.1)&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Aldosterone: &lt;/strong&gt;typically &amp;gt;350 pmol/l (normal range 100-800)&lt;/p&gt;
&lt;p&gt;If the ratio is normal, and clinical suspicion is low, the patient may resume their normal medications,  and usually be discharged from endocrine follow up to consider alternative diagnoses.&lt;/p&gt;
&lt;p&gt;If results are normal or borderline, but a high degree of clinical suspicion of Conn’s syndrome remains, consider salt loading and repeating the test. Salt loading is usually with 120mmol/day (slow sodium tablets) for 72 hours. Alternatively, ask the patient to eat a high salt diet, for example a shop bought pizza the day before the test.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Ratio elevated but patient is not a surgical candidate&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the patient is unfit for, or declines surgery, consider starting spironolactone. Imaging and selective venous sampling are unnecessary in these patients. Typical starting dose is 50mg which will often result in a dramatic improvement in BP control and allow downtitration or cessation of other medications. If BP remains elevated, increase spironolactone to maximum tolerated dose: typically 150-200mg daily. Good BP and serum potassium control will often be achieved with this as a single agent, though careful BP and serum potassium monitoring is mandatory.&lt;/p&gt;
&lt;p&gt;Male patients should be warned that they may experience troublesome mastalgia, gynaecomastia or erectile dysfunction. In this case, the dose of spironolactone should be reduced to that tolerated. A combination of low dose spironolactone with a potassium sparing diuretic for example amiloride will often control both the BP and hypokalaemia. Standard anihypertensives can also be added if the BP remains resistant.&lt;/p&gt;
&lt;p&gt;The newer aldosterone antagonist eplerenone can also be used in patients with troublesome side effects on spironolactone, though seems less effective in clinical practise. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Ratio elevated and patient suitable for surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the biochemistry is consistent with Conn's syndrome and the patient potentially suitable for surgery: proceed to CT scan of the adrenals and discuss selective venous sampling.&lt;/p&gt;
&lt;p&gt;Spironolactone may be started at this stage and may acheive rapid control of hypertension and hypokalaemia. This therapeutic trial tends to predict a good surgical outcome, though some patients may choose to remain on long term medical therapy. Spironolactone will need to be withdrawn four weeks prior to selective venous sampling if applicable.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Unilateral adenoma clearly visible in a patient under 50&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Review CT scans at a multidisciplinary meeting. In patients under 50, if a unilateral adenoma is clearly visible with a normal contralateral gland, then unilateral disease is highly likely. Surgical referral can be considered with no further investigations. If imaging is not definitive, proceed to adrenal venous sampling in all patients.&lt;/p&gt;
&lt;p&gt;In patients over 50, adrenal venous sampling should be considered in all patients and the results of the CT interpreted with caution since incidental adrenal adenomas are a common finding on imaging this group. Without definite evidence that aldosterone hypersecretion is unilateral, a patient could undergo surgery to remove a benign incidental adenoma, but still have aldosterone excess from the apparently normal looking contralateral hyperplastic gland.&lt;span&gt;   &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider selective venous sampling in all other patients&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Selective venous sampling of both adrenal veins is mandatory in patients over 50 and those with ambiguous imaging results. Cannulation of the right adrenal vein can be technically difficult. Interpretation may be improved in such cases by administering synacthen at the time of cannulation. &lt;/p&gt;
&lt;p&gt;Unilateral disease is typified by an aldosterone:cortisol ratio in the affected gland &amp;gt;4:1. The ratio should also be greater than that in the contralateral adrenal gland, and greater than that in the inferior vena cava. All other results should be considered ambiguous and consistent with bilateral disease. These patients should not be considered for surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Refer for adrenalectomy for unilateral disease&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is expected to be curative, or at least dramatically improve the control of hypertension and hypokalaemia leading to withdrawal of multiple medications. A successful trial of spironolactone also helps predict a good response to surgery in patients with unilateral disease.&lt;/p&gt;
&lt;p&gt;Unilateral adrenalectomy is usually performed by a laparascopic approach. Prophylactic vaccination may be given in patients requiring left sided surgery in case splenectomy is necessary.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Bilateral disease confirmed on sampling: start spironolactone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If the patient is unfit for, or declines surgery, consider starting spironolactone. Imaging and selective venous sampling are unnecessary in these patients. Typical starting dose is 50mg which will often result in a dramatic improvement in BP control and allow downtitration or cessation of other medications. If BP remains elevated, increase spironolactone to maximum tolerated dose: typically 150-200mg daily. Good BP and serum potassium control will often be achieved with this as a single agent, though careful BP and serum potassium monitoring is mandatory.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Male patients should be warned that they may experience troublesome mastalgia, gynaecomastia or erectile dysfunction. In this case, the dose of spironolactone should be reduced to that tolerated. A combination of low dose spironolactone with a potassium sparing diuretic for example amiloride will often control both the BP and hypokalaemia. Standard anihypertensives can also be added if the BP remains resistant. &lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 17px; "&gt;The newer aldosterone antagonist eplerenone can also be used in patients with troublesome side effects on spironolactone, though seems less effective in clinical practise. &lt;/span&gt;&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Once good control of BP and serum potassium are achieved, consider discharging patient to care of the GP for long term follow up.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Von Hippel Lindau</value></CCondName><CQueMgt><value>Aldosterone:renin ratio below 800 
				</value><value>Clinical evaluation more suggestive of Cushing's 
				</value><value>Clinical and biochemical suspicion of Conn's persists 
				</value><value>Clinical and biochemical diagnosis of Conn's confirmed 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/addisons-disease/</value><value>http://www.endobible.com/condition/addisons-disease/examination</value><value>http://www.endobible.com/condition/addisons-disease/investigation</value><value>http://www.endobible.com/condition/addisons-disease/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/conns-syndrome/management</CURLMgt><CURLTop>http://www.endobible.com/condition/addisons-disease/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Adrenal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Arrange for all imaging and biochemical results to be reviewed by a multidisciplinary team, to ensure that all relevant investigations have been conducted, and to determine future management.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Immediate alpha blockade should be started in all patients suspected of having a phaeochromocytoma on imaging criteria.&lt;/p&gt;
&lt;p&gt;MIBG scanning, urine and serum metanephrines should then be arranged to confirm or refute the diagnosis and further &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/phaeochromocytoma/management"&gt;management&lt;/a&gt; determined according to those results.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Imaging characteristics&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Benign features include small size, an attenuation coefficient Hounsfield unit (HU) value &amp;lt;10, rapid washout of enhancement of lesions with HU&amp;gt;10, smooth outline, homogeneous with no calcification within the lesion.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Functional status&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;All patients with an adrenal lesion require functional assessment as a non functioning small and benign appearing lesion may not require any further investigation or treatment. Adrenocortical adenomas can be clinically non functioning, or cause biochemical or subclinical Cushing’s or Conn’s syndrome. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Patients should be fully assessed for Conn's syndrome&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Renin:aldosterone ratios should be assessed at baseline. If the ratio is suggestive of &lt;a href="http://www.endobible.com/condition/conns-syndrome/investigation" target="_blank"&gt;Conn's&lt;/a&gt;, this will need to be confirmed by taking the patient off interfering medication and with selective venous sampling in many cases.&lt;/p&gt;
&lt;p&gt;Spironolactone should then be considered as should surgical treatment.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Patients should be fully assessed for possible Cushing's syndrome&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;2x24hr urinary free cortisol measurements, low dose dexamethasone suppression testing and serum ACTH levels should be taken in the first instance.&lt;/p&gt;
&lt;p&gt;Further investigation and management of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-syndrome/investigation"&gt;Cushing’s syndrome&lt;/a&gt; should then be discussed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Non functioning lesions&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Small lesions with clearly benign characteristics, &amp;lt;3cm in size and with HU &amp;lt;10, should be discussed at a multidisciplinary meeting, and may be appropriately managed conservatively according to latest &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.aace.com/pub/pdf/guidelines/AdrenalGuidelines.pdf"&gt;guidelines&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Annual biochemical assessment may be recommended but repeated imaging may not be necessary.&lt;/p&gt;
&lt;p&gt;Repeat imaging should be considered and discussed by the multidisciplinary team for lesions &amp;gt;3cm.&lt;/p&gt;
&lt;p&gt;Other lesions may have suspicious characteristics, for example those &amp;gt;5cm, with heterogeneous appearances, high Hounsfield unit values, low washout, calcification, or evidence suggestive of haemorrhage or infarction, and are best managed surgically as for possible malignancy.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Possible malignant features on imaging&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Suspicious characteristics include size &amp;gt;5cm, heterogeneous appearances, high Hounsfield unit values, low washout, calcification, or evidence suggestive of haemorrhage or infarction. These lesions are invariably best treated surgically. Full biochemical assessment should still be performed prior to surgery in these cases as functioning lesions require specific pre operative preparation.&lt;/p&gt;
&lt;p&gt;Adrenocortical carcinoma may frequently secrete androgens or glucocorticoids, and phaeochromocytomas may be hard to distinguish from malignant adrenal masses. Arrange urine metanephrines, urinary free cortisol, adrenal androgen profile, low dose dexamethasone testing, and random renin:aldosterone ratio in the first instance in all cases.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider adrenal biopsy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If it is uncertain whether an adrenal mass represents a metastasis of a known primary on imaging grounds, needle biopsy is helpful. This must never be performed until phaeochromocytoma has been ruled out biochemically.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Surgery should then be considered in all cases and discussed at a multidisciplinary meeting. Functionality should not alter the decision on whether surgery is appropriate, but will determine the pre operative preparation required.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Adrenal Cushing's syndrome, Conn's syndrome and phaeochromocytoma&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These should all be managed and followed up in the usual way.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Adrenal cancer&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should be managed according to the multidisciplinary team: generally with surgery and mitotane in the first instance and further surgery and chemotherapy as indicated.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Non functioning, true incidentalomas&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Recent &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.aace.com/pub/pdf/guidelines/AdrenalGuidelines.pdf"&gt;guidelines&lt;/a&gt; indicate that small, benign, non functioning adenomas may be managed conservatively with annual biochemical follow up and repeat imaging at six to 12 months, as appropriate and as determined by a multidisciplinary team discussion.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Von Hippel Lindau</value></CCondName><CQueMgt><value>Discuss results at a multidisciplinary meeting 
				</value><value>Possible phaeochromocytoma 
				</value><value>Benign imaging characteristics 
				</value><value>Suspicious imaging characteristics 
				</value><value>Follow up arrangements 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/addisons-disease/</value><value>http://www.endobible.com/condition/addisons-disease/examination</value><value>http://www.endobible.com/condition/addisons-disease/investigation</value><value>http://www.endobible.com/condition/addisons-disease/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/adrenal-incidentalomas/management</CURLMgt><CURLTop>http://www.endobible.com/condition/addisons-disease/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Adrenal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Ensure full investigation has been performed at baseline&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should include the following in all patients with a phaeochromocytoma: thorough family history and documented family tree; 1x plasma metanephrine; chest radiograph; CT adrenals; MIBG scan and baseline pituitary function. Further cross sectional imaging will depend on results of MIBG scan, and on which gene defect is present: SDHB, SDHC or SDHD mutations.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Explain results and treatment options&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients need to understand their diagnosis and the importance of adhering to medical treatment.&lt;/p&gt;
&lt;p&gt;This is particularly important because the medication may not be well tolerated, but non compliance can have fatal consequences.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate medical treatment with alpha blockade&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Usual treatment starts with phenoxybenzamine. This may be started at a low dose eg 10mg daily, and should be gradually uptitrated to a usual maximum of 40-60mg in divided doses daily. Close BP monitoring is required and patients must be advised to keep up a high fluid intake.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;This may have unpleasant side effects, for example dizziness, malaise and swollen ankles.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Doxazosin, usually in a sustained release preparation, may be used if phenoxybenzamine is unavailable or not tolerated. Dose should be titrated to the maximum tolerated.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Once a date is set for surgery, the dose of phenoxybenzamine should be uptitrated further until the patient develops significant hypotension and nasal congestion. This may require hospital admission, intravenous fluids or even blood transfusion for haemodilution and postural hypotension.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Add beta blockade for symptomatic tachycardia&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Once a patient is fully alpha blocked, typically after about several weeks in an out patient setting, initiate beta blockade, for example with propranolol if they develop significant and symptomatic tachycardia.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;This is not always necessary and must only be given after the patient is fully alpha blocked. Close BP monitoring is again required and the dose should be increased to the maximum tolerated or 240mg in divided doses.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Arrange surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ideally patients will have been fully alpha and beta blocked over a period of at least six weeks prior to surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Peri-operative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Ideally, patients should be admitted preoperatively for intravenous alpha blockade prior to surgery.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If the patient is already on full oral treatment, administer intravenous phenoxybenzamine over three days prior to surgery.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Monitor postural blood pressure and haemoglobin over successive days.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Patients frequently require intravenous fluid support for dramatic falls in blood pressure. Full blood count should be checked daily, as a dramatic fall in haemoglobin may occur, which should be treated with pre operative blood transfusions if necessary. This occurs due to haemodilution as the vascular bed dilates and the intravascular volume expands. This preparation should prevent dramatic changes in blood pressure peri operatively, although an anaesthetist experienced in this procedure is essential.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If iv phenoxybenzamine is unavailable, the patient will require uptitration of their oral phenoxybenzamine in the week prior to surgery. This may also require admission and the dose should be increased by 10mg every 24hours until significant hypotension and nasal stuffiness occur. Patients may require intravenous fluid support as above, and ALL patients should start on iv fluids overnight before planned surgery to minimise the chance of significant perioperative hypotension.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Emergency management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;In the acutely unwell patient, or one presenting with a crisis, the first priority should be fluid resuscitation. This should prevent a catastrophic fall in blood pressure occurring when alpha blockade is initiated.&lt;/p&gt;
&lt;p&gt;Beta blockade is added only after the patient appears to be fully alpha blocked, which may take several days.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Post operative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;All medication may be stopped routinely. Blood pressure should be closely monitored. Arrange for urinary metanephrines to be repeated at six to 12 weeks.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Post operative follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Reasssess symptoms, blood pressure and metanephrines approximately three months post operatively.&lt;/p&gt;
&lt;p&gt;Review and discuss the histological findings, malignant or benign, and arrange oncology multidisciplinary review for future management. Further screening and follow up depends on the genetic diagnosis.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Counselling and screening of both patients and their family members must be discussed.&lt;/p&gt;
&lt;p&gt;No agreed international guidelines have been agreed for the follow up of SDH mutation carriers. However, phaeochromocytoma and extra-adrenal paragangliomas have been reported in SDHB, SDHC and SDHD carriers. Thyroid tumours have also been reported in SDHB and SDHD mutation carriers. Renal and gastrointestinal stromal tumours have also been described with SDHB, and there is a much higher association with malignant disease with SDHB. &lt;/p&gt;
&lt;p&gt;The frequency of clinical, biochemical and imaging follow ups suggested below is from the author's clinical experience only, and may well change with further research.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All family members should be screened and followed up in the same way as patients until proved to be non carriers of the mutation.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;At diagnosis or gene confirmation, imaging of the abdomen, neck and thorax should be arranged.&lt;/p&gt;
&lt;p&gt;MRI scanning is usually preferred to CT in patients requiring multiple surveillance images, since this does not expose the patient to ionising radiation.&lt;/p&gt;
&lt;p&gt;Ultrasound may be preferred for initial imaging of the neck.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Annual follow up must include a review of symptoms, blood pressure and family history.&lt;/p&gt;
&lt;p&gt;Annual follow up should also include: full blood count, urea and electrolytes, liver function test, 2x24hr urine metanephrines and urine microscopy. Imaging of the entire abdomen should be performed using CT or MRI every year.&lt;/p&gt;
&lt;p&gt;Imaging of the neck and thorax should be considered every three years.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Carotid ultrasound scanning should be performed at baseline as well as imaging the adrenals and abdomen using CT or MRI in all gene carriers as well as confirmed patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Annual follow up must include a review of symptoms, blood pressure and family history.&lt;/p&gt;
&lt;p&gt;Annual follow up should also include full blood count, urea and electrolytes, liver function test, and 2x24hr urine metanephrines. &lt;/p&gt;
&lt;p&gt;Consider repeat imaging of the adrenals, abdomen and neck every three to five years.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Genetic counselling and screening of family members must also be discussed, although carriers of mutations in this gene tend to present with a solitary tumour.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Carotid ultrasound scanning should be performed at baseline as well as imaging the adrenals and abdomen using CT or MRI in all gene carriers as well as confirmed patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Annual follow up must include a review of symptoms, blood pressure and family history.&lt;/p&gt;
&lt;p&gt;Annual follow up should also include full blood count, urea and electrolytes, liver function test and 2x24hr urine metanephrines.  &lt;/p&gt;
&lt;p&gt;Consider repeat imaging only if clinically indicated as this syndrome is not well characterised and tends to present with a single mass only.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Von Hippel Lindau</value></CCondName><CQueMgt><value>Urine metanephrine strongly positive or plasma metanephrine positive 
				</value><value>Genetic counselling and further screening 
				</value><value>Family members 
				</value><value>Baseline imaging at diagnosis of SDHB mutation 
				</value><value>Annual follow up of SDHB 
				</value><value>Baseline imaging at diagnosis of SDHD mutation 
				</value><value>Annual follow up of SDHD 
				</value><value>Genetic counselling and screening for SDHC mutation 
				</value><value>Baseline imaging of SDHC 
				</value><value>Annual follow up of SDHC 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/addisons-disease/</value><value>http://www.endobible.com/condition/addisons-disease/examination</value><value>http://www.endobible.com/condition/addisons-disease/investigation</value><value>http://www.endobible.com/condition/addisons-disease/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/succinate-dehydrogenase-mutations/management</CURLMgt><CURLTop>http://www.endobible.com/condition/addisons-disease/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Adrenal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Reassure no sign of phaeochromocytoma and discharge&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Other diagnoses that may be considered include thyrotoxicosis for generalised anxiety, menopause for flushing and sweating attacks, spontaneous hypoglycaemia for fasting associated attacks, carcinoid syndrome for episodic flushing and diarrhoea. &lt;/p&gt;
&lt;p&gt;Alternative diagnoses such as anxiety and agitated depression, or cardiac arrythmia, should also be considered and appropriate referral for further investigation considered.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thorough clinical assessment is necessary looking particularly for sleep apnoea or depression&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Both of these may cause chronic increases in catecholamine release and lead to false positive screening tests, though results are unlikely to be &amp;gt;3x the upper limit of normal.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Check drug history thoroughly including depot psychotropics&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Many drugs, particularly psychotropic agents which interfere with serotonin and catecholamine uptake or metabolism, may cause false positive screening.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Check plasma metanephrines&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the clinical picture is unclear, or is consistent with a phaeochromocytomaormal, proceed to check plasma metanephrines. Most &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://cat.inist.fr/?aModele=afficheN&amp;amp;cpsidt=18131566"&gt;experts agree&lt;/a&gt; that normal plasma levels should be considered reassuring and allow reassurance and discharge in most cases, since the test is highly &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://acb.rsmjournals.com/cgi/content/abstract/45/1/6"&gt;sensitive and specific&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;If the clinical picture is not convincing and OSA is likely, arrange investigation and treatment prior to repeating investigations.&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This may take some months, but catecholamine release should fall and normalise after treatment of OSA.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt; Clonidine suppression test&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;&lt;a href="http://www.endobible.com/investigation/clonidine-suppression-test/" target="_blank" style="color: rgb(236, 0, 140); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt;Clonidine testing&lt;/a&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt; is occassionally useful in cases where there is hypertension and modest elevations of urine metanephrines (&amp;lt;4xULN). These grey cases can usually be resolved by taking a careful medication history, seeking evidence of sleep apnoea or by checking serum metanephrines as a normal result will effectively exclude a phaeochromocytoma. If no cause has been found, the clonidine test may be useful though it is expensive, timely and poorly tolerated by most patients. Clonidine acts via the alpha preganglionic receptors and should reduce catecholamine secretion. This test confirms the absence of phaeochromocytoma if noradrenaline levels suppress to normal and less than 50% basal, and metanephrines have fallen by greater than 40% or to within the normal range.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Discuss with a biochemist.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Ensure full investigation has been performed at baseline&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should include the following in all patients: thorough family history and documented family tree; 1x plasma metanephrine; chest radiograph; CT adrenals; MIBG scan; baseline pituitary function; fasting gut hormones; calcitonin; and, further cross sectional imaging depending on results of MIBG scan.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Explain results and treatment options&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients need to understand their diagnosis and the importance of adhering to medical treatment.&lt;/p&gt;
&lt;p&gt;This is particularly important because the medication may not be well tolerated, but non compliance can have fatal consequences.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate medical treatment with alpha blockade&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Usual treatment starts with phenoxybenzamine. This may be started at a low dose eg 10mg daily, and should be gradually uptitrated to a usual maximum of 40-60mg in divided doses daily. Close BP monitoring is required and patients must be advised to keep up a high fluid intake.&lt;/p&gt;
&lt;p&gt;This may have unpleasant side effects, for example dizziness, malaise and swollen ankles.&lt;/p&gt;
&lt;p&gt;Doxazosin, usually in a sustained release preparation, may be used if phenoxybenzamine is unavailable or not tolerated. Dose should be titrated to the maximum tolerated.&lt;/p&gt;
&lt;p&gt;Once a date is set for surgery, the dose of phenoxybenzamine should be uptitrated further until the patient develops significant hypotension and nasal congestion. This may require hospital admission, intravenous fluids or even blood transfusion for haemodilution and postural hypotension.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Add beta blockade for symptomatic tachycardia&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Once a patient is fully alpha blocked, typically after about several weeks in an out patient setting, initiate beta blockade, for example with propranolol if they develop significant and symptomatic tachycardia.&lt;/p&gt;
&lt;p&gt;This is not always necessary and must only be given after the patient is fully alpha blocked. Close BP monitoring is again required and the dose should be increased to the maximum tolerated or 240mg in divided doses.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Arrange surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ideally patients will have been fully alpha and beta blocked over a period of at least six weeks prior to surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Peri operative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ideally, patients should be admitted preoperatively for intravenous alpha blockade prior to surgery.&lt;/p&gt;
&lt;p&gt;If the patient is already on full oral treatment, administer intravenous phenoxybenzamine over three days prior to surgery.&lt;/p&gt;
&lt;p&gt;Monitor postural blood pressure and haemoglobin over successive days.&lt;/p&gt;
&lt;p&gt;Patients frequently require intravenous fluid support for dramatic falls in blood pressure. Full blood count should be checked daily, as a dramatic fall in haemoglobin may occur, which should be treated with pre operative blood transfusions if necessary. This occurs due to haemodilution as the vascular bed dilates and the intravascular volume expands. This preparation should prevent dramatic changes in blood pressure peri operatively, although an anaesthetist experienced in this procedure is essential.&lt;/p&gt;
&lt;p&gt;If iv phenoxybenzamine is unavailable, the patient will require uptitration of their oral phenoxybenzamine in the week prior to surgery. This may also require admission and the dose should be increased by 10mg every 24hours until significant hypotension and nasal stuffiness occur. Patients may require intravenous fluid support as above, and ALL patients should start on iv fluids overnight before planned surgery to minimise the chance of significant perioperative hypotension.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Emergency management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;In the acutely unwell patient, or one presenting with a crisis, the first priority should be fluid resuscitation. This should prevent a catastrophic fall in blood pressure occurring when alpha blockade is initiated.&lt;/p&gt;
&lt;p&gt;Beta blockade is added only after the patient appears to be fully alpha blocked which may take several days.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Post operative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;All medication may be stopped routinely.&lt;/p&gt;
&lt;p&gt;Blood pressure should be closely monitored.&lt;/p&gt;
&lt;p&gt;Arrange for urinary metanephrines to be repeated at six to 12 weeks.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Reasssess symptoms, blood pressure and metanephrines approximately three months post operatively.&lt;/p&gt;
&lt;p&gt;Review and discuss the histological findings: malignant or benign.&lt;/p&gt;
&lt;p&gt;Arrange oncology multidisciplinary review for future management of malignant disease. This may include resumption of alpha and beta blockade, MIBG therapy, chemotherapy or repeat surgery.&lt;/p&gt;
&lt;p&gt;Discuss genetic testing, family screening and future surveillance imaging where a syndrome is suspected, for example in the presence of other suggestive features, extra-adrenal disease or phaeochromocytomas occurring at a young age (&amp;lt;45 years).&lt;/p&gt;
&lt;p&gt;For benign disease apparently cured by surgery, long term follow up is still required.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Annual follow up must include a review of symptoms, blood pressure, family history and 2x24hr urinary collections for metanephrines in all patients with a history of phaeochromocytoma&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Further investigations are required in patients with familial syndromes.&lt;/p&gt;
&lt;p&gt;Imaging should only be repeated where clinically indicated by a rise in metanephrines, symptom recurrence or if indicated in the presence of a familial syndrome.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Von Hippel Lindau</value></CCondName><CQueMgt><value>Urine metanephrines negative 
				</value><value>Urine metanephrines borderline/positive (&amp;lt;3x upper limit of normal) 
				</value><value>Doubts persist, for example about interfering medications 
				</value><value>Urine metanephrine strongly positive or plasma metanephrine positive 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/addisons-disease/</value><value>http://www.endobible.com/condition/addisons-disease/examination</value><value>http://www.endobible.com/condition/addisons-disease/investigation</value><value>http://www.endobible.com/condition/addisons-disease/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/phaeochromocytoma/management</CURLMgt><CURLTop>http://www.endobible.com/condition/addisons-disease/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Adrenal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;If all screening investigations are negative, including a synacthen test, the patient should be reassured and discharged to their primary physician.&lt;/p&gt;
&lt;p&gt;Diagnoses such as depression or chronic fatigue syndrome may be considered.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Take blood for a random cortisol and start emergency treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hydrocortisone 100mg should be given by intramuscular injection and continued every six hours until the patient has responded.&lt;/p&gt;
&lt;p&gt;Intravenous fluid resuscitation, typically with 0.9% sodium chloride, should be initiated until the patient has responded.&lt;/p&gt;
&lt;p&gt;If clinical suspicion is modest and the patient is not acutely unwell await results of 9am cortisol or synacthen test before starting treatment. A 9am or random cortisol above 500nmol/l is sufficient to exclude the diagnosis.&lt;/p&gt;
&lt;p&gt;Borderline results should be interpreted in the light of clinical findings and usually require a formal synacthen test prior to treating or reassuring the patient. Ensure thyroid function, blood count and electrolytes have all been assessed at this stage.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Start replacement therapy. Emergency intramuscular treatment is not usually required at diagnosis.&lt;/p&gt;
&lt;p&gt;Patients with severe symptoms should be treated with higher starting doses, for example 20mg on waking, and again five and ten hours later. Once clinical improvement occurs, revert to standard replacement therapy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Typical maintenance doses are hydrocortisone 10mg on waking, 5mg at lunchtime, 5mg with the evening meal, or at 0, five and ten hours after waking.&lt;/p&gt;
&lt;p&gt;Replacement doses of hydrocortisone do not need to be taken with food, and so should be taken as soon as possible after waking to prevent symptoms of insufficiency, for example dizziness on rising.&lt;/p&gt;
&lt;p&gt;The final dose should be taken at least four hours before retiring, or it may interfere with sleep.&lt;/p&gt;
&lt;p&gt;Some patients prefer to take just two doses a day which are typically taken on waking and after approximately eight hours. Such a regime frequently requires larger doses to control symptoms throughout the day, which may have adverse long term consequences.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Typical maintenance dose of fludrocortisone is 100mcg in one or two divided doses.&lt;/p&gt;
&lt;p&gt;Fludrocortisone is required in all patients on modern low dose glucocorticoid replacement therapy. It is not necessary to start in the acute phase since very high serum cortisol levels will access renal mineralocorticoid receptors.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Adrenal suppression due to long term steroid use may be difficult to manage. Where possible, the causative agents should be slowly withdrawn under supervision. However, as the dose is reduced it is important to assess for axis recovery, usually with a 9am cortisol. If this is below 100nmol/l the axis clearly remains suppressed. Patients with levels between 100-500nmol/l  should undergo a synacthen test to confirm whether they are safe to continue weaning off treatment.&lt;/p&gt;
&lt;p&gt;Where there is evidence of on going adrenal suppression, low dose hydrocortisone (10mg, 5mg and 5mg) may be started, to protect the patient from hypoadrenalism while the causative drug is reduced and stopped. Pre dose cortisol and ACTH levels may then be assessed periodically to assess for axis recovery before considering reducing the dose of hydrocortisone. Once the axis appears normal, hydrocortisone or the causative drug can both be stopped safely.&lt;/p&gt;
&lt;p&gt;Complications of Cushing's syndrome for example osteoporosis, hypertension, skin damage and glucose intolerance may all occur with long term exogenous steroid use. These patients therefore require aggressive screening and treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients on glucocorticoid replacement therapy need to understand the importance of absolute compliance with their regime and be educated as to what to do in emergencies and during intercurrent illnesses. A formal education session with an endocrine nurse is ideal as soon as possible after diagnosis. Written information should be provided, and patients and their families should be taught how to administer intramuscular hydrocortisone, and how to recognise when this is necessary. All patients should be offered a steroid identification card, and other forms of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.medicalert.org/"&gt;emergency identification&lt;/a&gt; should be discussed.&lt;/p&gt;
&lt;p&gt;The &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.addisons.org.uk/info/emergency/page1.html"&gt;Addison's disease self help group&lt;/a&gt; has produced excellent advice sheets on long term steroid use, emergency identification, and instructions on what to do in emergency situations.&lt;/p&gt;
&lt;p&gt;Patients should be offered a further education session six to 12 weeks after diagnosis to ensure good understanding. Future education updates should then be offered regularly and life long, for example at alternate year visits.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients newly diagnosed with Addison’s will need early clinical review which may be appropriately performed by an endocrine specialist nurse, or general practitioner. They should then be reviewed by an endocrinologist at around six weeks.&lt;/p&gt;
&lt;p&gt;Check symptoms, postural blood pressure and serum electrolytes.&lt;/p&gt;
&lt;p&gt;Consider performing a hydrocortisone day curve with renin assessments pre and 120 minutes post dose. This is useful if there is any doubt about dose titration, for example if the patient is taking a relatively large dose on waking but still feels symptomatic prior to the next dose.&lt;/p&gt;
&lt;p&gt;It is useful to document a hydrocortisone day curve on at least one occasion in most patients, once they are taking what appears to be an appropriate dose, in order to confirm this as their life long regime.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Check symptoms, weight and postural blood pressure annually. Serum electrolytes should also be checked at least annually prior to clinic. TSH and thyroxine should be checked at least every other year, or annually in patients with positive thyroid autoantibodies.&lt;/p&gt;
&lt;p&gt;Ensure that the patient's steroid card, emergency instructions, and emergency medical identification are all up to date.&lt;/p&gt;
&lt;p&gt;Routine repetition of hydrocortisone day curves and plasma renin activity are not usually required.&lt;/p&gt;
&lt;p&gt;It may be appropriate to alternate annual visits between endocrinologist and endocrine specialist nurse where available.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pregnant patients with Addison's disease require particular care. Patients need to be reminded to take an additional oral dose of hydrocortisone if they have vomited. They also need ready access to emergency im hydrocortisone to be taken in the event of severe vomiting. Close monitoring of symptoms, blood pressure (including postural BP) and electrolyte estimation is useful to help determine whether an increase in the dose of mineralocorticoid or glucocorticoid is necessary. This is commonly required later in pregnancy, with dose requirements returning to normal post partum.&lt;/p&gt;
&lt;p&gt;100mg hydrocortisone should be given im at the start of labour, and repeated every 6 hours until the baby has delivered. Patients can usually revert to their pre pregnancy dose following delivery, but may require double dose for 24 to 48 hours depending on their clinical status. &lt;/p&gt;
&lt;p&gt;During breast feeding and the early post partum weeks, patients may require advice on changing the timing of their glucocorticoid therapy in view of frequent night waking. However, total daily dose does not typcially need to be increased during this period. &lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Von Hippel Lindau</value></CCondName><CQueMgt><value>Investigations normal, and no alarm symptoms for malignancy 
				</value><value>Clinical suspicion is high and the patient is unwell 
				</value><value>Emergency treatment 
				</value><value>Addison's disease is confirmed on synacthen test 
				</value><value>Standard glucocorticoid replacement therapy 
				</value><value>Standard mineralocorticoid replacement therapy 
				</value><value>Adrenal suppression due to medication use 
				</value><value>Education on long term steroid use 
				</value><value>Arrange clinical review within six weeks 
				</value><value>Annual life long follow up 
				</value><value>Pregnancy, delivery and breast feeding 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/addisons-disease/</value><value>http://www.endobible.com/condition/addisons-disease/examination</value><value>http://www.endobible.com/condition/addisons-disease/investigation</value><value>http://www.endobible.com/condition/addisons-disease/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/addisons-disease/management</CURLMgt><CURLTop>http://www.endobible.com/condition/addisons-disease/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Adrenal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If the history and examination give only a low clinical suspicion of Cushing's and the initial screen is negative - explain results, reassure and discharge the patient. &lt;a href="http://jcem.endojournals.org/content/93/5/1526.abstract" target="_blank" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;Endocrine society guidance&lt;/a&gt; suggests an initial screen may comprise either urinary free cortisol, late night salivary cortisol, a low dose or overnight dexamethasone suppression test depending on the centre. In our centre, 2 urinary collections and an out patient low dose dexamethasone suppression test are used. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If the clinical suspicion remains high or the initial biochemical screen is positive, proceed to further investigation. The guidance above suggests a second of these tests and or a midnight serum cortisol or dexamethasone-CRH test be performed at this stage followed by formal assessment of the cause of the Cushing's if this second test is also abnormal. In our centre, we usually proceed to hospital admission for this stage, followed by localising studies. Recent &lt;a href="http://jcem.endojournals.org/cgi/content/abstract/jc.2008-0125v1" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;guidelines&lt;/a&gt; give more detail on the procedures for screening and confirming the diagnosis of Cushing's.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If the clinical suspicion is high but the tests are negative recheck the medication history in case the clinical features are secondary to exogenous steroid use. It is also valid to wait and reassess the patient with a suggestive clinical assessment but normal biochemistry after 6 months to determine whether their condition has progressed, or to assess for cyclical disease.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;In our centre, the following tests are performed prior to hospital admission:&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Low dose dexamethasone suppression test,&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Baseline 9am pituitary function including ACTH, cortisol, insulin-like growth factor-I, luteinising hormone, follicule stimulating hormone, thyroid stimulating hormone, free thyroxine, estrodiol/testosterone, sex hormone binding globulin and prolactin,&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Adrenal androgen profile including testosterone, androstenedione, dehydroepiandrosterone and 17 hydroxyprogesterone.&lt;/p&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In order to confirm the diagnosis of Cushing’s syndrome, most patients will require hospital admission. A sleeping midnight cortisol and supervised low dose dexamethasone suppression test (for cortisol in all patients and also for androgens if the patient is virilised) should be performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Arrange a chest radiograph, dynamic MRI scan of the pituitary, and CT scan of the chest and adrenals at diagnosis in all cases. Pitutiary incidental lesions are common and so a biochemical picture suggestive of pitutiary disease will require inferior petrosal sinus sampling to confirm this. Conversely, discreet adrenal nodules may be seen in patients in whom a clear diagnosis of pitutiary dependant disease has been established. For this reason, we advocate imaging in all patients after biochemical confirmation of Cushing's.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If the patient has obvious Cushing's clinically, fails to suppress their cortisol on low dose dexamethasone suppression testing, has a low or undetectable ACTH, a normal MRI pituitary and an obvious adrenal lesion (with or without elevated androgens) the diagnosis of adrenal Cushing's is obvious. Assessment of circadian rhythm with a &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/cortisol-day-curve-or-circadian-rhythm/"&gt;cortisol day curve&lt;/a&gt; may be used as an indicator of initial disease severity, and as a baseline to compare biochemical control on medical treatment. However, with adrenal disease, the expectation is of complete surgical cure so this may not be considered necessary.&lt;/p&gt;
&lt;p&gt;A high dose dexamethasone suppression test is used by some units to help differentiate between pituitary and ectopic sources of ACTH in difficult Cushing’s syndrome. Corticotrophin releasing hormone test is similarly used in selected cases only. These tests are generally not required in the assessment of adrenal Cushing's.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review all results at a multidisciplinary meeting&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Typical indicators of pituitary disease are raised urinary free cortisols, detectable midnight serum cortisol as well as partial suppression of serum cortisol with dexamethasone, and a detectable or elevated serum ACTH.&lt;/p&gt;
&lt;p&gt;Pituitary MRI may or may not be obviously abnormal.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Inferior petrosal sinus sampling with simultaneous CRH testing&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Selective venous catheterisation of the petrosal sinuses allows simultaneous sampling of central and peripheral blood to compare ACTH levels. A central to peripheral gradient above 4:1 confirms a central, i.e. pituitary, source of ACTH. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; text-align: left; "&gt;An ACTH response to CRH testing further supports a suspicion of pituitary disease. In one &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/10022405" target="_blank" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;large series&lt;/a&gt;, a bilateral IPS: peripheral ratio of &amp;gt;2, obtained 5 minutes after CRH stimulation has a sensitivity of 97% and specificity of 100% in diagnosing Cushing's disease.&lt;font face="arial, helvetica, clean, sans-serif" size="2"&gt; &lt;/font&gt;Sampling of both sinuses simultaneously also provides evidence of disease lateralisation prior to planning surgery: a ratio of &amp;gt;1.4 at 5 minutes post CRH has a sensitivity of 83% in correctly laterising the adenoma in this large series. &lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Start medical treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Patients should be prepared medically prior to surgery to optimise the safety of the procedure. Typically metyrapone 500-750mg daily in divided doses is used.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Warn patient of the symptoms of hypoadrenalism, for example nausea and dizziness at the start of treatment, and offer supply of dexamethasone for emergency use. A "block and replace" regmine of high dose metyrapone with low dose dexamethasone may be used in some cases where it is difficult to titrate up the metyrapone without causing symptomatic hypoadrenalism. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Reassess cortisol levels with &lt;a href="http://www.endobible.com/investigation/metyrapone-cortisol-day-curve/" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;'metyrapone day curve'&lt;/a&gt; at three days. Arrange weekly monitoring of liver function during treatment. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Patients with very severe disease not controlled by metyrapone may require the addition of ketoconazole. Patients unfit for surgery may continue long term medical treatment, though this requires long term monitoring. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;A new multireceptor ligand somatostain analog &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/22674211" target="_blank" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;Pasireotide&lt;/a&gt; has also recently been licensed as a specific pituitary directed therapy for patients unsuitable for or not cured by surgery. This appears to control biochemical and local disease, although carries with it an increased risk of diabetes.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Aim for medical optimisation for six weeks prior to surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Medical treatment aims to control cortisol excess to approximate mean serum levels of 250-300nmol/l, control blood pressure and ensure good diabetes control if indicated, prior to surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Trans-sphenoidal surgery is the standard treatment for pituitary disease.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review all results at a multidisciplinary meeting&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Typical indicators are raised urinary free cortisol levels and detectable midnight cortisol, as well as a lack of suppression with dexamethasone, elevated basal ACTH levels, no response to CRH testing and no central to peripheral gradient on inferior petrosal sinus sampling. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review CT chest and adrenals&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ectopic ACTH secretion is most commonly from a bronchial tumour.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Further localising studies&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the source of the ectopic ACTH is not obvious, consider total body imaging with octreotide or MIBG scan, followed by cross sectional imaging, for example MRI of any suspicious areas. &lt;/p&gt;
&lt;p&gt;Consider performing selective venous catheterisation of suspicious areas for measurements of ACTH to confirm disease localisation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Start medical treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt; &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Patients should be prepared medically prior to surgery to optimise the safety of the procedure. Typically metyrapone 500-750mg daily in divided doses is used.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Warn patient of the symptoms of hypoadrenalism, for example nausea and dizziness at the start of treatment, and offer supply of dexamethasone for emergency use. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Reassess cortisol levels with &lt;a href="http://www.endobible.com/investigation/metyrapone-cortisol-day-curve/" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;'metyrapone day curve' &lt;/a&gt;at three days. Arrange weekly monitoring of liver function during treatment.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If control is not acheived, consider adding ketoconazole, or further increasing the dose in a block and replace regime. In exceptional cases, or for adrenal cancer, consider use of mitotane, with intensive monitoring.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Aim for medical optimisation for six weeks prior to surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Medical treatment aims to control cortisol excess to approximate mean serum levels of 250-300nmol/l, control blood pressure, and ensure good diabetes control if indicated, prior to surgery. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ideally, Cushing's syndrome due to ectopic ACTH should be treated by resection of the tumour after medical optimisation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider bilateral adrenalectomy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the source of ACTH is not identified, it is usual to continue long term medical treatment until the source becomes apparent.&lt;/p&gt;
&lt;p&gt;Long term use of adrenolytic therapy may be poorly tolerated however, and safe long term control can also be achieved with bilateral adrenalectomy, which should also be considered in all cases. &lt;/p&gt;
&lt;p&gt;Life long follow up remains necessary post adrenalectomy, with periodic surveillance imaging and biochemical assessments until source is identified.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review all results at a multidisciplinary meeting&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Typical indicators are raised urinary free cortisol levels and detectable midnight cortisol as well as undetectable or low ACTH levels, and no response to high or low dose dexamethasone suppression testing. &lt;/p&gt;
&lt;p&gt;Adrenal androgens may also be elevated but will not suppress with dexamethasone.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review CT adrenals and consider MRI if necessary&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Adrenal tumours are usually easily identified on CT, and their imaging characteristics and size are useful indicators of malignant potential - low Hounsfield units and small size are predictive of benign curable disease.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Start medical treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients should be prepared medically prior to surgery to optimise the safety of the procedure. Typically metyrapone 500-750mg daily in divided doses is used.&lt;/p&gt;
&lt;p&gt;Warn patient of the symptoms of hypoadrenalism, for example nausea and dizziness at the start of treatment, and offer supply of dexamethasone for emergency use. &lt;/p&gt;
&lt;p&gt;Reassess cortisol levels with &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/metyrapone-cortisol-day-curve/"&gt;'metyrapone day curve' &lt;/a&gt;at three days.&lt;/p&gt;
&lt;p&gt;Arrange weekly monitoring of liver function during treatment. If control not achieved, consider adding or substituting with ketoconazole. In exceptional cases and adrenal cancer, consider use of mitotane with intensive monitoring.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Aim for medical optimisation for six weeks prior to surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Control of cortisol excess to an approximate mean serum level of 250-300nmol/l, good control of blood pressure with other agents if necessary, and optimisation of diabetes control should all be acheived during this period.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Adrenalectomy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Refer to a specialist adrenal or urological multidisciplinary team for consideration of laparascopic surgical resection after six weeks medical optimisation. Stop all adrenolytic therapy, and give 100mg hydrocortisone im on induction of anaesthesia and continue 6 hourly until the patient can eat and drink. Revert to oral hydrocortisone 20mg tds until the patient is clinically well (48h), then reduce to 10mg waking, 5mg at midday and 5mg early evening. This should be continued until the patient has been reassessed for hypothalamopituitary adrenal axis recovery, though this may take many months. &lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cure is defined by a post operative 9am cortisol &amp;lt;50nmol/l&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;An undetectable 9am cortisol the morning after surgery confirms cure and is useful in patients with ACTH dependant disease. After adrenalectomy, cure and adrenal suppression is the norm, and so this is unecessary. These patients should be started empirically on hydrocortisone replacement therapy: 100mg im 6 hourly during anaesthesia, reverting to high dose oral replacement of 20mg tds for the first few days after surgery, reverting to standard low dose replacement therapy: typically 10mg on waking, 5mg at five hours and 5mg at nine hours, once they are well. This should then be adjusted according to symptoms and hydrocortisone day curve, and reassessment of hypothalamo-pituitary-adrenal axis recovery as necessary. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Long term follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Check pre hydrocortisone dose cortisol and ACTH levels prior to all follow up assessments.&lt;/p&gt;
&lt;p&gt;Assess control at three, six and 12 months post treatment, and then usually on an annual basis long term. &lt;/p&gt;
&lt;p&gt;Formally reassess for disease recurrence or re-emergence of normal hypothalomic pituitary adrenal axis with 9am cortisol, midnight cortisol, low dose dexamethasone suppression testing and 2x urinary free cortisols. Reassess at least every six months initially, or whenever their pre dose serum cortisol becomes detectable.&lt;/p&gt;
&lt;p&gt;Ensure cardiovascular and bone health are assessed long term.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Continue medical treatment with six monthly assessment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Adrenal Cushing's should be cured after adrenalectomy. Non cure immediately following surgery should lead to review of the patient's results - did they actually have bilateral adrenal disease or was it in fact ACTH dependant?&lt;/p&gt;
&lt;p&gt;Also, review the histology carefully, as late recurrence may indicate that the patient actually had adrenocortical carcinoma. Satisfactory biochemical control is evidenced by clinical response and a mean serum cortisol, during a &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/cortisol-day-curve-or-circadian-rhythm/"&gt;circadian rhythm&lt;/a&gt;, of 250-300nmol/l. However, if the patient has adrenocortical carcinoma, they should be started on mitotane and considered for an oncological clinical trial.&lt;/p&gt;
&lt;p&gt;Bone densitometry should be also be assessed in non-cured patients. Calcium and vitamin D should be considered in all patients, and further treatments for &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/osteoporosis/management"&gt;osteoporosis&lt;/a&gt; discussed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Reassessment for recurrent or persistent disease&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This requires two urinary free cortisols, a 9am pre-dose cortisol and ACTH, and a low dose dexamethasone suppresssion test for cortisol. This should be performed every six months initially, and at least annually long term.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Further treatments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider repeat surgery to remove the adrenal remnant in the non-cured patient with unilateral adrenal disease, or bilateral adrenalectomy if the histology and review of the clinical case suggests bilateral ACTH independant disease eg primary pigmented nodular adrenal hyperplasia or Carney complex.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Post adrenalectomy assessments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients on steroid replacement therapy require a pre dose 9am cortisol before each visit. They also require an ACTH and renin assessment prior to, and 120 minutes after, their hydrocortisone and fludrocortisone doses to guide replacement therapy and monitor for the development of Nelson’s syndrome or the emergence of an adrenal remnant.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Long term follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Check pre-dose cortisol level and ACTH prior to first follow up assessment.&lt;/p&gt;
&lt;p&gt;Assess control at three, six and 12 months post treatment, and then usually on an annual basis long term.&lt;/p&gt;
&lt;p&gt;Formally reassess for disease recurrence or re-emergence of normal hypothalomo-pituitary-adrenal axis with 9am cortisol, midnight cortisol, low dose dexamethasone suppression testing and urinary free cortisols. Reassess at least every six months initially, or whenever their pre dose serum cortisol becomes detectable.&lt;/p&gt;
&lt;p&gt;Patients with previous pituitary surgery or radiotherapy need to be monitored for the development of anterior pituitary failure. All patients require that cardiovascular risks and bone health are assessed long term.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Cushing's syndrome due to long term steroid use may be difficult to manage. Where possible, the causative agents should be slowly withdrawn under supervision. However, as the dose is reduced it is important to assess for axis recovery, usually with a 9am cortisol. If this is below 100nmol/l the axis clearly remains suppressed. Patients with levels between 100-500nmol/l  should undergo a Synacthen test to confirm whether they are safe to continue weaning off treatment.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Where there is evidence of on going adrenal suppression, low dose hydrocortisone (10mg, 5mg and 5mg) may be started, to protect the patient from hypoadrenalism while the causative drug is reduced and stopped. If the axis appears normal, the causative drug can be stopped safely.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Complications of Cushing's for example osteoporosis, hypertension, skin damage and glucose intolerance may all occur with exogenous steroid use, and so these patients also require aggressive screening and treatment.&lt;/p&gt;
				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Von Hippel Lindau</value></CCondName><CQueMgt><value>Initial clinical assessment 
				</value><value>Confirm diagnosis 
				</value><value>Imaging and localising studies 
				</value><value>Further investigations 
				</value><value>Pituitary dependent Cushing's confirmed 
				</value><value>Cushing's syndrome due to ectopic ACTH confirmed 
				</value><value>Adrenal Cushing's confirmed 
				</value><value>Clinically cured 
				</value><value>Not cured 
				</value><value>Exogenous steroid use confirmed 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/addisons-disease/</value><value>http://www.endobible.com/condition/addisons-disease/examination</value><value>http://www.endobible.com/condition/addisons-disease/investigation</value><value>http://www.endobible.com/condition/addisons-disease/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/cushings-syndrome/management</CURLMgt><CURLTop>http://www.endobible.com/condition/addisons-disease/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Pituitary</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;If the history and examination give only a low clinical suspicion of Cushing's and the initial screen is negative - explain results, reassure and discharge the patient. &lt;a href="http://jcem.endojournals.org/content/93/5/1526.abstract" target="_blank"&gt;Endocrine society guidance&lt;/a&gt; suggests an initial screen may comprise either urinary free cortisol, late night salivary cortisol, a low dose or overnight dexamethasone suppression test depending on the centre. In our centre, 2 urinary collections and an out patient low dose dexamethasone suppression test are used. &lt;/p&gt;
&lt;p&gt;If the clinical suspicion remains high or the initial biochemical screen is positive, proceed to further investigation. The guidance above suggests a second of these tests and or a midnight serum cortisol or dexamethasone-CRH test be performed at this stage followed by formal assessment of the cause of the Cushing's if this second test is also abnormal. In our centre, we usually proceed to hospital admission for this stage, followed by localising studies. Recent &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://jcem.endojournals.org/cgi/content/abstract/jc.2008-0125v1"&gt;guidelines&lt;/a&gt; give more detail on the procedures for screening and confirming the diagnosis of Cushing's.&lt;/p&gt;
&lt;p&gt;If the clinical suspicion is high but the tests are negative recheck the medication history in case the clinical features are secondary to exogenous steroid use. It is also valid to wait and reassess the patient with a suggestive clinical assessment but normal biochemistry after 6 months to determine whether their condition has progressed, or to assess for cyclical disease.&lt;/p&gt;
&lt;p&gt;In our centre, the following tests are performed prior to hospital admission:&lt;/p&gt;
&lt;p&gt;Low dose dexamethasone suppression test,&lt;/p&gt;
&lt;p&gt;Baseline 9am pituitary function including ACTH, cortisol, insulin-like growth factor-I, luteinising hormone, follicule stimulating hormone, thyroid stimulating hormone, free thyroxine, estrodiol/testosterone, sex hormone binding globulin and prolactin,&lt;/p&gt;
&lt;p&gt;Adrenal androgen profile including testosterone, androstenedione, dehydroepiandrosterone and 17 hydroxyprogesterone.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Cushing's syndrome due to long term steroid use may be difficult to manage. Where possible, the causative agents should be slowly withdrawn under supervision. However, as the dose is reduced it is important to assess for axis recovery, usually with a 9am cortisol. If this is below 100nmol/l the axis clearly remains suppressed. Patients with levels between 100-500nmol/l  should undergo a Synacthen test to confirm whether they are safe to continue weaning off treatment.&lt;/p&gt;
&lt;p&gt;Where there is evidence of on going adrenal suppression, low dose hydrocortisone (10mg, 5mg and 5mg) may be started, to protect the patient from hypoadrenalism while the causative drug is reduced and stopped. If the axis appears normal, the causative drug can be stopped safely.&lt;/p&gt;
&lt;p&gt;Complications of Cushing's for example osteoporosis, hypertension, skin damage and glucose intolerance may all occur with exogenous steroid use, and so these patients also require aggressive screening and treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In order to confirm the diagnosis of Cushing’s syndrome, most patients will require hospital admission to complete a sleeping midnight cortisol, and supervised low dose dexamethasone suppression test (for cortisol in all patients and also for androgens if the patient is virilised).&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Arrange a chest radiograph, dynamic MRI scan of the pituitary, and CT scan of the chest and adrenals at diagnosis in all cases.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Assessment of circadian rhythm with a &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/cortisol-day-curve-or-circadian-rhythm/"&gt;cortisol day curve&lt;/a&gt; is useful as an indicator of initial disease severity, though this is not a diagnostic test, and should only be performed after biochemical confirmation of diagnosis.&lt;/p&gt;
&lt;p&gt;A high dose dexamethasone suppression test is also used by some units to help differentiate between pituitary and ectopic sources of ACTH in Cushing’s syndrome.&lt;/p&gt;
&lt;p&gt;Corticotrophin releasing hormone test is similarly used only in selected cases only. Where pituitary disease is suspected, it is usefully combined with petrosal sampling.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review all results at a multidisciplinary meeting&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Typical indicators are raised UFCs, detectable midnight cortisol as well as partial suppression with dexamethasone, and detectable or elevated ACTH.&lt;/p&gt;
&lt;p&gt;Pituitary MRI may or may not be obviously abnormal.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Inferior petrosal sinus sampling with simultaneous CRH testing&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Selective venous catheterisation of the petrosal sinuses allows simultaneous sampling of central and peripheral blood to compare ACTH levels. A central to peripheral gradient above 4:1 confirms a central, i.e. pituitary, source of ACTH. &lt;/p&gt;
&lt;p style="text-align: left; "&gt;An ACTH response to CRH testing further supports a suspicion of pituitary disease. In one &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/10022405" target="_blank"&gt;large series&lt;/a&gt;, a bilateral IPS: peripheral ratio of &amp;gt;2, obtained 5 minutes after CRH stimulation has a sensitivity of 97% and specificity of 100% in diagnosing Cushing's disease.&lt;font face="arial, helvetica, clean, sans-serif" size="2"&gt;&lt;span style="line-height: 16.666667938232422px; "&gt; &lt;/span&gt;&lt;/font&gt;Sampling of both sinuses simultaneously also provides evidence of disease lateralisation prior to planning surgery: a ratio of &amp;gt;1.4 at 5 minutes post CRH has a sensitivity of 83% in correctly laterising the adenoma in this large series. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Start medical treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients should be prepared medically prior to surgery to optimise the safety of the procedure. Typically metyrapone 500-750mg daily in divided doses is used.&lt;/p&gt;
&lt;p&gt;Warn patient of the symptoms of hypoadrenalism, for example nausea and dizziness at the start of treatment, and offer supply of dexamethasone for emergency use. A "block and replace" regmine of high dose metyrapone with low dose dexamethasone may be used in some cases where it is difficult to titrate up the metyrapone without causing symptomatic hypoadrenalism. &lt;/p&gt;
&lt;p&gt;Reassess cortisol levels with &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/metyrapone-cortisol-day-curve/"&gt;'metyrapone day curve'&lt;/a&gt; at three days. Arrange weekly monitoring of liver function during treatment. &lt;/p&gt;
&lt;p&gt;Patients with very severe disease not controlled by metyrapone may require the addition of ketoconazole. Patients unfit for surgery may continue long term medical treatment, though this requires long term monitoring. &lt;/p&gt;
&lt;p&gt;A new multireceptor ligand somatostain analog &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/22674211" target="_blank"&gt;Pasireotide&lt;/a&gt; has also recently been licensed as a specific pituitary directed therapy for patients unsuitable for or not cured by surgery. This appears to control biochemical and local disease, although carries with it an increased risk of diabetes. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Aim for medical optimisation for six weeks prior to surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Medical treatment aims to control cortisol excess to approximate mean serum levels of 250-300nmol/l, control blood pressure and ensure good diabetes control if indicated, prior to surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Trans-sphenoidal surgery is the standard treatment for pituitary disease.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review all results at a multidisciplinary meeting&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Typical indicators are raised UFCs and detectable midnight cortisol, as well as lack of suppression with dexamethasone, elevated basal ACTH levels, no response to corticotrophin releasing hormone testing and no central to peripheral gradient on inferior petrosal sinus sampling. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review CT chest and adrenals&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ectopic ACTH secretion is most commonly from a bronchial tumour.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Further localising studies&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider total body imaging with octreotide scan/MIBG scan, followed by cross sectional imaging, for example MRI of any suspicious areas. &lt;/p&gt;
&lt;p&gt;Consider selective venous catheterisation of suspicious areas for measurements of ACTH.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Start medical treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients should be prepared medically prior to surgery to optimise the safety of the procedure. Typically metyrapone 500-750mg daily in divided doses is used.&lt;/p&gt;
&lt;p&gt;Warn patient of the symptoms of hypoadrenalism, for example nausea and dizziness at the start of treatment, and offer supply of dexamethasone for emergency use. &lt;/p&gt;
&lt;p&gt;Reassess cortisol levels with &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/metyrapone-cortisol-day-curve/"&gt;'metyrapone day curve' &lt;/a&gt;at three days. Arrange weekly monitoring of liver function during treatment.&lt;/p&gt;
&lt;p&gt;Arrange weekly monitoring of liver function during treatment. If control is not acheived, consider adding ketoconazole, or further increasing the dose in a block and replace regime. In exceptional cases, or for adrenal cancer, consider use of mitotane, with intensive monitoring.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Aim for medical optimisation for six weeks prior to surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Medical treatment aims to control cortisol excess to approximate mean serum levels of 250-300nmol/l, control blood pressure, and ensure good diabetes control if indicated, prior to surgery. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ideally, Cushing's syndrome due to ectopic ACTH should be treated by resection of the tumour after medical optimisation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider bilateral adrenalectomy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the source of ACTH is not identified, initial management is usually to continue long term medical treatment until the source becomes apparent.&lt;/p&gt;
&lt;p&gt;Long term use of adrenolytic therapy may be poorly tolerated however, and safe long term control can also be achieved with bilateral adrenalectomy, which should also be considered in all cases. &lt;/p&gt;
&lt;p&gt;Lifelong follow up remains necessary post adrenalectomy, with periodic surveillance imaging and biochemical assessments until source is identified.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review all results at a multidisciplinary meeting&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Typical indicators are raised UFCs, and detectable midnight cortisol as well as undetectable or low ACTH levels and no response to high or low dose dexamethasone suppression testing. &lt;/p&gt;
&lt;p&gt;Adrenal androgens may also be elevated but will not suppress with dexamethasone.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review CT adrenals and consider MRI if necessary&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Adrenal tumours are usually easily identified on CT, and their &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/adrenal-incidentalomas/management"&gt;imaging characteristics&lt;/a&gt; and size are useful indicators of malignant potential - low Hounsfield units and small size are predictive of benign curable disease.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Start medical treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients should be prepared medically prior to surgery to optimise the safety of the procedure. Typically metyrapone 500-750mg daily in divided doses is used.&lt;/p&gt;
&lt;p&gt;Warn patient of the symptoms of hypoadrenalism, for example nausea and dizziness at the start of treatment, and offer supply of dexamethasone for emergency use. &lt;/p&gt;
&lt;p&gt;Reassess cortisol levels with &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/metyrapone-cortisol-day-curve/"&gt;'metyrapone day curve' &lt;/a&gt;at three days.&lt;/p&gt;
&lt;p&gt;Arrange weekly monitoring of liver function during treatment. If control not achieved, consider adding or substituting with ketoconazole. In exceptional cases and adrenal cancer, consider use of mitotane with intensive monitoring.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Aim for medical optimisation for six weeks prior to surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Control of cortisol excess to approximate mean of 250-300nmol/l, good control of blood pressure with other agents if necessary, ensure good diabetes control if indicated.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Adrenalectomy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Refer to specialist MDT for surgical resection after six weeks medical optimisation.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Continue medical treatment with six monthly assessment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Satisfactory control is evidenced by clinical response and a mean serum cortisol, during a circadian rhythm, of 250-300nmol/l.&lt;/p&gt;
&lt;p&gt;2xUFC within the normal range is an alternative reflection of adequate biochemical control while awaiting definitive treatment.&lt;/p&gt;
&lt;p&gt;Bone densitometry should be assessed in such patients. Calcium and vitamin D should be considered in all patients, and further treatments for &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/osteoporosis/management"&gt;osteoporosis&lt;/a&gt; discussed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Re-assessment for recurrent or persistent disease&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This requires 2x24hr UFC, 9am pre-dose cortisol and ACTH and LDDST for cortisol only.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Re-assessment for development of Nelson's syndrome&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;To detect and monitor Nelson's syndrome, ACTH should be checked both before and 120 minutes post hydrocortisone dose in patients who have undergone bilateral adrenalectomy. Rising ACTH alone does not indicate the development of Nelson's syndrome, but mandates repeat pituitary MRI scanning.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Further treatments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider further medical treatment, for example with pasireotide, or repeat surgery, adrenalectomy, or conventional radiotherapy if patients are not cured. &lt;/p&gt;
&lt;p&gt;Following radiotherapy, further surgery or radiosurgery can be considered in exceptional cases.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Post adrenalectomy assessments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients on steroid replacement therapy require a pre-dose 9am cortisol as well as a ACTH and rennin assessments prior to, and 120 minutes after, their hydrocortisone and fludrocortisone doses to guide replacement therapy and monitor for Nelson’s syndrome or emergence of an adrenal remnant.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Long term follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Check pre-dose cortisol level and ACTH prior to first follow up assessment.&lt;/p&gt;
&lt;p&gt;Assess control at three, six and 12 months post treatment, and then usually on an annual basis long term.&lt;/p&gt;
&lt;p&gt;Formally reassess for disease recurrence or re-emergence of normal hypothalomo-pituitary-adrenal axis with 9am cortisol, midnight cortisol, low dose dexamethasone suppression testing and 2xUFCS, at least every six months initially, or whenever their pre dose serum cortisol becomes detectable.&lt;/p&gt;
&lt;p&gt;Ensure cardiovascular and bone health are assessed long term.&lt;/p&gt;
&lt;p&gt;Also ensure that pitutary function is reassessed annually in all patients post pituitary surgery, with dynamic function testing at least every two years following radiotherapy.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cure is defined by a post operative 9am cortisol &amp;lt;50nmol/l&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients with a low 9am cortisol post operatively, will need to commence hydrocortisone replacement therapy typically with 10mg on waking, 5mg at five hours and 5mg at nine hours, adjusted according to symptoms and hydrocortisone day curve as necessary. &lt;/p&gt;
&lt;p&gt;Unfortunately, though an undetectable post op cortisol is prognostically favourable, it does not guarantee long term cure, and so even patients clinically in remission require ongoing reassessments. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Long term follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Check pre-dose cortisol level and ACTH prior to every follow up assessment.&lt;/p&gt;
&lt;p&gt;Assess control at three, six and 12 months post treatment, and then usually on an annual basis long term. &lt;/p&gt;
&lt;p&gt;Formally reassess for disease recurrence or re-emergence of normal hypothalomo-pituitary-adrenal axis with pre-dose 9am cortisol, midnight cortisol, low dose dexamethasone suppression testing and 2xUFCS, at least every six months initially, or whenever their pre-dose serum cortisol becomes detectable.&lt;/p&gt;
&lt;p&gt;Ensure cardiovascular and bone health are assessed long term.&lt;/p&gt;
&lt;p&gt;Also ensure that pitutary function is re-assessed annually in all patients post pituitary surgery, with dynamic function testing at least every two years following radiotherapy.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Prolactinoma and Hyperprolactinaemia</value></CCondName><CQueMgt><value>Initial clinical assessment 
				</value><value>Exogenous steroid use confirmed 
				</value><value>Confirm diagnosis 
				</value><value>Imaging and localising studies 
				</value><value>Further investigations 
				</value><value>Pituitary dependent Cushing's confirmed 
				</value><value>Cushing's syndrome due to ectopic ACTH confirmed 
				</value><value>Adrenal Cushing's confirmed 
				</value><value>Not cured 
				</value><value>Clinically cured 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/diabetes-insipidus/</value><value>http://www.endobible.com/condition/diabetes-insipidus/examination</value><value>http://www.endobible.com/condition/diabetes-insipidus/investigation</value><value>http://www.endobible.com/condition/diabetes-insipidus/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/cushings-disease/management</CURLMgt><CURLTop>http://www.endobible.com/condition/diabetes-insipidus/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Adrenal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Ensure full investigation has been performed at baseline&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;At diagnosis of a phaeochromocytoma, a thorough assessment is required. This should include the following in all patients: thorough family history and documented family tree; 1x plasma metanephrine; chest radiograph; CT or MRI adrenals; MIBG scan; and further cross sectional imaging depending on results of MIBG scan.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Explain results and treatment options&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients need to understand their diagnosis and the importance of adhering to medical treatment.&lt;/p&gt;
&lt;p&gt;This is particularly important because the medication may not be well tolerated, but non compliance can have fatal consequences.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate medical treatment with alpha blockade&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Usual treatment starts with phenoxybenzamine. This may be started at a low dose eg 10mg daily, and should be gradually uptitrated to a usual maximum of 40-60mg in divided doses daily. Close BP monitoring is required and patients must be advised to keep up a high fluid intake.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;This may have unpleasant side effects, for example dizziness, malaise and swollen ankles.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Doxazosin, usually in a sustained release preparation, may be used if phenoxybenzamine is unavailable or not tolerated. Dose should be titrated to the maximum tolerated.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Once a date is set for surgery, the dose of phenoxybenzamine should be uptitrated further until the patient develops significant hypotension and nasal congestion. This may require hospital admission, intravenous fluids or even blood transfusion for haemodilution and postural hypotension.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Add beta blockade for symptomatic tachycardia&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Once a patient is fully alpha blocked, typically after about several weeks in an out patient setting, initiate beta blockade, for example with propranolol if they develop significant and symptomatic tachycardia.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;This is not always necessary and must only be given after the patient is fully alpha blocked. Close BP monitoring is again required and the dose should be increased to the maximum tolerated or 240mg in divided doses.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Arrange surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Ideally patients will have been fully alpha and beta blocked over a period of at least six weeks prior to surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Peri-operative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Ideally, patients should be admitted preoperatively for intravenous alpha blockade prior to surgery.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If the patient is already on full oral treatment, administer intravenous phenoxybenzamine over three days prior to surgery.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Monitor postural blood pressure and haemoglobin over successive days.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Patients frequently require intravenous fluid support for dramatic falls in blood pressure. Full blood count should be checked daily, as a dramatic fall in haemoglobin may occur, which should be treated with pre operative blood transfusions if necessary. This occurs due to haemodilution as the vascular bed dilates and the intravascular volume expands. This preparation should prevent dramatic changes in blood pressure peri operatively, although an anaesthetist experienced in this procedure is essential.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;If iv phenoxybenzamine is unavailable, the patient will require uptitration of their oral phenoxybenzamine in the week prior to surgery. This may also require admission and the dose should be increased by 10mg every 24hours until significant hypotension and nasal stuffiness occur. Patients may require intravenous fluid support as above, and ALL patients should start on iv fluids overnight before planned surgery to minimise the chance of significant perioperative hypotension.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Emergency management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;In the acutely unwell patient, or one presenting with a crisis, the first priority should be fluid resuscitation. This should prevent a catastrophic fall in blood pressure occurring when alpha blockade is initiated.&lt;/p&gt;
&lt;p&gt;Beta blockade is added only after the patient appears to be fully alpha blocked which may take several days.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Post operative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;All medication may be stopped routinely.&lt;/p&gt;
&lt;p&gt;Blood pressure should be closely monitored.&lt;/p&gt;
&lt;p&gt;Arrange for urinary metanephrines to be repeated at six to 12 weeks.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Counselling and screening of patients and family members for phaeochromocytomas, neurological, retinal, renal, pancreatic and epididymal and broad ligament tumours must be discussed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;At diagnosis, perform an MRI of the whole brain, spinal cord and abdomen and arrange audiological and ophthalmoligical reviews.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;There is no internationally agreed guideline on the follow up of VHL. However, the &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.vhl.org/handbook/vhlhb4.php#Suggested"&gt;VHL family alliance&lt;/a&gt; recommends an annual screening programme.&lt;/p&gt;
&lt;p&gt;Annual follow up must include a review of symptoms, blood pressure and family history. It should also include full blood count, urea and electrolytes, liver function test, glucose, 2x24hr urine metanephrines, urine microscopy, and ultrasound adrenal/kidney. An annual ophthalmology review with fluorescein angioscopy should also be arranged.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Chest radiograph, MRI brain and spine, and CT or MRI abdomen to image the adrenals, kidneys and pancreas should all be repeated at least every three years to age 50, then every five years.&lt;/p&gt;
&lt;p&gt;Imaging should be repeated more frequently if clinically indicated, or after lesions have been identified.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Audiometry assessment should be performed at diagnosis and repeated if hearing loss is suspected.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All first degree relatives require the same annual follow ups until the disease has been genetically excluded.&lt;/p&gt;
&lt;p&gt;Screening should start as early as age five in asymptomatic family members, as retinal lesions and phaeochromocytoma have been reported from this age.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Von Hippel Lindau</value></CCondName><CQueMgt><value>Urine metanephrine strongly positive or plasma metanephrine positive 
				</value><value>Genetic counselling and screening 
				</value><value>Baseline investigations at diagnosis 
				</value><value>Annual follow up 
				</value><value>Further imaging 
				</value><value>Audiology 
				</value><value>Screening of family members 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/addisons-disease/</value><value>http://www.endobible.com/condition/addisons-disease/examination</value><value>http://www.endobible.com/condition/addisons-disease/investigation</value><value>http://www.endobible.com/condition/addisons-disease/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/von-hippel-lindau/management</CURLMgt><CURLTop>http://www.endobible.com/condition/addisons-disease/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Pituitary</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;If the clinical suspicion is low, and electrolytes, pituitary function, glucose and paired osmolalities are normal, the patient may be reassured and discharged.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If clinical suspicion remains after the initial investigations, and if any offending drugs have been removed, and electrolyte disturbances have been corrected, proceed to a formal water deprivation test. If this is normal, the patient should be reassured and discharged with advice.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If water deprivation test is diagnostic of diabetes insipidus, start treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Long term treatment is usually given as an intranasal spray (typical dose 1-2x10mcg inhalations on retiring).&lt;/p&gt;
&lt;p&gt;Mild cases may be controlled with oral desmopressin (typical dose 100-300mcg on retiring), and top up oral doses may also be added during the day in those whose symptoms are not fully controlled with once daily treatment.&lt;/p&gt;
&lt;p&gt;In patients with a normal thirst mechanism, treatment aims to relieve nocturia and extreme thirst. A short period of polyuria and thirst is allowed just before a dose to prevent water overload developing and to maintain normal serum biochemistry.&lt;/p&gt;
&lt;p&gt;Long term monitoring of symptoms, urea and electrolytes, is usually all that is required. Hyponatraemia indicates excessive replacement, which should prompt consideration of dose reduction.&lt;/p&gt;
&lt;p&gt;In patients with extensive hypothalamic damage and loss of the normal thirst mechanism, it may be necessary to calculate a fixed oral intake and DDAVP dose. This requires very close monitoring of fluid input and output as well as serum and urine biochemistry at the start of treatment. This should usually occur within a supervised hospital environment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A formal water deprivation test is not necessary before starting treatment in the acute setting, for example in the hours or days following pituitary surgery. In this situation, if the patient is polyuric as evidenced by passing &amp;gt;150mls urine for two successive hours, serum electrolytes and spot urine and plasma osmolalites should be tested. If these are consistent with DI, start emergency treatment with subcutaneous doses of desmopressin (typical dose 1mcg).&lt;/p&gt;
&lt;p&gt;Urea and electrolytes and paired urine and serum osmolalities should be performed daily in the acute phase to confirm the need for ongoing treatment and to prevent over-treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Arrange clinical review, ideally by an endocrine specialist nurse, within a week to ensure that symptoms are controlled and to reassess serum electrolytes and paired osmolalities.&lt;/p&gt;
&lt;p&gt;In patients on replacement therapy, nasal desmopressin tends to control symptoms for approximately 16 hours. Symptoms occurring before this time require an increase in the size or frequency of desmopressin dose.&lt;/p&gt;
&lt;p&gt;If the patient does not experience at least a short period of thirst during the day, they are at risk of over-replacement and water overload. This should prompt dose reduction, as should hyponatraemia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Where hypopituitarism is confirmed, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypopituitarism/management"&gt;hormone replacement therapy&lt;/a&gt; should be started immediately with glucocorticoid replacement therapy taking priority over all other treatments.  &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If there is possible GH or ACTH deficiency perform insulin, arginine-GHRH or glucagon stress testing.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ensure that investigations into the cause of DI have been arranged and discussed in a multidisciplinary setting. Pituitary MRI scan, pituitary function, serum angiotensin converting enzyme, alfa feto protein, human choriotropic hormone, auto-antibody screen and chest radiograph are the minimum investigations required in all cases.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Future management depends on underlying diagnosis.&lt;/p&gt;
&lt;p&gt;If no underlying diagnosis has been reached - baseline and dynamic pituitary function, MRI scan, tumour markers and auto-antibody screen are all normal - the patient will require a thorough review at a multidisciplinary meeting. They will then require clinical follow up within a week, then at three and six months with repeat electrolytes before each visit. Annual review thereafter is usually satisfactory.&lt;/p&gt;
&lt;p&gt;Imaging is usually repeated on at least one further occasion, even where the initial results appear to be normal. The timing of this should be determined by the multidisciplinary team.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Blood pressure, volume status, symptoms and electrolytes and osmolalities should be assessed annually.&lt;/p&gt;
&lt;p&gt;Ask the patient how long their thirst is controlled for after a dose of desmopressin, and how they felt if they have ever missed a dose. Nasal desmopressin tends to control symptoms for approximately 16 hours. Symptoms occurring before this time require an increase in the size or frequency of desmopressin dose. Lack of thirst and passage of very little urine may suggest over-replacement.&lt;/p&gt;
&lt;p&gt;Pituitary function should also be repeated annually with dynamic testing as indicated. Repeat MRI scanning should be considered in all cases at one year or as determined by the multidisciplinary team.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is usually managed by renal physicians.&lt;/p&gt;
&lt;p&gt;Where this is secondary, the underlying cause should be treated i.e. remove the causative drug, or correct the electrolyte abnormality.&lt;/p&gt;
&lt;p&gt;Where this is familial or idiopathic, standard treatment is with hydrochlorothiazide or amiloride but this is often unsatisfactory.&lt;/p&gt;
&lt;p&gt;Non-steroidal anti-inflammatory drugs may also improve symptoms in some cases.&lt;/p&gt;
&lt;p&gt;If there is a partial response to desmopressin on water deprivation testing, it may be appropriate to try high dose desmopressin.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CCondName><value>Prolactinoma and Hyperprolactinaemia</value></CCondName><CQueMgt><value>Low clinical suspicion 
				</value><value>Moderate clinical suspicion 
				</value><value>Confirmed central diabetes insipidus 
				</value><value>Standard treatment 
				</value><value>Emergency treatment 
				</value><value>Early follow up 
				</value><value>Start appropriate hormone replacement therapy 
				</value><value>Consider dynamic pituitary function testing 
				</value><value>Consider further investigations into cause 
				</value><value>Long term follow up 
				</value><value>Annual review 
				</value><value>Nephrogenic diabetes insipidus 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/diabetes-insipidus/</value><value>http://www.endobible.com/condition/diabetes-insipidus/examination</value><value>http://www.endobible.com/condition/diabetes-insipidus/investigation</value><value>http://www.endobible.com/condition/diabetes-insipidus/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/diabetes-insipidus/management</CURLMgt><CURLTop>http://www.endobible.com/condition/diabetes-insipidus/</CURLTop><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;In familial short stature (also referred to as genetic short stature) bone age and growth velocity are normal for chronological age, and adult height is appropriate for the familial pattern.&lt;/p&gt;
&lt;p&gt;No treatment is required for this condition.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Constitutional growth delay is characterised by delayed bone age, normal growth velocity, and predicted adult height appropriate to the family pattern. This should be regarded as a normal variant and as such does not usually require treatment, though most children and families benefit from reassurance and counselling. However these patients frequently do not reach their parental target, and patients with constitutional growth delay often have a first- or second-degree relative who also had constitutional growth delay.&lt;/p&gt;
&lt;p&gt;In boys aged 10-13 years with mild growth delay, treatment with oxandrolone 1.25-2.5mg daily for 6-12 months can be beneficial. Boys aged over 13 years with more severe delay of growth and puberty usually benefit from androgen therapy, i.e. testosterone depot 50-250mg 2-4 weekly for a limited period, usually 4-6 months. GH is not licenced for use in constitutional growth delay, although higher doses may ameliorate growth.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Short stature is confirmed in a child with a standing height of &amp;lt;-2.0 SD for chronological age, sex and ethnic background. A child with a height velocity below the 5th to 10th percentile for age, with no clear aetiology should also be treated as for confirmed short stature. &lt;/p&gt;
&lt;p&gt;Patients with the phenotype of hypothalamic-pituitary dysfunction (eg microphallus, septo-optic dysplasia, tumour in the hypothalamic-pituitary region or history of cranial irradiation) with decelerating growth, and patients with other deficits in their hypothalamic-pituitary hormones require full assessment as for their underlying condition. Their short stature can be treated conventionally depending on their other health issues.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;GH therapy is also used for confirmed short stature associated with other non-GH deficiency causes, with different doses required according to underlying diagnosis and patient response. Excellent guidance is available on &lt;a href="http://www.shortstature-forum.com/" target="_blank"&gt;Short stature forum&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;In Turner syndrome (TS) and Noonan syndrome (not licensed by the EMEA) GH 0.05-0.067mg/kg/day is recommended. In small for gestational age patients GH 0.033 or 0.067mg/kg/day (European dose) may be used.&lt;/p&gt;
&lt;p&gt;In Prader-Willi syndrome the recommended dose is 0.05mg/kg/day. In chronic renal failure the recommended dose is 0.08mg/kg/day.&lt;/p&gt;
&lt;p&gt;In idiopathic short stature (not licensed by the EMEA) a starting dose of 0.05mg/kg/day is recommended.&lt;/p&gt;
&lt;p&gt;Linear growth must be monitored every 6 months during therapy to help with dose titration. Serum IGF-I should also be monitored 6-12 monthly to ensure doses are not excessive, though in paediatrics unlike in adult endocrinology, dose adjustments are not generally guided by IGF-I assessments.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Short stature in GHD tends to have and excellent response to GH therapy. GH therapy in a dose of 0.025-0.035mg/kg/day (UK dose) is given in as daily subcutaneous injections in children from the time of diagnosis of GHD until completion of growth after puberty. Some specialists recommend increasing the dose during puberty. &lt;/p&gt;
&lt;p&gt;Recombinant human GH administration increases adult height into the normal range for the population and into the child’s genetic target range provided the treatment is started in early childhood. However, delayed treatment, severity of GHD, IGF-I level, severity of short stature and dose of GH may predict the response in individual patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Severe primary IGFD, results from genetic defects of GH action, e.g. GH receptor defects, and so does not respond to GH therapy. Recombinant human IGF-1 is licensed and indicated for long-term treatment in this condition as defined by height &amp;lt;-3 SD, IGF-I &amp;lt;-3 SD (FDA, or &amp;lt;2.5th centile EMEA), with normal GH reserve on dynamic testing.&lt;/p&gt;
&lt;p&gt;The recommended starting dosage is 40 mcg/kg twice daily SC and must always be given with a meal. The dose should be increased to 80 mcg/kg and then to 120 mcg/kg twice daily within 2-3 months. Preprandial glucose monitoring should be considered at treatment initiation and until a well-tolerated dose is established.&lt;/p&gt;
&lt;p&gt;If frequent symptoms of hypoglycaemia occur, preprandial glucose monitoring should continue. If hypoglycaemia occurs with recommended doses, despite adequate food intake, the dose should be reduced.&lt;/p&gt;
&lt;p&gt;Adverse effects include hypoglycaemia, lipohypertrophy, and tonsillar hypertrophy, intracranial hypertension with papilloedema may develop and cause visual changes, headache, nausea, or vomiting; rapid growth may cause slipped capital femoral epiphysis and scoliosis progression; protein substance administration may cause local or systemic reaction (e.g. flushing, hypotension/hypertension, rash, dyspnoea).&lt;/p&gt;
&lt;p&gt;Linear growth must be monitored every 6 months to ensure adequate therapeutic response.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss treatment aims, timescales and outcomes&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Treatment aims to replicate the natural process of puberty and should occur over approximately the same timescale - approximately two to three years.&lt;/p&gt;
&lt;p&gt;Adult patients should be warned that accelerating the process may have adverse long term psychological and physical consequences, for example poor breast development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss fertility issues at, or soon after, diagnosis&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If appropriate, fertility should be discussed early with the patient and their family.&lt;/p&gt;
&lt;p&gt;Patients need to understand that successful pubertal induction will not affect or restore fertility, although appropriate uterine development is necessary prior to possible future pregnancies.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Karyotype analysis&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Adult patients with absent puberty require karyotype analysis to differentiate between different causes, for example Klinefelter's syndrome, androgen insensitivity or Turner's syndrome.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review baseline pituitary function&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is any doubt that hypogonadotropic hypogonadism may not be isolated, consider dynamic function testing.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;MRI pituitary&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If karyotype is normal, and cause of hypogonadotropic hypogonadism is uncertain, thorough investigation for other causes should be performed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider assessing bone age&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Delayed bone age supports the diagnosis of absent puberty.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment: females&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose estrogen replacement therapy.&lt;/p&gt;
&lt;p&gt;Typical starting dose in an estrogen naive patient is 1.25mcg ethinylestradiol. Increase dose to 2.5mcg, then by 2.5mcg increments every six months to 10mcg. The dose may then increase to 15mcg.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider pelvic ultrasound scan to assess uterine size at this stage.&lt;/p&gt;
&lt;p&gt;Once the patient experiences vaginal bleeding or if the patient has tolerated 15mcg, consider adding cyclical progesterone.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatment regimens&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p class="MsoNormal"&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for cardiovascular or thromboembolic disease will also need to be considered. &lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia eg 1x350mcg progesterone only pill daily.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Duration of treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Continue sex hormone replacement therapy until the time of the natural menopause - typically to age 50.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry and of pituitary function where indicated.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Klinefelter’s, Kallmann’s or underlying pituitary disease will require specific follow up.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment: male patients&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose testosterone therapy, and warn patient of expected psychological and physical effects.&lt;/p&gt;
&lt;p&gt;Typical starting dose in a testosterone naive patient is approximately 20% of the usual adult dose. This has traditionally been given as 50mg testosterone ester as an intramuscular injection, monthly, though an alternative is to use very low dose daily testosterone gel using a metered dose delivery system.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Monthly testosterone treatment is then typically increased by a further 50mg every six months according to clinical response.&lt;/p&gt;
&lt;p&gt;Alternatives include low dose depot testosterone, or topical gel using the same dosing schedule.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Treatment monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Routine monitoring of serum testosterone levels is not necessary until the expected adult dose is reached.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Peak and trough levels may then be useful to confirm the appropriateness of the final dose in patients taking monthly testosterone undecanoate. Peak 7 days post injection should typically be 25-30nmol/l, with a predose trough level of 8-12nmol/l. Subsequently, the dose should not be altered unless the clinical response is suboptimal, or in the light of changes in serum monitoring of prostate specific antigen, full blood count, liver function, or pre dose testosterone levels.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;In patients taking depot preparations, a random or pre dose level of 15-20nmol/l, and for patients taking daily topical preparations, a level of 15-20nmol/l 4-6 hours post application of the gel is usually sufficient.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Once patient is virilised appropriately and established on full adult dose, offer switching to alternative preparation, for example daily gel or depot preparation.&lt;/p&gt;
&lt;p&gt;Optimise final dose according to symptoms and serum levels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Annual monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Annual random levels are sufficient in patients on topical and depot preparations. Annual pre dose levels are required in those on injectable testosterone esters. &lt;/p&gt;
&lt;p&gt;Digital rectal examination, prostate specific antigen, full blood count and liver function tests should also be performed annually with dose reduction and onward referral if abnormalities arise.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry and of pituitary function where indicated.&lt;/p&gt;
&lt;p&gt;Patients with Turner’s syndrome, Klinefelter’s, Kallmann’s or underlying pituitary disease will require specific follow up.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling. Follow the treatment pathway for pubertal induction. &lt;/p&gt;
&lt;p&gt;For further management see &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/turners-syndrome/"&gt;Turner&lt;/a&gt; syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueMgt><value>Familial short stature confirmed 
				</value><value>Constitutional delay of growth 
				</value><value>Short stature confirmed 
				</value><value>Short stature confirmed without GH deficiency 
				</value><value>GH deficiency confirmed 
				</value><value> Primary IGF-I deficiency 
				</value><value>Absent puberty (any cause) 
				</value><value>Turner syndrome 
				</value></CQueMgt><CQueInv><value>Calculate height velocity 
				</value><value>Full blood count, ESR and ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Antiendomyseal and antigliadin antibodies 
				</value><value>Glycosylated haemoglobin and fasting glucose and lipids 
				</value><value>Growth hormone 
				</value><value>IGF-I and IGF-BP-3 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary and MRI olfactory bulbs 
				</value><value>Bone age 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram 
				</value><value>Echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Parathyroid hormone 
				</value><value>Karyotype 
				</value><value>Hearing test 
				</value></CQueInv><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="background-color: white; font-size: 9pt; "&gt;H&lt;/span&gt;&lt;span style="background-color: white; color: rgb(99, 97, 85); font-size: 9pt; "&gt;eight velocity requires a minimum of 6 months measurements. Age needs to be decimalised ie 10.5 years, not 10 years 6 months. This is expressed cm/year.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;b&gt;&lt;span style='font-size:13.5pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:#939598;mso-fareast-language:
EN-GB'&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:
Calibri;background:white"&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency. Low ferritin may also be a marker of malnutrition.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;ESR is an important screen for inflammatory conditions such as Crohn's disease or juvenile chronic arthritis.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
background:white"&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Important indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function test may be surprisingly normal in liver disease. Albumin is a marker of malnutrition. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hypercalcaemia may occur with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with short stature should be screened for Coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypoadrenal patients may have hypoglycaemia. Diabetes mellitus is usually clinically obvious but needs to be ruled out in patients with weight loss.&lt;/p&gt;
&lt;p&gt;Baseline assessment of lipids is also useful in patients with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In newborns, a single serum growth hormone level of less than 7 microgram/L (taken between days 3 and 5) confirms a diagnosis of neonatal GHD.&lt;/p&gt;
&lt;p&gt;After the newborn period, a single random serum growth hormone level over 7mcg/l is reassuring but does not exclude GH deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;These are useful tests for diagnosing severe GHD. Low IGF-I is in keeping with GH deficiency, in the presence of low GH secretion. &lt;/p&gt;
&lt;p&gt;In mild GHD, peak GH 5-7ng/ml, IGF-I and IGFBP-3 have lower diagnostic sensitivity and may be normal. Patients who have a deficiency of 3 or more pituitary hormones and an IGF-1 level of &amp;lt;50ng/ml can be considered to have GHD and may not require provocative testing.&lt;/p&gt;
&lt;p&gt;Low serum IGF-I should be interpreted cautiously as it may be associated with poor nutrition, or chronic illness. Serum IGFBP-3 concentration is generally less helpful that IGF-I for the diagnosis of GHD, except in very young children when IGF-I may be unreliable.&lt;/p&gt;
&lt;p&gt;In pubertal children, these tests are less reliable and dynamic testing will be required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estradial/testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These should be in the prepubertal range in children presenting with short stature prior to or associated with delayed puberty. This confirms that dynamic testing of GH reserve will require stilboestrol (1.0mg twice daily for the two days prior to the GH provocation test in both boys and girls) priming.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Age and pubertal stage related reference ranges are available to aid the interpretation of LH and FSH. Pre puberty, these are expected to be low. Post completion of puberty, if the sex hormones are confirmed as low, then low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) may indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example primary or auto-immune ovarian failure, or secondary to mumps or testicular trauma in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia in a child with short stature may be suggestive of pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Hypoprolactinaemia may also be seen in some genetic causes of hypopituitarism.&lt;/p&gt;
&lt;p&gt;Serum prolactin is affected by many factors, for example stress, nipple stimulation, interfering medications and PCOS, and so if elevated, should be repeated on at least two occasions. Elevated prolactin levels should also prompt the PEG precipitation test to determine whether this is biologically active or the inactive 'macroprolactin'.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis commonly causes weight loss but thyrotoxic children are almost always tall. &lt;/p&gt;
&lt;p&gt;Thyroid dysfunction is also more common in people with Turner syndrome.&lt;/p&gt;
&lt;p&gt;It is essential to assess levels of both thyroxine and TSH in patients suspected of pituitary disease and prior to a GH provocation test.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 500nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with pituitary disease and levels below this may require formal assessment for ACTH reserve, for example with an &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;insulin&lt;/a&gt; stress test or &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;glucagon&lt;/a&gt; test.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI pituitary should be performed in all patients with confirmed GH deficiency to seek underlying pathology, and in patients presenting later with hypogonadotropic hypogonadism. Patients with suspected Kallman's syndrome also require MRI of the olfactory bulbs in patients. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18955511" target="_blank"&gt;Late onset&lt;/a&gt;, mild, isolated hypogonadism may not require imaging however.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph of the left hand and wrist to assess bone age in patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A chest XR should be performed in all patients with multiple congenital abnormalities and with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is usefully performed at presentation in adults as it is required prior to starting dopamine agonist therapy or testing dynamic pituitary function if necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed to seek coarctation of the aorta or bicuspid aortic valve in patients with confirmed Turner's syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner’s and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; (ITT) should be performed if GH deficiency is suspected, and will also detect ACTH deficiency subject to the usual safety exclusion criteria. ITT should not be performed in young children, or when there is a history of convulsions, and never in infants. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon&lt;/a&gt; testing should be performed as a second confirmatory test of GH deficiency, or if an insulin stress test is contraindicated due to age or the patient's condition.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is generally considered the second best &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;dynamic test&lt;/a&gt; of GH reserve. However, this may also be performed without GHRH (in which case the interpretation is the same as an insulin stress test) in patients with suspected hypothalamic problems eg irradiation, as they may not mount the typical exuberant response to GHRH.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in patients with long standing nutritional deficiency, chronic illness, hypopituitarism or severe delay of puberty. This should also be considered in all patients with long standing hypogonadism and it may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with the phenotypic features of pseudohypoparathyroidism should have PTH levels documented to determine their underlying diagnosis.&lt;/p&gt;
&lt;p&gt;Levels will be low in hypoparathyroidism, high in pseudohypoparathyroidism, and normal in patients with pseudopseudohypoparathyrdoidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all girls presenting with short stature to exclude Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner's syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/short-stature/</value><value>http://www.endobible.com/condition/short-stature/examination</value><value>http://www.endobible.com/condition/short-stature/investigation</value><value>http://www.endobible.com/condition/short-stature/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/short-stature/management</CURLMgt><CURLTop>http://www.endobible.com/condition/short-stature/</CURLTop><CURLInv>http://www.endobible.com/condition/short-stature/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Thyroid</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt;Any patient with a solitary palpable nodule greater than 1cm in diameter, or any nodule with suspicious characteristics arising within a multinodular goitre, or any nodule with associated lymph nodes, will require urgent an ultrasound scan. The radiological characteristics taken with the level of clinical suspicious will then determine whether ultrasound guided aspiration is required according to international &lt;/span&gt;&lt;a href="http://www.aace.com/pub/pdf/guidelines/thyroid_nodules.pdf" style="text-decoration: none; color: rgb(236, 0, 140); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt;guidelines&lt;/a&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt;. Clinically guided fine needle aspirations of thyroid nodules are now rarely performed, and only if ultrasound is unavailable to help define whether aspiration is indicated at all, and which area of the lesion to aspirate.&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt;Patients with suspected eye disease require evaluation by an endocrinologist or ophthalmologist experienced in &lt;a href="http://www.endobible.com/condition/graves-disease/management" target="_blank"&gt;Graves' ophthalmopathy&lt;/a&gt;.&lt;/span&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt; Patients should be reassured that treatment is available and is highly effective, and a detailed patient &lt;/span&gt;&lt;a href="http://www.british-thyroid-association.org/info-for-patients/Docs/ptinfo-TED.pdf" style="text-decoration: none; color: rgb(236, 0, 140); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt;information sheet&lt;/a&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt; is available. Simple lubricants, avoidance of smoky environments, and avoidance of bright sunlight and strong winds by wearing sunglasses should be advised in all patients.&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Smoking increases the risk of developing new ophthalmopathy, increases the severity of existing ophthalmopathy, reduces the efficacy of treatment for ophthalmopathy, and increases the risk of ophthalmopathy deteriorating or developing de novo following radioactive iodine treatment.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;General advice must be given and referral to a formal smoking cessation clinic discussed.&lt;/p&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Offspring of women with high TSH receptor antibodies (TRABs) are at risk of foetal and neonatal thyroid dysfunction. It is therefore useful to test TRABs prior to pregnancy or before the end of the second trimester. Women with negative antibodies require no special monitoring. Women with positive antibodies should be considered at risk of complications. Obstetricians should therefore consider ultrasound monitoring to seek evidence of foetal thyroid dysfunction eg for foetal growth retardation,hydrops, goitre or cardiac failure. TSH testing of cord blood may also be performed and neonatalogists warned at the time of delivery. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;It is standard practise to use propylthiouracil rather than carbimazole in patients who may be or are planning &lt;a href="http://www.endo-society.org/guidelines/final/upload/Clinical-Guideline-Management-of-Thyroid-Dysfunction-during-Pregnancy-Postpartum.pdf" target="_blank" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;pregnancy&lt;/a&gt;, due to small but real concerns regarding teratogenicity from carbimazole. Treatment may frequently be stopped by the second trimester as the disease often spontaneously improves until the post partum period. Monitoring should continue throughout pregnancy and breastfeeding, and carbimazole substituted for propylthiouracil if required during the second trimester (since organogenesis is complete, and the risk of liver failure from propyl thiouracil outweighs the risks of carbimazole during this stage of the pregnancy). &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Patients with uncontrolled thyrotoxicosis should be advised to avoid pregnancy until biochemical control is achieved due to the risk of miscarriage. Treatment during pregnancy requires close monitoring typically every six weeks.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Radioactive iodine is contraindicated in pregnant or breast feeding individuals. Women should be advised to avoid conception for six months and men should avoid fathering children for four months following radioactive iodine treatment.&lt;/p&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Any patient with severe clinical or biochemical thyrotoxicosis requires immediate medical treatment, before long term decisions are taken. All patients must also receive verbal and written safety &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/carbimazole-warning-sheet/"&gt;warnings&lt;/a&gt; regarding drug therapy, and clear instructions on the need for serial blood tests and dose adjustment.&lt;/p&gt;
&lt;p&gt;Usual treatment starts with high dose carbimazole, for example 40-60mg daily, though lower doses (5-10mg) may be appropriate in those with milder disease.&lt;/p&gt;
&lt;p&gt;Patients with tachycardia or other severe symptoms are also usually treated with beta blockade, for example propranolol 120-240mg daily in divided doses.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients should receive instructions as to the timing of dose reduction and firm arrangements made for serial monitoring. Appropriate dose reduction will depend on symptom control, and on the rapidity of the fall in free thyroxine levels in the early stages, as TSH does not tend to respond as quickly to treatment.&lt;/p&gt;
&lt;p&gt;Typical monitoring intervals are every six weeks, with dose reduction from 40mg, to 20mg, 15mg, 10mg and then to maintenance therapy of 5mg. Long term treatment should be monitored with serum TSH, aiming for a level within the normal range with complete resolution of all symptoms.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Treatment duration and likelihood of relapse should be discussed with all patients at the start of a treatment course, and &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/info-for-patients/Docs/bta_patient_hyperthyroidism.pdf"&gt;other options&lt;/a&gt; discussed.&lt;/p&gt;
&lt;p&gt;Typical treatment courses for Graves' thyrotoxicosis are 18 months. All patients with auto-immune hyperthyroidism should be warned of a 50% chance of disease recurrence after their initial treatment course. Male patients, older patients, those with high antibody titres, those with previous episodes and those with severe biochemical disease are at the highest risk of future recurrence.&lt;/p&gt;
&lt;p&gt;Patients with hyperthyroidism secondary to thyroid nodules or multinodular goitres will need life long medical treatment if they do not choose to have radioactive iodine.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dose titration may be difficult or inappropriate in occasional circumstances. In such cases, high dose carbimazole (40-60mg) may be continued, and thyroxine added once the serum thyroxine falls to within the normal range. Thyroxine dose is then adjusted according to symptoms and aiming for a normal serum TSH level.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Agranulocytosis is an uncommon but important side effect of all anti-thyroid drugs. Patients should receive written and verbal &lt;a href="http://www.endobible.com/investigation/carbimazole-warning-sheet/" target="_blank" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;warnings&lt;/a&gt; to discontinue the drug until they have had a blood count checked if they develop a severe sore throat or mouth ulcers.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Mild neutropaenia &amp;lt;1.5x10*9 is commonly observed in people with Graves disease, some racial groups and with anti-thyroid drugs.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count 1-1.5 - continue drug but institute close monitoring of blood count. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count &amp;lt;1 - stop antithyroid drug and monitor blood count daily.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count &amp;lt;1 with suspected sepsis or in the unwell patient - stop antithyroid drug and arrange urgent admission. Treat as for neutropaenic sepsis, remembering that pseudomonas is a common infective organism in this group. Monitor blood count every 12 hours initially and take haematological advice. Bone marrow biopsy may be helpful to determine response. Granulocyte-colony stimulating factor (GCSF) should be considered after haematology review of the patient's response to drug cessation. DO NOT RECHALLENGE THE PATIENT WITH AN ALTERNATIVE ANTI-THYROID DRUG.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Rash is common and usually controlled by antihistamines. Alternatively switch to alternative anti-thyroid drug.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Arthralgia and arthritis are uncommon with carbimazole but more common with PTU. Stop the drug. Check antibody screen including ANCA for drug induced lupus and discuss wtih rheumatologist. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Mild abnormalities of liver function are common with thyrotoxicosis and do not require treatment. Mild transaminitis (&amp;lt;1.6x upper limit of normal) is also common after 3 months therapy with PTU and does not require treatment or monitoring unless baseline liver function was abnormal.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Allergic hepatitis with submassive necrosis occurs in 0.1-0.2% of patients receiving PTU. Stop PTU and involve a hepatologist immediately if this is suspected.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Carbimazole is not associated with this condition, but may cause a cholestatic picture of abnormal liver function. Stop the drug and inform hepatology if this is suspected, though complete resolution is normal on drug withdrawal. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;It is usual to start medical treatment at presentation particularly in those with severe biochemical disease in order to allow them to make an informed decision regarding long term management. However, radioactive iodine is the best long term treatment for thyrotoxicosis in most cases.&lt;/p&gt;
&lt;p&gt;Detailed &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.rcplondon.ac.uk/Pubs/contents/0621b67a-4880-4a1b-9942-57a666efee4a.pdf"&gt;guidance&lt;/a&gt; on the indications and precautions needed for radioactive iodine are available. Radioactive iodine is highly effective at rendering patients euthyroid, usually after one treatment, and offers the advantage of preventing future recurrence in auto-immune thyroid disease. Patients must be warned about standard radiation precautions, and given &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/info-for-patients/Docs/bta_patient_hyperthyroidism.pdf%20"&gt;written information&lt;/a&gt; about this and other available treatments. Patients should also be warned that transient thyroid swelling may occur, repeat applications may be necessary, long term monitoring is required, and hypothyroidism requiring thyroxine replacement therapy may ensue.&lt;/p&gt;
&lt;p&gt;Radioactive iodine is absolutely contraindicated in pregnancy. Women should also be advised to avoid conception for six months, and men should avoid fathering children for four months following radioactive iodine treatment. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid function should be assessed at 6 and 12 weeks post radioactive iodine, then at least every three months for the first year after radioactive iodine, and then annually thereafter for emerging hypothyroidism or for recurrent thyrotoxicosis.&lt;/p&gt;
&lt;p&gt;Subsequent &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypothyroidism/management"&gt;hypothyroidism&lt;/a&gt; should be treated conventionally.&lt;/p&gt;
&lt;p&gt;Subsequent recurrence of hyperthyroidism may occur, and should be treated with a repeat application of radioactive iodine.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;
&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.rcplondon.ac.uk/Pubs/contents/0621b67a-4880-4a1b-9942-57a666efee4a.pdf" style="text-decoration: none; color: rgb(236, 0, 140); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt;Radioactive iodine&lt;/a&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt; should be discussed with an experienced ophthalmologist in the case of suspected Graves' eye disease, as 15% patients may experience new or worsened ophthalmopathy within 6 months of treatment, though it is usually mild. Mild to moderate eye disease does not preclude the use of radioactive iodine, but it is standard practise to render the patient euthyroid medically, ensure the patient has given up smoking if relevant, and confirm that their eye disease is inactive before treatment.  The ophthalmologist will also advise whether an individual patient will require &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18299459" target="_blank" style="text-decoration: none; color: rgb(236, 0, 140); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt;prophylactic treatment&lt;/a&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16.666667938232422px; "&gt; to reduce this risk. If so, a course of ,3 months prednisolone is usually given. In our institution, we have adopted a low dose regimen: 1 day before radioactive iodine is administered, patients start on 0.3mg/kg prednisolone for one week, with the dose reduced gradually over a six week course (eg 25mg then 20mg, 15mg, 10mg, 5mg, 2,5mg for one week each). Bisphosphonate cover is only given if the course is anticipated to last for more than three months. Proton pump inhibitors are considered in patients at high risk of gastrointestingal bleeding (previous ulcer, or taking concomitant aspirin, clopidogrel, warfarin, bisphosphonate or selective serotonin reuptake inhibitor) but are not given routinely.&lt;/span&gt;&lt;/p&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Surgery is rarely recommended as a first line treatment for straight forward thyrotoxicosis. However, all options should be discussed with patients to allow an informed choice to be made.&lt;/p&gt;
&lt;p&gt;Patients who do not tolerate medical therapy, or who require life long treatment but are unsuitable for radioactive iodine, should strongly consider surgery as a definitive treatment. Surgery may also be used during the second trimester of pregnancy, if severe thyrotoxicosis cannot be controlled medically. Patients with obstructive symptoms from nodular disease are also recommended surgery in most cases. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;After treatment for thyrotoxicosis, most patients can be followed up by their family physician long term with an annual TSH alone. This is sufficient to monitor thyroxine replacement, or detect early recurrence of thyrotoxicosis. Patients will auto-immune thyroid disease are at increased risk of developing further auto-immune conditions, though routine monitoring is not generally necessary if their initial screening tests were satisfactory. &lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease. &lt;/p&gt;
&lt;p&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;B12 deficiency may indicate associated pernicious anaemia or coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypokalaemia may occur in association with thyrotoxicosis with hypokalaemic periodic paralysis, which is more common in people of Chinese ethnic origin.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function should be tested at baseline before starting medical treatments.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypercalcaemia may occur with thyrotoxicosis and glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Addison's disease may be associated with auto-immune thyrotoxicosis. A 9am cortisol can be a useful screen, although a &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/synacthen-test/"&gt;synacthen&lt;/a&gt; test is required to formally exclude this condition. Serum cortisol levels below 250nmol/l demand thorough assessment, levels above 590nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Ensure patients have stopped sex steroid therapy, for example HRT or the combined oral contraceptive pill for six weeks prior to test.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A low TSH confirms a clinical suspicion of hyperthyroidism.&lt;/p&gt;
&lt;p&gt;TSH levels within the normal range imply normal thyroid function, except in those with potential pituitary disease, in whom a normal TSH may be seen with hypothyroidism.&lt;/p&gt;
&lt;p&gt;Ideal treatment of thyroid disease is reflected by control of symptoms and a serum TSH in the middle of the reference range approximately 1mU/L.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;TSH and free thyroxine should be tested together in all patients suspected of having thyroid dysfunction.&lt;/p&gt;
&lt;p&gt;Elevated thyroxine implies hyperthyroidism of any cause. The level of this elevation is a useful indicator of disease severity.&lt;/p&gt;
&lt;p&gt;Elevated thyroxine combined with suppressed TSH confirms the cause to be primary hyperthyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;ECG should be performed in all patients at baseline to document and confirm any arrhythmias or other changes.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;There are multiple different tests available for thyroid auto-antibodies, with varying levels of sensitivity.&lt;/p&gt;
&lt;p&gt;Thyroid peroxidise (TPO) antibodies are commonly used as an initial screen and may be positive in patients with any auto-immune thyroid condition. Higher titres occur in patients with Hashimoto’s thyroiditis and hypothyroidism.&lt;/p&gt;
&lt;p&gt;TSH receptor stimulating antibodies occur specifically in Graves' disease, and may be particularly helpful in the assessment of pregnant patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Free liothyronine levels are not usually necessary for the assessment and treatment of thyrotoxicosis, though they may be useful if the TSH is suppressed and thyroxine level normal. The pattern of an elevated liothyronine, suppressed TSH, and normal thyroxine is known as 'T3 toxicosis', and is often seen with nodular thyroid disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with auto-immune thyroid dysfunction are at increased risk of developing diabetes mellitus.&lt;/p&gt;
&lt;p&gt;Falling insulin requirements, hypoglycaemia or new weight loss may all be early signs of thyrotoxicosis or of Addison's disease in patients with established diabetes.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound scan may be helpful where the aetiology of hyperthyroidism is unclear, and nodular disease is suspected. This is not required in thyrotoxicosis with positive antibodies or eye signs as the diagnosis of Graves' disease is apparent.&lt;/p&gt;
&lt;p&gt;Ultrasound scan is essential in the assessment of palpable &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.aace.com/pub/pdf/guidelines/thyroid_nodules.pdf%20"&gt;thyroid nodules&lt;/a&gt; and to guide how, and whether, to perform fine needle aspiration.&lt;/p&gt;
&lt;p&gt;Ultrasound scan with colour doppler flow may be useful in patients with thyrotoxicosis, who are taking amiodarone therapy to determine whether the gland is inflamed and so determine the best treatment approach (steroids or anti-thyroid drugs).&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Bone mineral density should be assessed where there is clinical suspicion of osteoporosis, for example in some older patients with biochemical thyrotoxicosis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with coeliac disease may well have low serum vitamin D levels.&lt;/p&gt;
&lt;p&gt;In patients with known or suspected osteoporosis, serum vitamin D levels will guide whether routine calcium and vitamin D supplementation is enough, or whether specific high dose vitamin D replacement is required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful in patients with acute thyrotoxicosis to help distinguish between Graves' disease, in which case the whole gland will have increased uptake, or viral or other forms of thyroiditis, in which case the gland will not take up iodine.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Tissue transglutaminase and anti gliadin antibodies should be checked if there is clinical suspicion of coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A short &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/synacthen-test/"&gt;synacthen&lt;/a&gt; test must be performed if there is clinical or biochemical suspicion of Addison’s disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Fine needle aspiration should be performed on any &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/thyroid-nodule/"&gt;suspicious nodules&lt;/a&gt;. Ultrasound scanning improves the safety and efficacy of this procedure.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Serum B12 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>9am cortisol 
				</value><value>Thyroid stimulating hormone 
				</value><value>Free thyroxine 
				</value><value>Electrocardiogram 
				</value><value>Thyroid auto-antibody screen 
				</value><value>Free liothyronine 
				</value><value>HbA1c and fasting glucose 
				</value><value>Thyroid ultrasound scan 
				</value><value>Bone densitometry 
				</value><value>Vitamin D levels 
				</value><value>Thyroid radionucleide uptake scan 
				</value><value>Coeliac auto-antibody screen 
				</value><value>Short synacthen test 
				</value><value>Ultrasound guided fine needle aspiration 
				</value></CQueInv><CCondName><value>Thyrotoxicosis or hyperthyroidism</value></CCondName><CQueMgt><value>Any suspicious characteristics 
				</value><value>Suspected eye disease 
				</value><value>All patients should be advised to stop smoking 
				</value><value>Pregnancy and fertility plans should be discussed with all patients 
				</value><value>Medical treatment of thyrotoxicosis 
				</value><value>Dose titration and thyroid function testing 
				</value><value>Treatment duration and likelihood of relapse 
				</value><value>Block and replace regimes 
				</value><value>Common side effects of antithyroid drugs 
				</value><value>Radioactive iodine should be offered to all patients with thyrotoxicosis 
				</value><value>Post radioactive iodine monitoring and treatment 
				</value><value>Graves' ophthalmopathy may be exacerbated by radioactive iodine therapy 
				</value><value>Surgery should be discussed with all patients 
				</value><value>Long term follow up 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/</value><value>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/examination</value><value>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/investigation</value><value>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/management</CURLMgt><CURLTop>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/</CURLTop><CURLInv>http://www.endobible.com/condition/thyrotoxicosis-or-hyperthyroidism/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients in whom a histological or biochemical diagnosis of a NET has been made require a full assessment.&lt;/p&gt;
&lt;p&gt;This should include fasting gut hormones and 2x24hr collections for 5HIAA in all cases. Baseline imaging should include cross sectional imaging CT or MRI of the chest, abdomen and pelvis, octreotide and MIBG scans, and further bowel imaging with endoscopy and barium imaging if indicated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All treatment options and follow up arrangements should be considered by a multidisciplinary team.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Typical doses would be 600mg of subcutaneous octreotide daily in divided doses, which may immediately control the symptoms of diarrhoea and flushing.&lt;/p&gt;
&lt;p&gt;A depot somatostatin analogue should then be started. This may not control symptoms immediately, so it is standard practise to continue octreotide for the first seven to ten days.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Where local symptoms are prominent, for example with sub acute bowel obstruction, surgery may be very effective.&lt;/p&gt;
&lt;p&gt;Tumour debulking may also be attempted depending on the site, size and stage of the disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MIBG treatment may be highly effective at controlling metastatic disease in those with positive uptake scans.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This may also be effective in patients with positive uptake scans, though is less widely available than MIBG treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This may be appropriate for large and symptomatic hepatic metastases.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Streptozocin and 5 flurouracil containing chemotherapy regimes may be highly effective for metastatic disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Somatostatin analogues&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These may reduce peptide hormone release dramatically and so improve diarrhoea, flushing and other symptoms.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Steroids&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hypoglycaemia of insulinomas may respond at least transiently to oral steriods.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Diazoxide&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This treatment is effective for hypoglycaemia but may cause oedema, hypertrichosis and hypokalaemia.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value>Assessment at diagnosis 
				</value><value>Refer to multidisciplinary meeting 
				</value><value>Treatment should be started with somatostatin analogues 
				</value><value>Consider surgery 
				</value><value>Meta-iodobenzylguianidine therapy 
				</value><value>Octreotide therapy 
				</value><value>Hepatic artery embolisation 
				</value><value>Chemotherapy 
				</value><value>Medical therapies for symptom control 
				</value></CQueMgt><CQueInv><value>Calculate height velocity 
				</value><value>Full blood count, ESR and ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Antiendomyseal and antigliadin antibodies 
				</value><value>Glycosylated haemoglobin and fasting glucose and lipids 
				</value><value>Growth hormone 
				</value><value>IGF-I and IGF-BP-3 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary and MRI olfactory bulbs 
				</value><value>Bone age 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram 
				</value><value>Echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Parathyroid hormone 
				</value><value>Karyotype 
				</value><value>Hearing test 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="background-color: white; font-size: 9pt; "&gt;H&lt;/span&gt;&lt;span style="background-color: white; color: rgb(99, 97, 85); font-size: 9pt; "&gt;eight velocity requires a minimum of 6 months measurements. Age needs to be decimalised ie 10.5 years, not 10 years 6 months. This is expressed cm/year.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;b&gt;&lt;span style='font-size:13.5pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:#939598;mso-fareast-language:
EN-GB'&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:
Calibri;background:white"&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency. Low ferritin may also be a marker of malnutrition.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;ESR is an important screen for inflammatory conditions such as Crohn's disease or juvenile chronic arthritis.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
background:white"&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Important indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function test may be surprisingly normal in liver disease. Albumin is a marker of malnutrition. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hypercalcaemia may occur with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with short stature should be screened for Coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypoadrenal patients may have hypoglycaemia. Diabetes mellitus is usually clinically obvious but needs to be ruled out in patients with weight loss.&lt;/p&gt;
&lt;p&gt;Baseline assessment of lipids is also useful in patients with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In newborns, a single serum growth hormone level of less than 7 microgram/L (taken between days 3 and 5) confirms a diagnosis of neonatal GHD.&lt;/p&gt;
&lt;p&gt;After the newborn period, a single random serum growth hormone level over 7mcg/l is reassuring but does not exclude GH deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;These are useful tests for diagnosing severe GHD. Low IGF-I is in keeping with GH deficiency, in the presence of low GH secretion. &lt;/p&gt;
&lt;p&gt;In mild GHD, peak GH 5-7ng/ml, IGF-I and IGFBP-3 have lower diagnostic sensitivity and may be normal. Patients who have a deficiency of 3 or more pituitary hormones and an IGF-1 level of &amp;lt;50ng/ml can be considered to have GHD and may not require provocative testing.&lt;/p&gt;
&lt;p&gt;Low serum IGF-I should be interpreted cautiously as it may be associated with poor nutrition, or chronic illness. Serum IGFBP-3 concentration is generally less helpful that IGF-I for the diagnosis of GHD, except in very young children when IGF-I may be unreliable.&lt;/p&gt;
&lt;p&gt;In pubertal children, these tests are less reliable and dynamic testing will be required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estradial/testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These should be in the prepubertal range in children presenting with short stature prior to or associated with delayed puberty. This confirms that dynamic testing of GH reserve will require stilboestrol (1.0mg twice daily for the two days prior to the GH provocation test in both boys and girls) priming.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Age and pubertal stage related reference ranges are available to aid the interpretation of LH and FSH. Pre puberty, these are expected to be low. Post completion of puberty, if the sex hormones are confirmed as low, then low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) may indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example primary or auto-immune ovarian failure, or secondary to mumps or testicular trauma in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia in a child with short stature may be suggestive of pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Hypoprolactinaemia may also be seen in some genetic causes of hypopituitarism.&lt;/p&gt;
&lt;p&gt;Serum prolactin is affected by many factors, for example stress, nipple stimulation, interfering medications and PCOS, and so if elevated, should be repeated on at least two occasions. Elevated prolactin levels should also prompt the PEG precipitation test to determine whether this is biologically active or the inactive 'macroprolactin'.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis commonly causes weight loss but thyrotoxic children are almost always tall. &lt;/p&gt;
&lt;p&gt;Thyroid dysfunction is also more common in people with Turner syndrome.&lt;/p&gt;
&lt;p&gt;It is essential to assess levels of both thyroxine and TSH in patients suspected of pituitary disease and prior to a GH provocation test.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 500nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with pituitary disease and levels below this may require formal assessment for ACTH reserve, for example with an &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;insulin&lt;/a&gt; stress test or &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;glucagon&lt;/a&gt; test.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI pituitary should be performed in all patients with confirmed GH deficiency to seek underlying pathology, and in patients presenting later with hypogonadotropic hypogonadism. Patients with suspected Kallman's syndrome also require MRI of the olfactory bulbs in patients. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18955511" target="_blank"&gt;Late onset&lt;/a&gt;, mild, isolated hypogonadism may not require imaging however.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph of the left hand and wrist to assess bone age in patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A chest XR should be performed in all patients with multiple congenital abnormalities and with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is usefully performed at presentation in adults as it is required prior to starting dopamine agonist therapy or testing dynamic pituitary function if necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed to seek coarctation of the aorta or bicuspid aortic valve in patients with confirmed Turner's syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner’s and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; (ITT) should be performed if GH deficiency is suspected, and will also detect ACTH deficiency subject to the usual safety exclusion criteria. ITT should not be performed in young children, or when there is a history of convulsions, and never in infants. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon&lt;/a&gt; testing should be performed as a second confirmatory test of GH deficiency, or if an insulin stress test is contraindicated due to age or the patient's condition.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is generally considered the second best &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;dynamic test&lt;/a&gt; of GH reserve. However, this may also be performed without GHRH (in which case the interpretation is the same as an insulin stress test) in patients with suspected hypothalamic problems eg irradiation, as they may not mount the typical exuberant response to GHRH.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in patients with long standing nutritional deficiency, chronic illness, hypopituitarism or severe delay of puberty. This should also be considered in all patients with long standing hypogonadism and it may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with the phenotypic features of pseudohypoparathyroidism should have PTH levels documented to determine their underlying diagnosis.&lt;/p&gt;
&lt;p&gt;Levels will be low in hypoparathyroidism, high in pseudohypoparathyroidism, and normal in patients with pseudopseudohypoparathyrdoidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all girls presenting with short stature to exclude Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner's syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/neuro-endocrine-tumours/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/short-stature/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be offered to all patients at, or soon after, diagnosis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If there is any doubt that hypogonadotropic hypogonadism may not be isolated, consider dynamic function testing.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If karyotype is apparently normal, then other causes of hypogonadotropic hypogonadism are possible. Thorough investigation should therefore be performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Delayed bone age supports the diagnosis of absent puberty. Growth hormone treatment should be considered in those with short stature and delayed bone age. This decision should be undertaken in conjunction with an experienced paediatric endocrinologist.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16px; "&gt;In Turner syndrome (TS) and Noonan syndrome (not licensed by the EMEA) growth is improved by treatment with growth hormone if the condition is detected prior to epiphyseal fusion. GH 0.05-0.067mg/kg/day is recommended. &lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 16px; "&gt;Statural growth should be monitored 6 monthly to determine treatment response, and allow dose titration and to confirm when final height is reached. During treatment, GH dose may be increased within the range above if there is a poor response in growth velocity. Once height stabilises, GH should be stopped unlike paediatric GH deficiency.&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If appropriate, fertility should be discussed early with the patient and their family.&lt;/p&gt;
&lt;p&gt;Patients need to understand that successful pubertal induction will not affect or restore fertility, although appropriate uterine development is necessary prior to possible future pregnancies.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;At confirmation of diagnosis, arrange the following tests in all cases: karyotype analysis, echocardiogram, renal ultrasound scan, pelvic ultrasound scan, bone densitometry scan, thyroid stimulating hormone, free thyroxine, thyroid and coeliac antibody screen, urea and electrolytes, liver function test, bone profile, fasting lipid profile, fasting glucose and HbA1c.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss treatment aims, timescales and outcomes&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Treatment aims to replicate the natural process of puberty and should occur over approximately the same timescale - approximately two to three years. Breast development and secondary sexual hair should occur. Some bleeding may occur during pubertal induction, at which point, cyclical progesterone should be added.&lt;/p&gt;
&lt;p&gt;Patients need to understand that accelerating the treatment may have adverse psychological and physical consequences, for example poor breast development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;The timing of estrogen initiation requires careful consideration on an individual case basis. The aim is to replicate natural puberty, without reducing potential gains in height that may be achieved with growth hormone. The decision needs to take into account the level of spontaneous pubertal development, current height, age at diagnosis and the patient wishes regarding GH therapy. Estrogen therapy should generally be started at the physiological age of puberty i.e. around 11 to 12 years. Delay of induction of puberty could have negative effects on uterine growth and secondary sexual characteristics.  &lt;/p&gt;
&lt;p&gt;Typical starting dose in an estrogen naive patient is 1.25mcg ethinylestradiol. Increase dose to 2.5mcg, then by 2.5mcg increments every six months to 10mcg. The dose may then increase to 15mcg.&lt;/p&gt;
&lt;p&gt;An alternative is to use topical estrogen therapy. This may give a better eventual breast shape, and is well tolerated, with the patches often easier to source in the community than low dose ethinylestradiol. A typical start dose is with one quarter of a 25mcg Estradiol patch given either overnight every day, or left on and replaced every 72 hours. The dose should then increase every 3-4 months to half a patch, then a whole 25mcg patch, then a 50mcg patch, then a 75mcg, then a 100mcg patch.  &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider pelvic ultrasound scan to assess uterine size at this stage.&lt;/p&gt;
&lt;p&gt;Once the patient experiences vaginal bleeding or if the patient has tolerated 15mcg orally, or 100mcg transdermally, consider adding cyclical progesterone. Measurement of LH and FSH levels may also be used to help judge whether the final dose of topic estradiol is sufficient, as some girls will require higher doses.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatment regimens&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for, cardiovascular or thromboembolic disease will also need to be considered.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia e.g. 1x350mcg progesterone only pill daily.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Duration of treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Continue sex hormone replacement therapy until the time of the natural menopause - typically to age 50.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Vaginal gels&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Topical estrogen may be beneficial to help vaginal dryness.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients should be offered life long annual follow up. The following tests should be arranged prior to every review: thyroid stimulating hormone, free thyroxine, urea and electrolytes, liver function test, fasting lipid profile, fasting glucose and HbA1c.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Every three to five years, consider repeating the following tests: echo three to five yearly; thyroid/coeliac antibodies five yearly; hearing test five yearly; and, bone densitometry scan recommended five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Cardiac magnetic resonance imaging and uterine ultrasound scan should be performed prior to considering pregnancy.&lt;/p&gt;
&lt;p&gt;Patients will require referral to a specialist fertility unit. In vitro fertilisation, using a donor egg, may be necessary.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value>Genetic counselling 
				</value><value>Review baseline pituitary function 
				</value><value>MRI pituitary 
				</value><value>Assess bone age in all children presenting with Turner syndrome 
				</value><value>Consider growth hormone therapy for short stature 
				</value><value>Discuss fertility issues at, or soon after, diagnosis 
				</value><value>Screening required at diagnosis 
				</value><value>Hormone replacement therapy 
				</value><value>Annual follow up 
				</value><value>Three to five yearly follow up 
				</value><value>Pre-pregnancy 
				</value></CQueMgt><CQueInv><value>Calculate height velocity 
				</value><value>Full blood count, ESR and ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Antiendomyseal and antigliadin antibodies 
				</value><value>Glycosylated haemoglobin and fasting glucose and lipids 
				</value><value>Growth hormone 
				</value><value>IGF-I and IGF-BP-3 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary and MRI olfactory bulbs 
				</value><value>Bone age 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram 
				</value><value>Echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Parathyroid hormone 
				</value><value>Karyotype 
				</value><value>Hearing test 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="background-color: white; font-size: 9pt; "&gt;H&lt;/span&gt;&lt;span style="background-color: white; color: rgb(99, 97, 85); font-size: 9pt; "&gt;eight velocity requires a minimum of 6 months measurements. Age needs to be decimalised ie 10.5 years, not 10 years 6 months. This is expressed cm/year.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;b&gt;&lt;span style='font-size:13.5pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:#939598;mso-fareast-language:
EN-GB'&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:
Calibri;background:white"&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency. Low ferritin may also be a marker of malnutrition.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;ESR is an important screen for inflammatory conditions such as Crohn's disease or juvenile chronic arthritis.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
background:white"&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Important indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function test may be surprisingly normal in liver disease. Albumin is a marker of malnutrition. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hypercalcaemia may occur with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with short stature should be screened for Coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypoadrenal patients may have hypoglycaemia. Diabetes mellitus is usually clinically obvious but needs to be ruled out in patients with weight loss.&lt;/p&gt;
&lt;p&gt;Baseline assessment of lipids is also useful in patients with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In newborns, a single serum growth hormone level of less than 7 microgram/L (taken between days 3 and 5) confirms a diagnosis of neonatal GHD.&lt;/p&gt;
&lt;p&gt;After the newborn period, a single random serum growth hormone level over 7mcg/l is reassuring but does not exclude GH deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;These are useful tests for diagnosing severe GHD. Low IGF-I is in keeping with GH deficiency, in the presence of low GH secretion. &lt;/p&gt;
&lt;p&gt;In mild GHD, peak GH 5-7ng/ml, IGF-I and IGFBP-3 have lower diagnostic sensitivity and may be normal. Patients who have a deficiency of 3 or more pituitary hormones and an IGF-1 level of &amp;lt;50ng/ml can be considered to have GHD and may not require provocative testing.&lt;/p&gt;
&lt;p&gt;Low serum IGF-I should be interpreted cautiously as it may be associated with poor nutrition, or chronic illness. Serum IGFBP-3 concentration is generally less helpful that IGF-I for the diagnosis of GHD, except in very young children when IGF-I may be unreliable.&lt;/p&gt;
&lt;p&gt;In pubertal children, these tests are less reliable and dynamic testing will be required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estradial/testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These should be in the prepubertal range in children presenting with short stature prior to or associated with delayed puberty. This confirms that dynamic testing of GH reserve will require stilboestrol (1.0mg twice daily for the two days prior to the GH provocation test in both boys and girls) priming.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Age and pubertal stage related reference ranges are available to aid the interpretation of LH and FSH. Pre puberty, these are expected to be low. Post completion of puberty, if the sex hormones are confirmed as low, then low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) may indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example primary or auto-immune ovarian failure, or secondary to mumps or testicular trauma in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia in a child with short stature may be suggestive of pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Hypoprolactinaemia may also be seen in some genetic causes of hypopituitarism.&lt;/p&gt;
&lt;p&gt;Serum prolactin is affected by many factors, for example stress, nipple stimulation, interfering medications and PCOS, and so if elevated, should be repeated on at least two occasions. Elevated prolactin levels should also prompt the PEG precipitation test to determine whether this is biologically active or the inactive 'macroprolactin'.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis commonly causes weight loss but thyrotoxic children are almost always tall. &lt;/p&gt;
&lt;p&gt;Thyroid dysfunction is also more common in people with Turner syndrome.&lt;/p&gt;
&lt;p&gt;It is essential to assess levels of both thyroxine and TSH in patients suspected of pituitary disease and prior to a GH provocation test.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 500nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with pituitary disease and levels below this may require formal assessment for ACTH reserve, for example with an &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;insulin&lt;/a&gt; stress test or &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;glucagon&lt;/a&gt; test.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI pituitary should be performed in all patients with confirmed GH deficiency to seek underlying pathology, and in patients presenting later with hypogonadotropic hypogonadism. Patients with suspected Kallman's syndrome also require MRI of the olfactory bulbs in patients. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18955511" target="_blank"&gt;Late onset&lt;/a&gt;, mild, isolated hypogonadism may not require imaging however.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph of the left hand and wrist to assess bone age in patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A chest XR should be performed in all patients with multiple congenital abnormalities and with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is usefully performed at presentation in adults as it is required prior to starting dopamine agonist therapy or testing dynamic pituitary function if necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed to seek coarctation of the aorta or bicuspid aortic valve in patients with confirmed Turner's syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner’s and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; (ITT) should be performed if GH deficiency is suspected, and will also detect ACTH deficiency subject to the usual safety exclusion criteria. ITT should not be performed in young children, or when there is a history of convulsions, and never in infants. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon&lt;/a&gt; testing should be performed as a second confirmatory test of GH deficiency, or if an insulin stress test is contraindicated due to age or the patient's condition.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is generally considered the second best &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;dynamic test&lt;/a&gt; of GH reserve. However, this may also be performed without GHRH (in which case the interpretation is the same as an insulin stress test) in patients with suspected hypothalamic problems eg irradiation, as they may not mount the typical exuberant response to GHRH.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in patients with long standing nutritional deficiency, chronic illness, hypopituitarism or severe delay of puberty. This should also be considered in all patients with long standing hypogonadism and it may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with the phenotypic features of pseudohypoparathyroidism should have PTH levels documented to determine their underlying diagnosis.&lt;/p&gt;
&lt;p&gt;Levels will be low in hypoparathyroidism, high in pseudohypoparathyroidism, and normal in patients with pseudopseudohypoparathyrdoidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all girls presenting with short stature to exclude Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner's syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/paediatric-turner-syndrome/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/short-stature/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;At diagnosis of MEN1, patients should undergo genetic testing, full blood count, urea and electrolytes, liver function, bone profile for calcium, parathyroid hormone, baseline pituitary function including prolactin, and fasting gut hormones.&lt;/p&gt;
&lt;p&gt;Chest radiograph, CT pancreas and MRI pituitary are also performed at diagnosis. Imaging is not repeated routinely in MEN1 patients, unless clinically indicated by new symptoms, or a rise in pituitary or gut hormones.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Each complication of MEN1 should be investigated and treated in the standard way for that condition. See management of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypercalcaemia/management"&gt;hypercalcaemia&lt;/a&gt;, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hyperprolactinaemia/management"&gt;prolactinoma&lt;/a&gt;, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-syndrome/management"&gt;Cushing’s&lt;/a&gt;, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/acromegaly/management"&gt;acromegaly&lt;/a&gt;, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/non-functioning-pituitary-adenoma/management"&gt;non functioning pituitary adenomas&lt;/a&gt;, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/insulinoma/management"&gt;insulinomas&lt;/a&gt;, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/neuro-endocrine-tumours/management"&gt;neuro-endocrine tumours&lt;/a&gt;.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients with confirmed MEN1 should be followed up on an annual basis life long to detect and treat complications.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should include: reassessment of family history, full blood count, urea and electrolytes, liver function test, bone profile, fasting glucose, fasting gut peptides and prolactin.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Chest radiograph should be repeated every three years.&lt;/p&gt;
&lt;p&gt;CT pancreas and MRI pituitary should be repeated if clinically indicated.&lt;/p&gt;
&lt;p&gt;Imaging and follow-up must be repeated more frequently when lesions are detected.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All first degree relatives should be followed up in the same way as confirmed cases, until genetic screening is negative.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value>Screening at diagnosis 
				</value><value>Complications 
				</value><value>Annual follow up 
				</value><value>Annual screen 
				</value><value>Further imaging 
				</value><value>Family members 
				</value></CQueMgt><CQueInv><value>Calculate height velocity 
				</value><value>Full blood count, ESR and ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Antiendomyseal and antigliadin antibodies 
				</value><value>Glycosylated haemoglobin and fasting glucose and lipids 
				</value><value>Growth hormone 
				</value><value>IGF-I and IGF-BP-3 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary and MRI olfactory bulbs 
				</value><value>Bone age 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram 
				</value><value>Echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Parathyroid hormone 
				</value><value>Karyotype 
				</value><value>Hearing test 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="background-color: white; font-size: 9pt; "&gt;H&lt;/span&gt;&lt;span style="background-color: white; color: rgb(99, 97, 85); font-size: 9pt; "&gt;eight velocity requires a minimum of 6 months measurements. Age needs to be decimalised ie 10.5 years, not 10 years 6 months. This is expressed cm/year.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;b&gt;&lt;span style='font-size:13.5pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:#939598;mso-fareast-language:
EN-GB'&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:
Calibri;background:white"&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency. Low ferritin may also be a marker of malnutrition.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;ESR is an important screen for inflammatory conditions such as Crohn's disease or juvenile chronic arthritis.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
background:white"&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Important indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function test may be surprisingly normal in liver disease. Albumin is a marker of malnutrition. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hypercalcaemia may occur with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with short stature should be screened for Coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypoadrenal patients may have hypoglycaemia. Diabetes mellitus is usually clinically obvious but needs to be ruled out in patients with weight loss.&lt;/p&gt;
&lt;p&gt;Baseline assessment of lipids is also useful in patients with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In newborns, a single serum growth hormone level of less than 7 microgram/L (taken between days 3 and 5) confirms a diagnosis of neonatal GHD.&lt;/p&gt;
&lt;p&gt;After the newborn period, a single random serum growth hormone level over 7mcg/l is reassuring but does not exclude GH deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;These are useful tests for diagnosing severe GHD. Low IGF-I is in keeping with GH deficiency, in the presence of low GH secretion. &lt;/p&gt;
&lt;p&gt;In mild GHD, peak GH 5-7ng/ml, IGF-I and IGFBP-3 have lower diagnostic sensitivity and may be normal. Patients who have a deficiency of 3 or more pituitary hormones and an IGF-1 level of &amp;lt;50ng/ml can be considered to have GHD and may not require provocative testing.&lt;/p&gt;
&lt;p&gt;Low serum IGF-I should be interpreted cautiously as it may be associated with poor nutrition, or chronic illness. Serum IGFBP-3 concentration is generally less helpful that IGF-I for the diagnosis of GHD, except in very young children when IGF-I may be unreliable.&lt;/p&gt;
&lt;p&gt;In pubertal children, these tests are less reliable and dynamic testing will be required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estradial/testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These should be in the prepubertal range in children presenting with short stature prior to or associated with delayed puberty. This confirms that dynamic testing of GH reserve will require stilboestrol (1.0mg twice daily for the two days prior to the GH provocation test in both boys and girls) priming.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Age and pubertal stage related reference ranges are available to aid the interpretation of LH and FSH. Pre puberty, these are expected to be low. Post completion of puberty, if the sex hormones are confirmed as low, then low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) may indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example primary or auto-immune ovarian failure, or secondary to mumps or testicular trauma in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia in a child with short stature may be suggestive of pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Hypoprolactinaemia may also be seen in some genetic causes of hypopituitarism.&lt;/p&gt;
&lt;p&gt;Serum prolactin is affected by many factors, for example stress, nipple stimulation, interfering medications and PCOS, and so if elevated, should be repeated on at least two occasions. Elevated prolactin levels should also prompt the PEG precipitation test to determine whether this is biologically active or the inactive 'macroprolactin'.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis commonly causes weight loss but thyrotoxic children are almost always tall. &lt;/p&gt;
&lt;p&gt;Thyroid dysfunction is also more common in people with Turner syndrome.&lt;/p&gt;
&lt;p&gt;It is essential to assess levels of both thyroxine and TSH in patients suspected of pituitary disease and prior to a GH provocation test.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 500nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with pituitary disease and levels below this may require formal assessment for ACTH reserve, for example with an &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;insulin&lt;/a&gt; stress test or &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;glucagon&lt;/a&gt; test.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI pituitary should be performed in all patients with confirmed GH deficiency to seek underlying pathology, and in patients presenting later with hypogonadotropic hypogonadism. Patients with suspected Kallman's syndrome also require MRI of the olfactory bulbs in patients. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18955511" target="_blank"&gt;Late onset&lt;/a&gt;, mild, isolated hypogonadism may not require imaging however.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph of the left hand and wrist to assess bone age in patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A chest XR should be performed in all patients with multiple congenital abnormalities and with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is usefully performed at presentation in adults as it is required prior to starting dopamine agonist therapy or testing dynamic pituitary function if necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed to seek coarctation of the aorta or bicuspid aortic valve in patients with confirmed Turner's syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner’s and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; (ITT) should be performed if GH deficiency is suspected, and will also detect ACTH deficiency subject to the usual safety exclusion criteria. ITT should not be performed in young children, or when there is a history of convulsions, and never in infants. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon&lt;/a&gt; testing should be performed as a second confirmatory test of GH deficiency, or if an insulin stress test is contraindicated due to age or the patient's condition.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is generally considered the second best &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;dynamic test&lt;/a&gt; of GH reserve. However, this may also be performed without GHRH (in which case the interpretation is the same as an insulin stress test) in patients with suspected hypothalamic problems eg irradiation, as they may not mount the typical exuberant response to GHRH.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in patients with long standing nutritional deficiency, chronic illness, hypopituitarism or severe delay of puberty. This should also be considered in all patients with long standing hypogonadism and it may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with the phenotypic features of pseudohypoparathyroidism should have PTH levels documented to determine their underlying diagnosis.&lt;/p&gt;
&lt;p&gt;Levels will be low in hypoparathyroidism, high in pseudohypoparathyroidism, and normal in patients with pseudopseudohypoparathyrdoidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all girls presenting with short stature to exclude Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner's syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/multiple-endocrine-neoplasia-type-1/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/short-stature/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;History&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Lack of weight gain, long standing symptoms and a clear relationship to meals are suggestive of reactive hypoglycaemia.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Arrange prolonged OGTT&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is a normal response to OGTT, reassure patient.  &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Reactive hypoglycaemia confirmed&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If reactive hypoglycaemia is evident on the glucose tolerance test, and insulinoma is &lt;u&gt;not&lt;/u&gt; suspected clinically, reassure the patient, arrange dietetic review and give simple advice on eating low glycaemic index foods to minimise symptoms. Severe symptoms may also improve with the alpha glucosidase inhibitor acarbose. Guar gum may also prevent symptoms in some people.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;History&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;A history of weight gain, a short history of typical attacks, a family history suggestive of MEN1, or documented hypoglycaemia are all highly suggestive and mandate admission for a formal fast.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Formal 48-72hr fast&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Fast should be terminated at any stage if the patient develops severe symptoms, such as loss of consciousness or fitting, or if urgent laboratory analysis confirms serum glucose &amp;lt;2.2mmol/l. &lt;/p&gt;
&lt;p&gt;Plasma should be sent for insulin and C peptide measurement as per protocol LINK, and paired blood and spot urine samples also sent for sulphonylurea screen.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Interpreting results&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Normal young women may run blood glucose levels as low as 2.2-3mmol/l. True hypoglycaemia (&amp;lt;2.2mmol/l) should be accompanied by very low insulin and C peptide levels.&lt;/p&gt;
&lt;p&gt;Factitious insulin use should be suspected if low C peptide is found with a detectable insulin level. It may be necessary for further analysis to be performed to detect insulin analogues in the serum in difficult cases. &lt;/p&gt;
&lt;p&gt;Elevated C peptide and insulin in the presence of hypoglycaemia indicates possible insulinoma, although sulphonylurea screen must also be performed at this stage.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Start treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;With biochemically confirmed hypoglycaemia, the fast must be terminated immediately. Emergency glucose administration should also be given, intravenously if necessary, and treatment with diazoxide is usually started.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Diazoxide&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is the first line of treatment. The dose should be uptitrated every 24-48hr to achieve normoglycaemia, although the patient needs to be warned about possible side effects including oedema, hypertrichosis and hypokalaemia.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Intravenous glucose infusion&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This may be necessary in severe cases while oral treatments are uptitrated.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Steroids&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Oral prednisolone may be added to diazoxide if necessary. Hypoglycaemia may respond to this, at least transiently.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Somatostatin analogues&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These may reduce peptide hormone release in neuroendocrine tumours and will usually improve diarrhoea and flushing. This treatment may be considered in insulinoma not responding to standard treatments.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Arrange localising studies and complete baseline investigations&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;CT pancreas is the usual first line investigation after biochemical diagnosis. If the lesion is not clear with this modality, trans abdominal and endoscopic ultrasound scans may be performed. Selective venous sampling with calcium stimulation should also be considered.&lt;/p&gt;
&lt;p&gt;If malignant insulinoma is suspected, or if no lesion is detected with conventional means, consider octreotide and MIBG scanning.&lt;/p&gt;
&lt;p&gt;At confirmation of biochemical diagnois, also arrange fasting gut hormones (using intravenous glucose to maintain safe blood glucose levels during the 12 hour fast), calcium, parathyroid hormone level and baseline pituitary function.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss results at multidisciplinary meeting and arrange surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Selective pancreatic surgery is usually possible.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Post operative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Stop all treatments immediately post operatively and closely monitor blood glucose levels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up arrangements&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Arrange formal post operative review at six weeks, then on an annual basis.&lt;/p&gt;
&lt;p&gt;Annual screens should include: reassessment of family history, full blood count, urea and electrolytes, liver function test, bone profile, prolactin, fasting glucose and HbA1c. &lt;/p&gt;
&lt;p&gt;The decision on repeat imaging of the pancreas should be determined by multidisciplinary discussion.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;All patients with confirmed MEN1 should be followed up accordingly&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;At diagnosis of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/multiple-endocrine-neoplasia-type-1/management"&gt;MEN1&lt;/a&gt;, discuss genetic counselling and family screening and arrange appropriate life long follow up.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value>Suspected reactive hypoglycaemia 
				</value><value>History suggestive of insulinoma or any documented hypoglycaemia 
				</value></CQueMgt><CQueInv><value>Calculate height velocity 
				</value><value>Full blood count, ESR and ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Antiendomyseal and antigliadin antibodies 
				</value><value>Glycosylated haemoglobin and fasting glucose and lipids 
				</value><value>Growth hormone 
				</value><value>IGF-I and IGF-BP-3 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary and MRI olfactory bulbs 
				</value><value>Bone age 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram 
				</value><value>Echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Parathyroid hormone 
				</value><value>Karyotype 
				</value><value>Hearing test 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="background-color: white; font-size: 9pt; "&gt;H&lt;/span&gt;&lt;span style="background-color: white; color: rgb(99, 97, 85); font-size: 9pt; "&gt;eight velocity requires a minimum of 6 months measurements. Age needs to be decimalised ie 10.5 years, not 10 years 6 months. This is expressed cm/year.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;b&gt;&lt;span style='font-size:13.5pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:#939598;mso-fareast-language:
EN-GB'&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:
Calibri;background:white"&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency. Low ferritin may also be a marker of malnutrition.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;ESR is an important screen for inflammatory conditions such as Crohn's disease or juvenile chronic arthritis.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
background:white"&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Important indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function test may be surprisingly normal in liver disease. Albumin is a marker of malnutrition. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hypercalcaemia may occur with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with short stature should be screened for Coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypoadrenal patients may have hypoglycaemia. Diabetes mellitus is usually clinically obvious but needs to be ruled out in patients with weight loss.&lt;/p&gt;
&lt;p&gt;Baseline assessment of lipids is also useful in patients with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In newborns, a single serum growth hormone level of less than 7 microgram/L (taken between days 3 and 5) confirms a diagnosis of neonatal GHD.&lt;/p&gt;
&lt;p&gt;After the newborn period, a single random serum growth hormone level over 7mcg/l is reassuring but does not exclude GH deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;These are useful tests for diagnosing severe GHD. Low IGF-I is in keeping with GH deficiency, in the presence of low GH secretion. &lt;/p&gt;
&lt;p&gt;In mild GHD, peak GH 5-7ng/ml, IGF-I and IGFBP-3 have lower diagnostic sensitivity and may be normal. Patients who have a deficiency of 3 or more pituitary hormones and an IGF-1 level of &amp;lt;50ng/ml can be considered to have GHD and may not require provocative testing.&lt;/p&gt;
&lt;p&gt;Low serum IGF-I should be interpreted cautiously as it may be associated with poor nutrition, or chronic illness. Serum IGFBP-3 concentration is generally less helpful that IGF-I for the diagnosis of GHD, except in very young children when IGF-I may be unreliable.&lt;/p&gt;
&lt;p&gt;In pubertal children, these tests are less reliable and dynamic testing will be required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estradial/testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These should be in the prepubertal range in children presenting with short stature prior to or associated with delayed puberty. This confirms that dynamic testing of GH reserve will require stilboestrol (1.0mg twice daily for the two days prior to the GH provocation test in both boys and girls) priming.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Age and pubertal stage related reference ranges are available to aid the interpretation of LH and FSH. Pre puberty, these are expected to be low. Post completion of puberty, if the sex hormones are confirmed as low, then low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) may indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example primary or auto-immune ovarian failure, or secondary to mumps or testicular trauma in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia in a child with short stature may be suggestive of pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Hypoprolactinaemia may also be seen in some genetic causes of hypopituitarism.&lt;/p&gt;
&lt;p&gt;Serum prolactin is affected by many factors, for example stress, nipple stimulation, interfering medications and PCOS, and so if elevated, should be repeated on at least two occasions. Elevated prolactin levels should also prompt the PEG precipitation test to determine whether this is biologically active or the inactive 'macroprolactin'.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis commonly causes weight loss but thyrotoxic children are almost always tall. &lt;/p&gt;
&lt;p&gt;Thyroid dysfunction is also more common in people with Turner syndrome.&lt;/p&gt;
&lt;p&gt;It is essential to assess levels of both thyroxine and TSH in patients suspected of pituitary disease and prior to a GH provocation test.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 500nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with pituitary disease and levels below this may require formal assessment for ACTH reserve, for example with an &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;insulin&lt;/a&gt; stress test or &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;glucagon&lt;/a&gt; test.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI pituitary should be performed in all patients with confirmed GH deficiency to seek underlying pathology, and in patients presenting later with hypogonadotropic hypogonadism. Patients with suspected Kallman's syndrome also require MRI of the olfactory bulbs in patients. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18955511" target="_blank"&gt;Late onset&lt;/a&gt;, mild, isolated hypogonadism may not require imaging however.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph of the left hand and wrist to assess bone age in patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A chest XR should be performed in all patients with multiple congenital abnormalities and with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is usefully performed at presentation in adults as it is required prior to starting dopamine agonist therapy or testing dynamic pituitary function if necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed to seek coarctation of the aorta or bicuspid aortic valve in patients with confirmed Turner's syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner’s and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; (ITT) should be performed if GH deficiency is suspected, and will also detect ACTH deficiency subject to the usual safety exclusion criteria. ITT should not be performed in young children, or when there is a history of convulsions, and never in infants. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon&lt;/a&gt; testing should be performed as a second confirmatory test of GH deficiency, or if an insulin stress test is contraindicated due to age or the patient's condition.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is generally considered the second best &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;dynamic test&lt;/a&gt; of GH reserve. However, this may also be performed without GHRH (in which case the interpretation is the same as an insulin stress test) in patients with suspected hypothalamic problems eg irradiation, as they may not mount the typical exuberant response to GHRH.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in patients with long standing nutritional deficiency, chronic illness, hypopituitarism or severe delay of puberty. This should also be considered in all patients with long standing hypogonadism and it may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with the phenotypic features of pseudohypoparathyroidism should have PTH levels documented to determine their underlying diagnosis.&lt;/p&gt;
&lt;p&gt;Levels will be low in hypoparathyroidism, high in pseudohypoparathyroidism, and normal in patients with pseudopseudohypoparathyrdoidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all girls presenting with short stature to exclude Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner's syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/insulinoma/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/short-stature/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;History&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Lack of weight gain, long standing symptoms and a clear relationship to meals are suggestive of reactive hypoglycaemia.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Arrange prolonged OGTT&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is a normal response to OGTT, reassure patient.  &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Reactive hypoglycaemia confirmed&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If reactive hypoglycaemia is evident on the glucose tolerance test, and insulinoma is &lt;u&gt;not&lt;/u&gt; suspected clinically, reassure the patient, arrange dietetic review and give simple advice on eating low glycaemic index foods to minimise symptoms. Severe symptoms may also improve with the alpha glucosidase inhibitor acarbose. Guar gum may also prevent symptoms in some people.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;History&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;A history of weight gain, a short history of typical attacks, a family history suggestive of MEN1, or documented hypoglycaemia are all highly suggestive and mandate admission for a formal fast.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Formal 48-72hr fast&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Fast should be terminated at any stage if the patient develops severe symptoms, such as loss of consciousness or fitting, or if urgent laboratory analysis confirms serum glucose &amp;lt;2.2mmol/l. &lt;/p&gt;
&lt;p&gt;Plasma should be sent for insulin and C peptide measurement as per protocol LINK, and paired blood and spot urine samples also sent for sulphonylurea screen.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Interpreting results&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Normal young women may run blood glucose levels as low as 2.2-3mmol/l. True hypoglycaemia (&amp;lt;2.2mmol/l) should be accompanied by very low insulin and C peptide levels.&lt;/p&gt;
&lt;p&gt;Factitious insulin use should be suspected if low C peptide is found with a detectable insulin level. It may be necessary for further analysis to be performed to detect insulin analogues in the serum in difficult cases. &lt;/p&gt;
&lt;p&gt;Elevated C peptide and insulin in the presence of hypoglycaemia indicates possible insulinoma, although sulphonylurea screen must also be performed at this stage.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Start treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;With biochemically confirmed hypoglycaemia, the fast must be terminated immediately. Emergency glucose administration should also be given, intravenously if necessary, and treatment with diazoxide is usually started.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Diazoxide&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is the first line of treatment. The dose should be uptitrated every 24-48hr to achieve normoglycaemia, although the patient needs to be warned about possible side effects including oedema, hypertrichosis and hypokalaemia.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Intravenous glucose infusion&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This may be necessary in severe cases while oral treatments are uptitrated.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Steroids&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Oral prednisolone may be added to diazoxide if necessary. Hypoglycaemia may respond to this, at least transiently.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Somatostatin analogues&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These may reduce peptide hormone release in neuroendocrine tumours and will usually improve diarrhoea and flushing. This treatment may be considered in insulinoma not responding to standard treatments.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Arrange localising studies and complete baseline investigations&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;CT pancreas is the usual first line investigation after biochemical diagnosis. If the lesion is not clear with this modality, trans abdominal and endoscopic ultrasound scans may be performed. Selective venous sampling with calcium stimulation should also be considered.&lt;/p&gt;
&lt;p&gt;If malignant insulinoma is suspected, or if no lesion is detected with conventional means, consider octreotide and MIBG scanning.&lt;/p&gt;
&lt;p&gt;At confirmation of biochemical diagnois, also arrange fasting gut hormones (using intravenous glucose to maintain safe blood glucose levels during the 12 hour fast), calcium, parathyroid hormone level and baseline pituitary function.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss results at multidisciplinary meeting and arrange surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Selective pancreatic surgery is usually possible.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Post operative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Stop all treatments immediately post operatively and closely monitor blood glucose levels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up arrangements&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Arrange formal post operative review at six weeks, then on an annual basis.&lt;/p&gt;
&lt;p&gt;Annual screens should include: reassessment of family history, full blood count, urea and electrolytes, liver function test, bone profile, prolactin, fasting glucose and HbA1c. &lt;/p&gt;
&lt;p&gt;The decision on repeat imaging of the pancreas should be determined by multidisciplinary discussion.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;All patients with confirmed MEN1 should be followed up accordingly&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;At diagnosis of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/multiple-endocrine-neoplasia-type-1/management"&gt;MEN1&lt;/a&gt;, discuss genetic counselling and family screening and arrange appropriate life long follow up.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value>Suspected reactive hypoglycaemia 
				</value><value>History suggestive of insulinoma or any documented hypoglycaemia 
				</value></CQueMgt><CQueInv><value>Calculate height velocity 
				</value><value>Full blood count, ESR and ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Antiendomyseal and antigliadin antibodies 
				</value><value>Glycosylated haemoglobin and fasting glucose and lipids 
				</value><value>Growth hormone 
				</value><value>IGF-I and IGF-BP-3 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary and MRI olfactory bulbs 
				</value><value>Bone age 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram 
				</value><value>Echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Parathyroid hormone 
				</value><value>Karyotype 
				</value><value>Hearing test 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="background-color: white; font-size: 9pt; "&gt;H&lt;/span&gt;&lt;span style="background-color: white; color: rgb(99, 97, 85); font-size: 9pt; "&gt;eight velocity requires a minimum of 6 months measurements. Age needs to be decimalised ie 10.5 years, not 10 years 6 months. This is expressed cm/year.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;b&gt;&lt;span style='font-size:13.5pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:#939598;mso-fareast-language:
EN-GB'&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
mso-ascii-font-family:Calibri;mso-hansi-font-family:Calibri;mso-bidi-font-family:
Calibri;background:white"&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency. Low ferritin may also be a marker of malnutrition.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;ESR is an important screen for inflammatory conditions such as Crohn's disease or juvenile chronic arthritis.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
background:white"&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Important indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function test may be surprisingly normal in liver disease. Albumin is a marker of malnutrition. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hypercalcaemia may occur with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with short stature should be screened for Coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypoadrenal patients may have hypoglycaemia. Diabetes mellitus is usually clinically obvious but needs to be ruled out in patients with weight loss.&lt;/p&gt;
&lt;p&gt;Baseline assessment of lipids is also useful in patients with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In newborns, a single serum growth hormone level of less than 7 microgram/L (taken between days 3 and 5) confirms a diagnosis of neonatal GHD.&lt;/p&gt;
&lt;p&gt;After the newborn period, a single random serum growth hormone level over 7mcg/l is reassuring but does not exclude GH deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;These are useful tests for diagnosing severe GHD. Low IGF-I is in keeping with GH deficiency, in the presence of low GH secretion. &lt;/p&gt;
&lt;p&gt;In mild GHD, peak GH 5-7ng/ml, IGF-I and IGFBP-3 have lower diagnostic sensitivity and may be normal. Patients who have a deficiency of 3 or more pituitary hormones and an IGF-1 level of &amp;lt;50ng/ml can be considered to have GHD and may not require provocative testing.&lt;/p&gt;
&lt;p&gt;Low serum IGF-I should be interpreted cautiously as it may be associated with poor nutrition, or chronic illness. Serum IGFBP-3 concentration is generally less helpful that IGF-I for the diagnosis of GHD, except in very young children when IGF-I may be unreliable.&lt;/p&gt;
&lt;p&gt;In pubertal children, these tests are less reliable and dynamic testing will be required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estradial/testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These should be in the prepubertal range in children presenting with short stature prior to or associated with delayed puberty. This confirms that dynamic testing of GH reserve will require stilboestrol (1.0mg twice daily for the two days prior to the GH provocation test in both boys and girls) priming.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Age and pubertal stage related reference ranges are available to aid the interpretation of LH and FSH. Pre puberty, these are expected to be low. Post completion of puberty, if the sex hormones are confirmed as low, then low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) may indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example primary or auto-immune ovarian failure, or secondary to mumps or testicular trauma in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia in a child with short stature may be suggestive of pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Hypoprolactinaemia may also be seen in some genetic causes of hypopituitarism.&lt;/p&gt;
&lt;p&gt;Serum prolactin is affected by many factors, for example stress, nipple stimulation, interfering medications and PCOS, and so if elevated, should be repeated on at least two occasions. Elevated prolactin levels should also prompt the PEG precipitation test to determine whether this is biologically active or the inactive 'macroprolactin'.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis commonly causes weight loss but thyrotoxic children are almost always tall. &lt;/p&gt;
&lt;p&gt;Thyroid dysfunction is also more common in people with Turner syndrome.&lt;/p&gt;
&lt;p&gt;It is essential to assess levels of both thyroxine and TSH in patients suspected of pituitary disease and prior to a GH provocation test.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 500nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with pituitary disease and levels below this may require formal assessment for ACTH reserve, for example with an &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;insulin&lt;/a&gt; stress test or &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;glucagon&lt;/a&gt; test.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI pituitary should be performed in all patients with confirmed GH deficiency to seek underlying pathology, and in patients presenting later with hypogonadotropic hypogonadism. Patients with suspected Kallman's syndrome also require MRI of the olfactory bulbs in patients. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18955511" target="_blank"&gt;Late onset&lt;/a&gt;, mild, isolated hypogonadism may not require imaging however.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph of the left hand and wrist to assess bone age in patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A chest XR should be performed in all patients with multiple congenital abnormalities and with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is usefully performed at presentation in adults as it is required prior to starting dopamine agonist therapy or testing dynamic pituitary function if necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed to seek coarctation of the aorta or bicuspid aortic valve in patients with confirmed Turner's syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner’s and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; (ITT) should be performed if GH deficiency is suspected, and will also detect ACTH deficiency subject to the usual safety exclusion criteria. ITT should not be performed in young children, or when there is a history of convulsions, and never in infants. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon&lt;/a&gt; testing should be performed as a second confirmatory test of GH deficiency, or if an insulin stress test is contraindicated due to age or the patient's condition.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is generally considered the second best &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;dynamic test&lt;/a&gt; of GH reserve. However, this may also be performed without GHRH (in which case the interpretation is the same as an insulin stress test) in patients with suspected hypothalamic problems eg irradiation, as they may not mount the typical exuberant response to GHRH.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in patients with long standing nutritional deficiency, chronic illness, hypopituitarism or severe delay of puberty. This should also be considered in all patients with long standing hypogonadism and it may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with the phenotypic features of pseudohypoparathyroidism should have PTH levels documented to determine their underlying diagnosis.&lt;/p&gt;
&lt;p&gt;Levels will be low in hypoparathyroidism, high in pseudohypoparathyroidism, and normal in patients with pseudopseudohypoparathyrdoidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all girls presenting with short stature to exclude Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner's syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/insulinoma/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/short-stature/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;At first presentation of an affected individual or family member, family history should be documented, and genetic screening should be arranged. If this confirms disease, or if it is not available, a full clinical screen should be arranged.&lt;/p&gt;
&lt;p&gt;This should include full blood count, urea and electrolytes, liver function, bone profile, PTH, calcitonin, baseline pituitary function, and 2x24 hour urinary metanephrines. Chest radiograph, neck ultrasound scan and CT adrenals should also be performed for disease staging at this point.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;See management sections of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/phaeochromocytoma/management"&gt;phaeochromocytoma&lt;/a&gt;, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypercalcaemia/management"&gt;hyperparathyroidism&lt;/a&gt; and &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/thyroid-nodule/management"&gt;thyroid nodules&lt;/a&gt; for further information. The detailed management of medullary cell carcinoma is beyond the scope of this guide.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Annual screen should include: re-assessment of family history, full blood count, urea and electrolytes, liver function test, bone profile, fasting glucose, calcitonin, prolactin, 2x24hr urinary metanephrines, and PTH if serum calcium is elevated. Chest radiograph and CT adrenals should be repeated every three years routinely. Imaging and follow-up must be repeated more frequently when lesions are detected.&lt;/p&gt;
&lt;p&gt;All first degree relatives should be followed up in the same way as confirmed cases, unless genetic screening is negative.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Life long follow up is mandatory.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value>Screening at diagnosis 
				</value><value>Complications of MEN2 should be treated in the usual way 
				</value><value>Annual screen 
				</value><value>All patients with confirmed MEN2 should be followed up annually to detect further complications and re-assess family history 
				</value></CQueMgt><CQueInv><value>Full blood count 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Glycosylated haemoglobin, fasting glucose and lipids 
				</value><value>Karyotype 
				</value><value>Pituitary function 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram, echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Bone age 
				</value><value>Hearing test 
				</value><value>Auto-antibody screen 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;This is a useful indicator of general health and as a screen for underlying disease including coeliac disease or hypopituitarism in a patient presenting with short stature and abnormal sexual development.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful screen for renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Diabetes has an increased incidence in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome also have an increased risk of renal and cardiovascular disease, and so cardiovascular risk modification is essential.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all patients with suspected Turner, androgen insensitivity and Klinefelter’s syndrome. XO is the commonest karyotype encountered in Turner syndrome, but mosaics and patients with partial deletions and other chromosomal abnormalities also occur.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Growth hormone, Insulin like growth factor I&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients with Turner syndrome and severe short stature may benefit from GH therapy. GH secretion does not need to be assessed following the diagnosis of Turner syndrome. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia may cause pubertal delay and hypogonadotropic hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is &lt;u&gt;not&lt;/u&gt; usually assessed in patients with Turner syndrome, though if a diagnosis of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-syndrome/"&gt;Cushing's&lt;/a&gt; is being considered, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/urinary-free-cortisol/"&gt;urinary free cortisols&lt;/a&gt; and a low dose &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/dexamethasone-suppression-test/"&gt;dexamethasone suppression&lt;/a&gt; test should be arranged instead.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estrodiol, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Estrodiol is usually low in Turner syndrome.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;LH and FSH should be checked in all patients presenting with hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyroid dysfunction may lead to pubertal delay. Turner syndrome is also associated with an increased incidence of thyroid disease.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Chest XR should be performed at diagnosis of Turner's as a simple screen for congenital abnormalities and coarctation of the aorta. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;ECG and echocardiogram should be performed to seek coarctation of the aorta or other abnormalities in patients with confirmed Turner syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph to assess bone age in younger patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid and coeliac antibodies should be assessed at diagnosis in patients with Turner syndrome, due to an increased incidence of these disorders.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be considered in all patients with long standing hypogonadism. It may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/multiple-endocrine-neoplasia-type-2/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/paediatric-turner-syndrome/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Any clinical suspicion of underlying or associated diagnoses needs specific investigation and treatment before the obesity can be appropriately managed. For example further investigations and treatment for suspected Cushing’s or polycystic ovarian syndrome (PCOS), or treatment for hypothyroidism, diabetes or depression should all take priority.&lt;/p&gt;
&lt;p&gt;Conversely, if no underlying medical condition is detected, this should also be discussed, as a proportion of patients may feel that there is an underlying imbalance or disease causing their obesity. It can be difficult to institute lifestyle change in such cases unless they fully understand their condition.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Establish and explain the patient’s individual cardiovascular risk profile and institute appropriate plan.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ensure blood pressure is below 150/90 and, if not, start treatment. &lt;/p&gt;
&lt;p&gt;This is important for cardiovascular risk reduction and is also mandatory before considering sibutramine therapy, although the licence for this medication has recentlly been suspended.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Obstructive sleep apnoea (OSA) may lead to poor quality of life, extreme fatigue and reduced capacity for exercise all of which make weight loss difficult. Untreated OSA also increases anaesthetic risk and so should be addressed before considering bariatric surgery.&lt;/p&gt;
&lt;p&gt;Consider referral for formal sleep assessment if indicated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specialist dietetic input is required in all cases. This may be most appropriately arranged through an eating disorder clinic, a diabetes specialist dietician, or a dietician with an interest in obesity depending on clinical need. &lt;/p&gt;
&lt;p&gt;Where orlistat is being considered, patients need to be reliably taking a &amp;lt;3% fat diet to prevent unpleasant side effects.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Encourage regular aerobic exercise with supervised exercise programmes tailored for the obese where available: 'exercise on prescription'.&lt;/p&gt;
&lt;p&gt;Where orthopaedic problems are present, consider referral for specialist assessment, although swimming can be safely recommended in almost all cases.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;National &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://guidance.nice.org.uk/CG43"&gt;guidelines&lt;/a&gt; suggest that pharmacotherapy should be considered only after three months dietary and life style changes. Where portion size appears to be a major problem, sibutramine has been widely used with close blood pressure monitoring. However, recent cardiovascular safety concerns have led to the suspension of its licence.&lt;/p&gt;
&lt;p&gt;Where diet appears to be particularly high in fat, orlistat may be more appropriate but must not be recommended without appropriate dietary changes. When used with a poor diet, unacceptable side effects of abdominal bloating, diarrhoea, steatorrhoea and faecal incontinence may occur.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with apparent severe underlying psychological issues should be referred appropriately for help with these. This is also mandatory in such patients to help assess suitability for bariatric surgery. &lt;/p&gt;
&lt;p&gt;Suspected depression should be specifically addressed usually through the GP. &lt;/p&gt;
&lt;p&gt;Suspected eating disorders should also be addressed through a specialist eating disorder psychiatric unit.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Bariatric surgery should be considered in patients with a BMI above 40 kg/m2, or over 35 kg/m2 with comorbidities according to &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://guidance.nice.org.uk/CG43"&gt;NICE&lt;/a&gt; guidelines. However, this is clearly not appropriate for all patients.&lt;/p&gt;
&lt;p&gt;It is usual to try lifestyle and medical means in the first instance. It is also mandatory to optimise the control of diabetes and other cardiovascular risks including sleep apnoea before referring for bariatric surgery. All patients need to have received specialist dietetic input before considering whether bariatric surgery is necessary or appropriate. Furthermore, patients need to understand how their lives are likely to be affected by surgery, as well as the risks and benefits involved.&lt;/p&gt;
&lt;p&gt;Not all patients require formal psychological assessment prior to bariatric surgery, though this should always be considered and is often helpful.&lt;/p&gt;
&lt;p&gt;Bariatric surgery should then only be performed in a specialist centre with appropriate specialist nursing and dietetic support for both the pre and post operative periods.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Long term follow up is very helpful in managing obesity. However, this is most appropriately offered in a specialist weight management clinic, with a specialist dietician rather than an endocrinologist, as further medical tests are rarely required.&lt;/p&gt;
&lt;p&gt;Following bariatric surgery, dietary supplements are frequently required, and monitoring for electrolyte, vitamin and mineral deficiencies may be indicated depending on the procedure undertaken.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value>Explain underlying causes 
				</value><value>Address cardiovascular risk profile 
				</value><value>Blood pressure 
				</value><value>Obstructive sleep apnoea 
				</value><value>Dietetic input 
				</value><value>Lifestyle advice 
				</value><value>Drug treatment 
				</value><value>Consider psychological or psychiatric assessment 
				</value><value>Consider bariatric surgery 
				</value><value>Follow up 
				</value></CQueMgt><CQueInv><value>Full blood count 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Glycosylated haemoglobin, fasting glucose and lipids 
				</value><value>Karyotype 
				</value><value>Pituitary function 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram, echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Bone age 
				</value><value>Hearing test 
				</value><value>Auto-antibody screen 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;This is a useful indicator of general health and as a screen for underlying disease including coeliac disease or hypopituitarism in a patient presenting with short stature and abnormal sexual development.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful screen for renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Diabetes has an increased incidence in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome also have an increased risk of renal and cardiovascular disease, and so cardiovascular risk modification is essential.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all patients with suspected Turner, androgen insensitivity and Klinefelter’s syndrome. XO is the commonest karyotype encountered in Turner syndrome, but mosaics and patients with partial deletions and other chromosomal abnormalities also occur.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Growth hormone, Insulin like growth factor I&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients with Turner syndrome and severe short stature may benefit from GH therapy. GH secretion does not need to be assessed following the diagnosis of Turner syndrome. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia may cause pubertal delay and hypogonadotropic hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is &lt;u&gt;not&lt;/u&gt; usually assessed in patients with Turner syndrome, though if a diagnosis of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-syndrome/"&gt;Cushing's&lt;/a&gt; is being considered, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/urinary-free-cortisol/"&gt;urinary free cortisols&lt;/a&gt; and a low dose &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/dexamethasone-suppression-test/"&gt;dexamethasone suppression&lt;/a&gt; test should be arranged instead.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estrodiol, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Estrodiol is usually low in Turner syndrome.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;LH and FSH should be checked in all patients presenting with hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyroid dysfunction may lead to pubertal delay. Turner syndrome is also associated with an increased incidence of thyroid disease.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Chest XR should be performed at diagnosis of Turner's as a simple screen for congenital abnormalities and coarctation of the aorta. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;ECG and echocardiogram should be performed to seek coarctation of the aorta or other abnormalities in patients with confirmed Turner syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph to assess bone age in younger patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid and coeliac antibodies should be assessed at diagnosis in patients with Turner syndrome, due to an increased incidence of these disorders.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be considered in all patients with long standing hypogonadism. It may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/obesity/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/paediatric-turner-syndrome/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Thyroid</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Any patient with a solitary palpable nodule greater than 1cm in diameter, or any nodule with suspicious characteristics arising within a multinodular goitre, or any nodule with associated lymph nodes, will require urgent an ultrasound scan. The radiological characteristics taken with the level of clinical suspicious will then determine whether ultrasound guided aspiration is required according to international &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.aace.com/pub/pdf/guidelines/thyroid_nodules.pdf"&gt;guidelines&lt;/a&gt;. Clinically guided fine needle aspirations of thyroid nodules are now rarely performed, and only if ultrasound is unavailable to help define whether aspiration is indicated at all, and which area of the lesion to aspirate.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;These patients are unlikely to have malignancy and are more likely to have a toxic follicular adenoma. However, their nodule should still be assessed clinically and with ultrasound if indicated in the usual way. Similarly if the nodule has any suspicious features it will still require ultrasound guided fine needle aspiration performed.&lt;/p&gt;
&lt;p&gt;If aspiration is not necessary, treatment is usually with radioactive iodine. If the nodule is shrinking at three months, no further assessment is indicated. If the patient declines or is unsuitable for radioactive iodine, surgery to resect the nodule or medical therapy with antithyroid drugs to control the thyrotoxicosis should be discussed in the usual way.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 17px; "&gt;Agranulocytosis is an uncommon but important side effect of all anti-thyroid drugs. Patients should receive written and verbal&lt;/span&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 17px; "&gt; &lt;/span&gt;&lt;a href="http://www.endobible.com/investigation/carbimazole-warning-sheet/" target="_blank" style="font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 17px; text-decoration: none; color: rgb(236, 0, 140); "&gt;warnings&lt;/a&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 17px; "&gt; &lt;/span&gt;&lt;span style="color: rgb(51, 51, 51); font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; line-height: 17px; "&gt;to discontinue the drug until they have had a blood count checked if they develop a severe sore throat or mouth ulcers.&lt;/span&gt;&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Mild neutropaenia &amp;lt;1.5x10*9 is commonly observed in people with Graves disease, some racial groups and with anti-thyroid drugs.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count 1-1.5 - continue drug but institute close monitoring of blood count. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count &amp;lt;1 - stop antithyroid drug and monitor blood count daily.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count &amp;lt;1 with suspected sepsis or in the unwell patient - stop antithyroid drug and arrange urgent admission. Treat as for neutropaenic sepsis, remembering that pseudomonas is a common infective organism in this group. Monitor blood count every 12 hours initially and take haematological advice. Bone marrow biopsy may be helpful to determine response. Granulocyte-colony stimulating factor (GCSF) should be considered after haematology review of the patient's response to drug cessation. DO NOT RECHALLENGE THE PATIENT WITH AN ALTERNATIVE ANTI-THYROID DRUG.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Rash is common and usually controlled by antihistamines. Alternatively switch to alternative anti-thyroid drug.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Arthralgia and arthritis are uncommon with carbimazole but more common with PTU. Stop the drug. Check antibody screen including ANCA for drug induced lupus and discuss wtih rheumatologist. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Mild abnormalities of liver function are common with thyrotoxicosis and do not require treatment. Mild transaminitis (&amp;lt;1.6x upper limit of normal) is also common after 3 months therapy with PTU and does not require treatment or monitoring unless baseline liver function was abnormal.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Allergic hepatitis with submassive necrosis occurs in 0.1-0.2% of patients receiving PTU. Stop PTU and involve a hepatologist immediately if this is suspected.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Carbimazole is not associated with this condition, but may cause a cholestatic picture of abnormal liver function. Stop the drug and inform hepatology if this is suspected, though complete resolution is normal on drug withdrawal. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;These patients should be assessed and the nodules aspirated if indicated. Thyroxine treatment should also be instituted and the nodule re-assessed at three months.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Non diagnostic results on fine needle aspiration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Non diagnostic aspirations should be repeated on at least two further occasions three months apart, according to British Thyroid Association &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/news/Docs/Thyroid_cancer_guidelines_2007.pdf"&gt;guidelines&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;If results are non diagnostic on two occasions, consider surgery to establish a diagnosis. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Benign results on fine needle aspiration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;A clearly benign result indicating thyroiditis may not need to be repeated. A result classified as Thy2 according to the Royal College of Physicians criteria indicates benign nodular disease, but should be repeated after 3-6 months.&lt;/p&gt;
&lt;p&gt;Many patients may then be discharged, or treated with radioactive iodine if there is thyrotoxicosis or the nodule has arisen within a multinodular goitre which merits treatment in its own right.&lt;/p&gt;
&lt;p&gt;This aims to shrink the nodules and treat the hyperthyroidism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follicular cells on fine needle aspiration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Any follicular cells are difficult to differentiate between benign and malignant disease. Those classified &lt;a href="http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/g089guidanceonthereportingofthyroidcytologyfinal.pdf" target="_blank"&gt;Thy 3a&lt;/a&gt; have atypical features, though Thy3f are more likely to represent a follicular cancer. Any Thy3 results must be referred for discussion at a thyroid multidisciplinary team for consideration of hemithyroidectomy, though in some cases a repeat aspiration of a low risk Thy3a lesion will be acceptable.&lt;/p&gt;
&lt;p&gt;If histology confirms the lesion to be a follicular adenoma then the patient can be discharged. If histology reveals a follicular carcinoma, completion thyroidectomy and radioactive iodine are required.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Results of fine needle aspiration suggestive, or diagnostic, of malignancy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Results diagnostic of malignancy (Thy5) require immediate referral to a thyroid multidisciplinary team for consideration of total thyroidectomy, followed by radioactive iodine if appropriate according to national &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/news/Docs/Thyroid_cancer_guidelines_2007.pdf"&gt;thyroid cancer guidelines&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Results suggestive of but not diagnostic of malignancy (Thy4) should be repeated to establish a diagnosis, and also referred to a multidisciplinary team.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Nodules should be assessed and treated conventionally in pregnant patients, though surgery should be deferred to the second trimester in most cases.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is the treatment of choice for most patients with thyrotoxicosis secondary to nodular disease, or euthyroid multinodular goitres causing early compressive symptoms. &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.rcplondon.ac.uk/Pubs/contents/0621b67a-4880-4a1b-9942-57a666efee4a.pdf"&gt;Radioactive iodine&lt;/a&gt; will prevent future growth and reduce the size of most goitres and solid nodules by up to 50%. Radioactive iodine is also the treatment of choice for hyperthyroidism due to nodular disease, which will otherwise require life long anti-thyroid drugs.&lt;/p&gt;
&lt;p&gt;Radioactive iodine is contraindicated in pregnant or breast feeding individuals. Women should be advised to avoid conception for six months and men should avoid fathering children for four months following radioactive iodine treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid function should be assessed at least every three months for the first year after radioactive iodine, and then annually thereafter for emerging hypothyroidism.&lt;/p&gt;
&lt;p&gt;All patients should be warned that monitoring is required and that hypothyroidism develops in up to 70% of patients. Subsequent &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypothyroidism/management"&gt;hypothyroidism&lt;/a&gt; should be treated conventionally.&lt;/p&gt;
&lt;p&gt;Inadequate control of thyrotoxicosis by six months should prompt consideration of a repeat application of radioactive iodine.&lt;/p&gt;
&lt;p&gt;Nodules should be shrinking within three months.&lt;/p&gt;
&lt;p&gt;New growth or change in the characteristics of a nodule despite previous radioactive iodine should prompt reassessment as for a new nodule.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Surgery should be discussed in all cases. Patients with a hyperfunctioning nodule who are unsuitable for, or decline, radioactive iodine may be offered a hemithyroidectomy. Thyroidectomy may also be considered for multinodular goitres, especially those causing compressive symptoms. Surgery is also appropriate after more than two non-diagnostic fine needle aspirations to establish a diagnosis, or after a Thy3, Thy4 or Thy5 aspiration result according to national &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/news/Docs/Thyroid_cancer_guidelines_2007.pdf"&gt;guidelines&lt;/a&gt; and MDT discussion.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Body habitus, weight and BMI 
				</value><value>Cardiovascular system 
				</value><value>Eyes: lid retraction and lid lag 
				</value><value>Graves' ophthalmopathy 
				</value><value>Skin and hair 
				</value><value>Hands and tremor 
				</value><value>Reflexes 
				</value><value>Musculature 
				</value><value>Thyroid gland, neck and nodes 
				</value></CQueExa><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease. &lt;/p&gt;
&lt;p&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;B12 deficiency may indicate associated pernicious anaemia or coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypokalaemia may occur in association with Grave's thyrotoxicosis with hypokalaemic periodic paralysis. This is more common in people of Chinese ethnic origin.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in Addison's disease which may be associated with auto-immune thyrotoxicosis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function should be tested at baseline before starting medical treatments.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hypercalcaemia may occur with thyrotoxicosis and glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ensure patients have stopped sex steroid therapy, for example HRT or the combined oral contraceptive pill for six weeks prior to test.&lt;/p&gt;
&lt;p&gt;A &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/synacthen-test/"&gt;synacthen&lt;/a&gt; test is required to formally exclude Addison’s, however, a 9am cortisol can be a useful screen. Levels below 250nmol/l demand thorough assessment, levels above 590nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A low thyroid stimulating hormone (TSH) confirms hyperthyroidism in suspected Graves' disease.&lt;/p&gt;
&lt;p&gt;TSH levels within the normal range imply normal thyroid function, except in those with potential pituitary disease, in whom a normal TSH may be seen with hypothyroidism.&lt;/p&gt;
&lt;p&gt;Ideal treatment of thyroid disease is reflected by control of symptoms and a serum TSH in the middle of the reference range approximately 1mU/L.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;TSH and free thyroxine should be tested together in all patients suspected of having thyroid dysfunction.&lt;/p&gt;
&lt;p&gt;Elevated thyroxine implies hyperthyroidism of any cause. Elevated thyroxine with suppressed TSH confirms this to be due to primary hyperthyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;ECG should be performed in all patients at baseline, to document and confirm any arrhythmias or other changes.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;There are multiple different tests available for thyroid auto-antibodies, with varying levels of sensitivity.&lt;/p&gt;
&lt;p&gt;Thyroid peroxidise antibodies are commonly used as an initial screen and may be positive in patients with any autoimmune thyroid condition, with higher titres occurring in patients with Hashimoto’s thyroiditis and hypothyroidism.&lt;/p&gt;
&lt;p&gt;TSH receptor stimulating antibodies occur specifically in Graves' disease, and may be particularly helpful in the assessment of pregnant patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Free liothyronine levels are not usually necessary for the assessment and treatment of Graves' disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with auto-immune thyroid dysfunction are at increased risk of developing diabetes mellitus.&lt;/p&gt;
&lt;p&gt;Falling insulin requirements or hypoglycaemia in established diabetes, may be an early sign of thyrotoxicosis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound scan is not usually required in the assessment of Graves' disease, though may be helpful where the aetiology of thyroid dysfunction is unclear, for example between nodular goitre and Graves' disease, or if a nodule is palpated within the gland.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Bone mineral density should be assessed where there is clinical suspicion of osteoporosis, for example in some older patients with biochemical thyrotoxicosis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with coeliac disease may well have low serum vitamin D levels.&lt;/p&gt;
&lt;p&gt;In patients with known or suspected osteoporosis, serum vitamin D levels will guide whether routine calcium and vitamin D supplementation is enough, or whether specific high dose vitamin D replacement is required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful in patients with acute thyrotoxicosis to help distinguish between Graves' disease, in which case the whole gland will have increased uptake, or viral or other forms of thyroiditis, in which case the gland will not take up iodine.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Tissue transglutaminase and anti gliadin antibodies should be checked if there is clinical suspicion of Coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This must be performed if there is clinical or biochemical suspicion of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/addisons-disease/"&gt;Addison’s disease&lt;/a&gt;.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The activity of Graves' ophthalmopathy can be difficult to assess. If in doubt, MRI scanning can confirm disease activity or quiescence and is also useful to asses disease severity.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Serum B12 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>9am cortisol 
				</value><value>Thyroid stimulating hormone 
				</value><value>Free thyroxine 
				</value><value>Electrocardiogram 
				</value><value>Thyroid auto-antibody screen 
				</value><value>Free liothyronine 
				</value><value>HbA1c and fasting glucose 
				</value><value>Thyroid ultrasound scan 
				</value><value>Bone densitometry 
				</value><value>Vitamin D levels 
				</value><value>Thyroid radionucleide uptake scan 
				</value><value>Coeliac auto-antibody screen 
				</value><value>Short synacthen test 
				</value><value>MRI orbits 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/graves-disease/examination</CURLExa><CCondName><value>Thyrotoxicosis or hyperthyroidism</value></CCondName><CQueMgt><value>Suspicious features 
				</value><value>Patients with thyrotoxicosis and an isolated nodule 
				</value><value>Common side effects of antithyroid drugs 
				</value><value>Patients with hypothyroidism and an isolated nodule 
				</value><value>Fine needle aspiration results 
				</value><value>Pregnancy and fertility plans should be discussed with all patients 
				</value><value>Radioactive iodine treatment 
				</value><value>Post radioactive iodine monitoring and hypothyroidism 
				</value><value>Thyroid surgery 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/hypothyroidism/</value><value>http://www.endobible.com/condition/hypothyroidism/examination</value><value>http://www.endobible.com/condition/hypothyroidism/investigation</value><value>http://www.endobible.com/condition/hypothyroidism/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/thyroid-nodule/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypothyroidism/</CURLTop><CURLInv>http://www.endobible.com/condition/graves-disease/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;To diagnose Graves' disease a detailed and full general examination is mandatory in the initial assessment of a patient. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Weight loss is common with thyrotoxicosis and should improve rapidly with treatment.&lt;/p&gt;
&lt;p&gt;Weight loss will also occur with the development of Addison's disease or with type 1 diabetes mellitus.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Detailed cardiac assessment is necessary.&lt;/p&gt;
&lt;p&gt;Tachycardia, atrial fibrillation and other arrhythmias may occur in thyrotoxicosis.&lt;/p&gt;
&lt;p&gt;Hypertension is also commonly seen with thyrotoxicosis.&lt;/p&gt;
&lt;p&gt;Orthostatic hypotension may occur, but may also indicate glucocorticoid deficiency with Addison’s disease.&lt;/p&gt;
&lt;p&gt;Congestive cardiac failure may complicate both hyperthyroidism and hypothyroidism due to cardiomyopathy, or rate related failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Lid retraction and lid lag may be seen in any cause of thyrotoxicosis.&lt;/p&gt;
&lt;p&gt;Lid retraction may be obvious at rest with the whites of the eyes visible above the iris. Any asymmetry of the eyes is suggestive of Graves' disease.&lt;/p&gt;
&lt;p&gt;Ask the patient to watch your horizontal finger as you very slowly lower it about 30cm away from their eyes. Delay in the upper eye lid following downward gaze will reveal the whites of the eye above the iris in the presence of lid lag.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Inspect the eyes carefully.&lt;/p&gt;
&lt;p&gt;Any asymmetry suggests Graves' disease as the cause of thyroid dysfunction.&lt;/p&gt;
&lt;p&gt;Swelling of the soft tissue around the eyes, redness of the whites of the eyes (conjunctival injection) or protrusion, lid asymmetry or muscle tethering all indicate Graves' ophthalmopathy.&lt;/p&gt;
&lt;p&gt;Examine the open and closed eyes from the side and above. Protrusion of one or both eyes is known as proptosis or exophthalmos.&lt;/p&gt;
&lt;p&gt;Ask the patient to close their eyes and ensure there is no cornea visible indicating full lid closure.&lt;/p&gt;
&lt;p&gt;Test external ocular movements. Diplopia in any direction, and any loss of movement or frank ophthalmoplegia are usually due to muscle tethering.  &lt;/p&gt;
&lt;p&gt;Acuity should also be tested. Drop in acuity in Graves' disease may indicate increased orbital pressure on the optic nerve which requires urgent assessment for decompression.&lt;/p&gt;
&lt;p&gt;Fundoscopy and ideally colour vision testing should also be performed. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Deeply tanned skin with pigmentation of scars may indicate Addison’s disease. Pallor may also occur with anaemia of any cause, for example due to pernicious anaemia, coeliac disease or pituitary dysfunction.&lt;/p&gt;
&lt;p&gt;Patches of symmetrical depigmentation of both hair and skin may occur with vitiligo.&lt;/p&gt;
&lt;p&gt;Patches of complete hair loss indicate associated alopecia areata. Loss of secondary sexual hair may occur in gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Pretibial myxoedema may occur with any auto-immune thyroid disease. This is seen as pinkish discolouration over thinned and yellow tinged skin with or without oedema, and most typically over the shins.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Examine the palms - hot, red and sweaty hands occur in hyperthyroidism.&lt;/p&gt;
&lt;p&gt;Ask the patient to hold out their hands in front of them. A resting tremor is usually obvious in hyperthyroidism, but may be highlighted by placing a sheet of paper over the hands to demonstrate it shaking.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Brisk reflexes are seen in hyperthyroidism, as is a general increase in resting movement.&lt;/p&gt;
&lt;p&gt;Look for 'jumpiness' in the patient during examination.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Proximal myopathy may occur with alterations in thyroid function. Ask the patient to slowly rise from a squatting position with a straight back and without using their arms or levering their upper body to help.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A Graves' gland will typically be diffusely and modestly enlarged. It may also be warm, minimally tender and with an audible bruit in very active disease.&lt;/p&gt;
&lt;p&gt;First inspect the neck from the front and ask the patient to swallow. Diffuse thyroid swelling, nodules, cysts and multinodular goitres may all be obvious as anterior neck masses that move on swallowing.&lt;/p&gt;
&lt;p&gt;Examine the neck thoroughly. This is usually performed from behind the seated patient and in a systematic fashion. The texture of the gland, tenderness, and the presence or absence nodularity or distinct lumps or lymph nodes must be noted.&lt;/p&gt;
&lt;p&gt;Ask the patient to swallow while palpating any nodules, and ensure to check for lymphadenopathy.&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Gonadal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Adult patients with absent puberty require karyotype analysis to confirm the clinical suspicion of Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be offered to all patients at, or soon after, diagnosis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If there is any doubt that hypogonadotropic hypogonadism may not be isolated, consider dynamic function testing.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If karyotype is apparently normal, then other causes of hypogonadotropic hypogonadism are possible. Thorough investigation should therefore be performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Delayed bone age supports the diagnosis of absent puberty. Growth hormone treatment should be considered in those with short stature and delayed bone age. This decision should be undertaken in conjunction with an experienced paediatric endocrinologist.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If appropriate, fertility should be discussed early with the patient and their family.&lt;/p&gt;
&lt;p&gt;Patients need to understand that successful pubertal induction will not affect or restore fertility, although appropriate uterine development is necessary prior to possible future pregnancies.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;At confirmation of diagnosis or transition to adult care arrange the following tests in all cases: karyotype analysis (if not performed already), echocardiogram, renal ultrasound scan, pelvic ultrasound scan, bone densitometry scan, thyroid stimulating hormone, free thyroxine, thyroid and coeliac antibody screen, urea and electrolytes, liver function test, bone profile, fasting lipid profile, fasting glucose and HbA1c.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients should be offered life long annual follow up. The following tests should be arranged prior to every review: thyroid stimulating hormone, free thyroxine, urea and electrolytes, liver function test, fasting lipid profile, fasting glucose and HbA1c.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Every three to five years, consider repeating the following tests: echo three to five yearly; thyroid/coeliac antibodies five yearly; hearing test five yearly; and, bone densitometry scan recommended five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Cardiac magnetic resonance imaging and uterine ultrasound scan should be performed prior to considering pregnancy.&lt;/p&gt;
&lt;p&gt;Patients will require referral to a specialist fertility unit. In vitro fertilisation, using a donor egg, may be necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss treatment aims, timescales and outcomes&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Treatment aims to replicate the natural process of puberty and should occur over approximately the same timescale - approximately two to three years. Breast development and secondary sexual hair should occur. Some bleeding may occur during pubertal induction, at which point, cyclical progesterone should be added.&lt;/p&gt;
&lt;p&gt;Patients need to understand that accelerating the treatment may have adverse psychological and physical consequences, for example poor breast development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose estrogen replacement therapy.&lt;/p&gt;
&lt;p&gt;An alternative is to use topical estrogen therapy. This may give a better eventual breast shape, and is well tolerated, with the patches often easier to source in the community than low dose ethinylestradiol. A typical start dose is with one quarter of a 25mcg Estradiol patch given either overnight every day, or left on and replaced every 72 hours. The dose should then increase every 3-4 months to half a patch, then a whole 25mcg patch, then a 50mcg patch, then a 75mcg, then a 100mcg patch.  &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider pelvic ultrasound scan to assess uterine size at this stage.&lt;/p&gt;
&lt;p&gt;Once the patient experiences vaginal bleeding or if the patient has tolerated 15mcg orally, or 100mcg transdermally, consider adding cyclical progesterone. Measurement of LH and FSH levels may also be used to help judge whether the final dose of topic estradiol is sufficient, as some girls will require higher doses.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatment regimens&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for cardiovascular or thromboembolic disease will also need to be considered.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia eg 1x350mcg progesterone only pill daily.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Duration of treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Continue sex hormone replacement therapy until the time of the natural menopause - typically to age 50.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Vaginal gels&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Topical estrogen may be beneficial to help vaginal dryness.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, weight, body habitus and BMI 
				</value><value>Olfactory nerves 
				</value><value>Breasts 
				</value><value>Cardiovascular examination 
				</value><value>Body hair 
				</value><value>Gastrointestinal system 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value></CQueExa><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be tested prior to and during testosterone treatment because of the risk of polycythaemia developing. Normocytic normochromic anaemia and eosinophilia may be seen with undiagnosed hypopituitarism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Haemochromotosis may be associated with the development of secondary hypogonadotropic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Liver function test may be surprisingly normal in cirrhosis.&lt;/p&gt;
&lt;p&gt;Albumin levels are required to calculate free androgen index in borderline cases and liver function should also be documented before starting testosterone replacement therapy in all.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypercalcaemia may occur with thyrotoxicosis and, rarely, with hypopituitarism, both of which may be associated with gynaecomastia. Hypercalcaemia may also occur with malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;PSA should be documented before considering testosterone replacement therapy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to their circadian release, sex hormones should be assessed early morning (typically at 9am), and repeated on more than one occasion.&lt;/p&gt;
&lt;p&gt;Sex hormone binding globulin is necessary to calculate the free androgen index. This is particularly important where testosterone levels are near normal, and the decision to start testosterone replacement is not clear cut.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Where sex hormones are confirmed as low, low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example secondary to mumps, testicular trauma, surgery or torsion in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia may present with tender gynaecomastia and hypogonadism in male patients.&lt;/p&gt;
&lt;p&gt;Multiple &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hyperprolactinaemia/"&gt;medications&lt;/a&gt; lead to elevations in serum prolactin, and high levels may also occur in non functioning pituitary adenomas.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis may cause gynaecomastia in some patients.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 590nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with possible pituitary disease and levels below this may require formal &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;assessment&lt;/a&gt; for ACTH reserve, depending on clinical suspicion.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Growth hormone, insulin like growth factor I&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;A normal growth hormone (GH) and insulin like growth factor I (IGF-I) taken together form a useful screen for acromegaly.&lt;/p&gt;
&lt;p&gt;Very low IGF-I levels alone are not diagnostic for GH deficiency but are a useful screen indicating potential pituitary dysfunction.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in all cases with documented hypogonadotropic hypogonadism and urgently if there is visual field loss or optic disc pallor.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI should include the olfactory bulbs in patients with suspected Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with possible malignancy should have a CXR performed at baseline.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Mammography and further imaging should be considered in patients with unilateral gynaecomastia, breast masses, changes to the overlying skin, or any other suspicious features.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads.&lt;/p&gt;
&lt;p&gt;This is also essential in patients presenting with gynaecomastia with a testicular mass.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty and gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; should be performed if GH or ACTH deficiency is suspected but not yet confirmed subject to the usual safety exclusion criteria.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon testing&lt;/a&gt; should be performed if GH or ACTH deficiency is suspected but not yet confirmed and the patient is unable to tolerate an insulin stress test.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If insulin stress testing is unavailable or contraindicated, &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;arginine-GHRH&lt;/a&gt; testing is a suitable alternative test for GH reserve.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be considered in all patients with long standing hypogonadism. It may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Alpha-feto protein and human chorionic gonadotropin should be assessed where testicular or other malignancy is suspected.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Prostate specific antigen 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary 
				</value><value>MRI olfactory bulbs 
				</value><value>Chest radiograph 
				</value><value>Mammography and or breast MRI 
				</value><value>Testicular or pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Karyotype 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Tumour markers 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/gynaecomastia/examination</CURLExa><CCondName><value>Turner syndrome</value></CCondName><CQueMgt><value>Karyotype analysis 
				</value><value>Genetic counselling 
				</value><value>Review baseline pituitary function 
				</value><value>MRI pituitary 
				</value><value>Consider assessing bone age 
				</value><value>Discuss fertility issues at, or soon after, diagnosis 
				</value><value>Screening required at diagnosis 
				</value><value>Annual follow up 
				</value><value>Three to five yearly follow up 
				</value><value>Pre-pregnancy 
				</value><value>Hormone replacement therapy 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/examination</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/investigation</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/turners-syndrome/management</CURLMgt><CURLTop>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</CURLTop><CURLInv>http://www.endobible.com/condition/gynaecomastia/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;To diagnose gynaecomastia a detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Gynaecomastia may be the presenting feature in patients with documented or unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with generalised adiposity may present with non glandular breast swelling. Patients with Cushing’s syndrome have central adiposity, and may have short stature if the disease developed in childhood. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient, and otherwise a diagnosis of Kallmann's syndrome may not be considered.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all cases.&lt;/p&gt;
&lt;p&gt;True gynaecomastia is present when the glandular tissue or breast bud is greater than 0.5cm in diameter.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with suspected hypogonadism to seek evidence of heart failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Examine specifically for stigmata of chronic liver or renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in adult males with gynaecomastia and suspected hypogonadism, and should be documented using an orchidometer.&lt;/p&gt;
&lt;p&gt;Testes should also be examined for abnormalities of texture, masses or lymphadenopathy as testicular tumours may present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyrotoxicosis which may disrupt gonadal function and present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients with possible pituitary disease, and so should be performed unless the diagnosis of Kallmann's, or isolated hypogonadotropic hypogonadism, has already been confirmed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Fine wrinkling of the skin occurs in hypopituitarism.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;
&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Doughy skin with soft tissue swelling also occurs in growth hormone excess.&lt;/p&gt;
&lt;p&gt;Café au lait patches, skin tags and axillary freckling may indicate associated syndromes, for example neurofibromatosis LINK, multiple endocrine neoplasia 2 LINK or McCune Albright syndrome.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;In all cases of hypercalaemia with suppressed PTH, it is mandatory to perform serum and urine protein electrophoresis and a chest radiograph. Other investigations and further management will depend on the clinical findings and are listed in further investigations.&lt;/p&gt;
&lt;p&gt;Where possible, remove offending drugs for example in milk alkali syndrome, or after psychiatric liaison for lithium use.&lt;/p&gt;
&lt;p&gt;Start definitive treatment for thyrotoxicosis or Addison’s disease if appropriate.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Calcium to creatinine clearance ratio &amp;lt;&amp;lt;0.01 and patient asymptomatic&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is consistent with a diagnosis of familial hypocalciuric hypercalcaemia. No further investigations or treatment are necessary. Family members should be informed about this diagnosis to prevent unnecessary investigations in the future.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Calcium to creatinine clearance ratio close to 0.01 and or possible symptoms&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;These results are inconclusive and have not fully excluded FHH. It may be worth repeating 24hr collection three times for both calcium and magnesium:creatinine clearance ratios. Alternatively, consider sequencing of the calcium sensing receptor.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Calcium to creatinine clearance ratio &amp;gt;&amp;gt;0.01&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;FHH is confidently excluded by the finding of raised urinary calcium excretion and an elevated calcium to creatinine clearance ratio.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Vitamin D deficiency detected &amp;lt;25ng/ml and calcium &amp;lt;3mmol/l&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Vitamin D should be replaced by prescribing a pure vitamin D supplement before repeating the investigations and deciding on future management. Suitable formulations are 10,000 units ergocalciferol orally per week or 100,000 units intra-muscularly.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Recommend high fluid intake and normal calcium diet in all patients&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;High calcium diets exacerbate hypercalcaemia. However, excluding calcium from the diet may also exacerbate hypercalcaemia as it may lead to further elevation of PTH and bony resorption.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Ensure all patients are not taking any interfering medications&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Look specifically for calcium or vitamin D containing supplements or antacids.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If the patient is suitable for and agreeable to surgery, arrange localising studies - neck ultrasound scan and MIBI.&lt;/p&gt;
&lt;p&gt;Refer to a parathyroid surgeon for minimally invasive surgery.&lt;/p&gt;
&lt;p&gt;If imaging fails to localise an adenoma, and the patient has not had previous neck surgery, consider bilateral neck exploration.&lt;/p&gt;
&lt;p&gt;If imaging fails to localise an adenoma, and the patient is more complex, or has had previous neck surgery, consider selective sampling or further imaging with CT scanning.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up post surgery&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Arrange monitoring of serum calcium, urea and electrolytes three months post surgery and review results and histology. If calcium is within the normal range post operatively, discharge.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Conservative management&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Surgery should be offered to all patients with primary hyperparathyroidism.&lt;/p&gt;
&lt;p&gt;However, if the patient is asymptomatic with no complications, they may decline or be unfit or otherwise unsuitable for surgery. In this case, arrange six monthly monitoring of serum calcium. &lt;/p&gt;
&lt;p&gt;Patients with stable serum calcium which is below 2.85mmol/l may be discharged for regular monitoring by the GP.&lt;/p&gt;
&lt;p&gt;Patients should be re-assessed if they develop new symptoms or complications, or their calcium rises, or they reconsider surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider bisphosphonate or other treatment for osteoporosis&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;The best treatment for osteoporosis in hyperparathyroidism is surgery. However, standard drug &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/osteoporosis/"&gt;treatment&lt;/a&gt; should be considered if the patient is not for surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider urology referral for symptomatic renal colic&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Renal colic should be managed in the usual way.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider Cinacalcit&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This drug is not yet in wide use and is expensive. However, it has been shown to reduce serum calcium effectively and so should be considered in patients unfit for surgery. It's effects on long term outcomes and short term symptoms have not been fully evaluated.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Arrange long term six monthly monitoring of serum calcium&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Unless the patient has undergone a surgical cure, long term monitoring (usually by their GP) should be arranged to allow early detection and treatment of complications.&lt;/p&gt;
&lt;p&gt;Definitive treatment should be reconsidered if their clinical condition changes.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypercalcaemia associated with acute renal failure, confusion, or other emergency features requires emergency treatment. Rapidly increasing and very high levels should also be treated immediately.&lt;/p&gt;
&lt;p&gt;Fluid resuscitation with 0.9% saline is the first line of treatment. Four litres per 24 hours is usually sufficient to bring calcium levels down. Patients with unstable cardiac disease, or others who may not tolerate fluid resuscitation should be discussed with a nephrologist to consider dialysis. Urgent parathyroid surgery or treatment of underlying disease, such as malignancy or sarcoidosis, will also usually bring calcium levels down quickly.&lt;/p&gt;
&lt;p&gt;If initial measures fail to control the hypercalcaemia, bisphosphonate infusion may be considered, after all initial investigations have been completed.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value>PTH results low or undetectable 
				</value><value>PTH results normal or elevated 
				</value><value>Confirmed primary hyperparathyroidism 
				</value><value>Emergency treatment of hypercalcaemia 
				</value></CQueMgt><CQueInv><value>Full blood count 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Glycosylated haemoglobin, fasting glucose and lipids 
				</value><value>Karyotype 
				</value><value>Pituitary function 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram, echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Bone age 
				</value><value>Hearing test 
				</value><value>Auto-antibody screen 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;This is a useful indicator of general health and as a screen for underlying disease including coeliac disease or hypopituitarism in a patient presenting with short stature and abnormal sexual development.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful screen for renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Diabetes has an increased incidence in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome also have an increased risk of renal and cardiovascular disease, and so cardiovascular risk modification is essential.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all patients with suspected Turner, androgen insensitivity and Klinefelter’s syndrome. XO is the commonest karyotype encountered in Turner syndrome, but mosaics and patients with partial deletions and other chromosomal abnormalities also occur.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Growth hormone, Insulin like growth factor I&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients with Turner syndrome and severe short stature may benefit from GH therapy. GH secretion does not need to be assessed following the diagnosis of Turner syndrome. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia may cause pubertal delay and hypogonadotropic hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is &lt;u&gt;not&lt;/u&gt; usually assessed in patients with Turner syndrome, though if a diagnosis of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-syndrome/"&gt;Cushing's&lt;/a&gt; is being considered, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/urinary-free-cortisol/"&gt;urinary free cortisols&lt;/a&gt; and a low dose &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/dexamethasone-suppression-test/"&gt;dexamethasone suppression&lt;/a&gt; test should be arranged instead.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estrodiol, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Estrodiol is usually low in Turner syndrome.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;LH and FSH should be checked in all patients presenting with hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyroid dysfunction may lead to pubertal delay. Turner syndrome is also associated with an increased incidence of thyroid disease.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Chest XR should be performed at diagnosis of Turner's as a simple screen for congenital abnormalities and coarctation of the aorta. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;ECG and echocardiogram should be performed to seek coarctation of the aorta or other abnormalities in patients with confirmed Turner syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph to assess bone age in younger patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid and coeliac antibodies should be assessed at diagnosis in patients with Turner syndrome, due to an increased incidence of these disorders.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be considered in all patients with long standing hypogonadism. It may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/hypercalcaemia/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/paediatric-turner-syndrome/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Gonadal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;The implications of diagnosis, and possibilities for fertility should be discussed at or soon after diagnosis. Counselling should be offered at diagnosis if appropriate.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Early discussion and referral for infertility is recommended.&lt;/p&gt;
&lt;p&gt;It is important for patients desiring fertility to have a realistic understanding of their options. The chance of an unaided conception is low with complete ovarian failure and an elevated FSH. However, occasional ovulatory cycles may occur early in the disease, and multiple assisted conception techniques are available, particularly using donor ova.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for cardiovascular or thromboembolic disease will also need to be considered.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia eg 1x350mcg progesterone only pill daily.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Estrogen replacement therapy requires no routine monitoring unless the patient is symptomatic, for example complaining of menstrual irregularity or hot flushes. &lt;/p&gt;
&lt;p&gt;Annual monitoring of TSH, free thyroxine, 9am cortisol and vitamin B12 levels should be initiated to screen for the development of other associated conditions.&lt;/p&gt;
&lt;p&gt;Specialist follow up may not be required long term.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; "&gt;&lt;span style="font-size: 8pt; font-family: Arial, sans-serif; "&gt;Consider assessing bone densitometry at diagnosis. Estrogen replacement therapy should be sufficient to improve bone densitometry. However, vitamin D levels should be checked, to determine whether supplementation is also necessary. &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; "&gt;&lt;span style="font-size: 8pt; font-family: Arial, sans-serif; "&gt;Consider repeating bone densitometry after five years of treatment in those with severe &lt;a href="http://www.endobible.com/condition/osteoporosis/management"&gt;&lt;span style="color:blue"&gt;osteoporosis&lt;/span&gt;&lt;/a&gt;, to determine whether additional treatment is indicated for example bisphosphonates.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, weight, body habitus and BMI 
				</value><value>Olfactory nerves 
				</value><value>Breasts 
				</value><value>Cardiovascular examination 
				</value><value>Body hair 
				</value><value>Gastrointestinal system 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value></CQueExa><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be tested prior to and during testosterone treatment because of the risk of polycythaemia developing. Normocytic normochromic anaemia and eosinophilia may be seen with undiagnosed hypopituitarism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Haemochromotosis may be associated with the development of secondary hypogonadotropic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Liver function test may be surprisingly normal in cirrhosis.&lt;/p&gt;
&lt;p&gt;Albumin levels are required to calculate free androgen index in borderline cases and liver function should also be documented before starting testosterone replacement therapy in all.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypercalcaemia may occur with thyrotoxicosis and, rarely, with hypopituitarism, both of which may be associated with gynaecomastia. Hypercalcaemia may also occur with malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;PSA should be documented before considering testosterone replacement therapy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to their circadian release, sex hormones should be assessed early morning (typically at 9am), and repeated on more than one occasion.&lt;/p&gt;
&lt;p&gt;Sex hormone binding globulin is necessary to calculate the free androgen index. This is particularly important where testosterone levels are near normal, and the decision to start testosterone replacement is not clear cut.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Where sex hormones are confirmed as low, low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example secondary to mumps, testicular trauma, surgery or torsion in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia may present with tender gynaecomastia and hypogonadism in male patients.&lt;/p&gt;
&lt;p&gt;Multiple &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hyperprolactinaemia/"&gt;medications&lt;/a&gt; lead to elevations in serum prolactin, and high levels may also occur in non functioning pituitary adenomas.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis may cause gynaecomastia in some patients.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 590nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with possible pituitary disease and levels below this may require formal &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;assessment&lt;/a&gt; for ACTH reserve, depending on clinical suspicion.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Growth hormone, insulin like growth factor I&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;A normal growth hormone (GH) and insulin like growth factor I (IGF-I) taken together form a useful screen for acromegaly.&lt;/p&gt;
&lt;p&gt;Very low IGF-I levels alone are not diagnostic for GH deficiency but are a useful screen indicating potential pituitary dysfunction.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in all cases with documented hypogonadotropic hypogonadism and urgently if there is visual field loss or optic disc pallor.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI should include the olfactory bulbs in patients with suspected Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with possible malignancy should have a CXR performed at baseline.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Mammography and further imaging should be considered in patients with unilateral gynaecomastia, breast masses, changes to the overlying skin, or any other suspicious features.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads.&lt;/p&gt;
&lt;p&gt;This is also essential in patients presenting with gynaecomastia with a testicular mass.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty and gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; should be performed if GH or ACTH deficiency is suspected but not yet confirmed subject to the usual safety exclusion criteria.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon testing&lt;/a&gt; should be performed if GH or ACTH deficiency is suspected but not yet confirmed and the patient is unable to tolerate an insulin stress test.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If insulin stress testing is unavailable or contraindicated, &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;arginine-GHRH&lt;/a&gt; testing is a suitable alternative test for GH reserve.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be considered in all patients with long standing hypogonadism. It may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Alpha-feto protein and human chorionic gonadotropin should be assessed where testicular or other malignancy is suspected.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Prostate specific antigen 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary 
				</value><value>MRI olfactory bulbs 
				</value><value>Chest radiograph 
				</value><value>Mammography and or breast MRI 
				</value><value>Testicular or pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Karyotype 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Tumour markers 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/gynaecomastia/examination</CURLExa><CCondName><value>Turner syndrome</value></CCondName><CQueMgt><value>Discuss diagnosis and offer counselling 
				</value><value>Fertility 
				</value><value>Initiate treatment 
				</value><value>Monitoring and follow up 
				</value><value>Bone densitometry 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/examination</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/investigation</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/premature-ovarian-failure/management</CURLMgt><CURLTop>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</CURLTop><CURLInv>http://www.endobible.com/condition/gynaecomastia/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;To diagnose gynaecomastia a detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Gynaecomastia may be the presenting feature in patients with documented or unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with generalised adiposity may present with non glandular breast swelling. Patients with Cushing’s syndrome have central adiposity, and may have short stature if the disease developed in childhood. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient, and otherwise a diagnosis of Kallmann's syndrome may not be considered.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all cases.&lt;/p&gt;
&lt;p&gt;True gynaecomastia is present when the glandular tissue or breast bud is greater than 0.5cm in diameter.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with suspected hypogonadism to seek evidence of heart failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Examine specifically for stigmata of chronic liver or renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in adult males with gynaecomastia and suspected hypogonadism, and should be documented using an orchidometer.&lt;/p&gt;
&lt;p&gt;Testes should also be examined for abnormalities of texture, masses or lymphadenopathy as testicular tumours may present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyrotoxicosis which may disrupt gonadal function and present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients with possible pituitary disease, and so should be performed unless the diagnosis of Kallmann's, or isolated hypogonadotropic hypogonadism, has already been confirmed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Fine wrinkling of the skin occurs in hypopituitarism.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;
&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Doughy skin with soft tissue swelling also occurs in growth hormone excess.&lt;/p&gt;
&lt;p&gt;Café au lait patches, skin tags and axillary freckling may indicate associated syndromes, for example neurofibromatosis LINK, multiple endocrine neoplasia 2 LINK or McCune Albright syndrome.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Gonadal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;From a practical perspective the following conditions should be excluded before confirming a diagnosis of PCOS. Thyroid dysfunction, prolactinoma, congenital adrenal hyperplasia, virilising tumours (ovarian or adrenal) and Cushing’s (diagnosis usually excluded clinically).&lt;/p&gt;
&lt;p&gt;In practise, the minimum assessment required before a diagnosis of PCOS can be considered likely are a normal prolactin, normal TSH and a testosterone &amp;lt;3.5nmol/l. In the presence of these results, no further investigations may be necessary in some cases. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Latest &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.ncbi.nlm.nih.gov/pubmed/18950759?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;amp;ordinalpos=8"&gt;guidelines&lt;/a&gt; from the Androgen excess society and PCOS society have clarified the diagnosis of PCOS, requiring both hyperandrogenism and ovulatory dysfunction.&lt;/p&gt;
&lt;p&gt;Evidence of hyperandrogenism may be either clinical, for example hirsuitism or acne, or biochemical such as elevated testosterone.&lt;/p&gt;
&lt;p&gt;Evidence of ovulatory dysfunction may also be either clinical, for example oligomenorrhoea or anovulatory cycles confirmed with a day 21 progesterone, or as evidenced by polycystic morphology on ultrasound scanning.&lt;/p&gt;
&lt;p&gt;These criteria replace and simplify the previous '&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.ncbi.nlm.nih.gov/pubmed/14688154"&gt;Rotterdam criteria&lt;/a&gt;' which required at least two out of three of: hyperandrogenism (either biochemical or clinical), or anovulation (as evidenced by oligomenorrhoea or infertility), or polycystic morphology on ultrasound scan.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Idiopathic hirsuitism, hirsuitism and hyperandrogenism, congenital adrenal hyperplasia, Cushing’s syndrome, virilising tumours, prolactinoma, thyroid dysfunction or the HAIRAN syndrome may all present with similar features to PCOS.&lt;/p&gt;
&lt;p&gt;If the clinical picture is consistant with PCOS but the testosterone is elevated, the simplest way to&lt;a href="http://jcem.endojournals.org/content/88/6/2634.full.pdf+html" target="_blank"&gt; exclude a virilising tumour&lt;/a&gt; is to perform a low dose dexamethasone suppression test. If there is a strong suspicion of CAH, and the patient is seeking fertility, a 17OHprogesterone should be performed with a synacthen test if the result is elevated, though this is not mandatory in all patients with hirsuitism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Weight&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Diet and lifestyle advice are essential for all patients with PCOS. Management of other cardiovascular risk factors should also be undertaken when indicated.&lt;/p&gt;
&lt;p&gt;Suggest patient support groups, for example &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.verity-pcos.org.uk"&gt;Verity&lt;/a&gt; website.&lt;/p&gt;
&lt;p&gt;Consider metformin with slow dose titration, to minimise gastrointestinal side effects, or controlled release metformin if this is poorly tolerated.&lt;/p&gt;
&lt;p&gt;Consider further management of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/obesity/management"&gt;obesity&lt;/a&gt;, for example with orlistat, sibutramine and bariatric surgery.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Acne&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Diet and lifestyle advice are essential for all patients with PCOS. &lt;/p&gt;
&lt;p&gt;A combined oral contraceptive pill should be considered as any will reduce free androgen levels. For severe androgenic acne, a combined pill containing the anti-androgen cyproterone such as cocyprindiol is more effective.&lt;/p&gt;
&lt;p&gt;Where acne is the primary clinical concern, non hormonal measures may be more appropriate, for example antibiotics or retinoic acid, and so specialist dermatology advice should be sought.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Hirsuitism&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Diet and lifestyle advice are essential for all patients with PCOS. &lt;/p&gt;
&lt;p&gt;Warn patients that all treatments for hirsuitism tend to take at least six months and none are 100% effective.&lt;/p&gt;
&lt;p&gt;Topical eflornithine or other topical measures may be considered first line, and are usually given in addition to metformin given for other indications.&lt;/p&gt;
&lt;p&gt;A combined oral contraceptive pill (COCP) should also be considered and for severe hirsuitism, one containing an anti-androgen is most effective such as cocyprindiol or dianette.&lt;/p&gt;
&lt;p&gt;An anti-androgen, for example spironolactone (dose titrate from 25 to 200mg), may be added to the COCP if no effects have been observed after at least six months. Cyproterone acetate has also been widely used although this is not licenced and requires close monitoring of liver function. Finasteride is another alternative anti-androgen for exceptional use only.&lt;/p&gt;
&lt;p&gt;Where the COCP is contraindicated - for example in patients over 35 years, smokers, those with a history of thromboembolism, or is not tolerated with mood disturbance - anti-androgens may still be prescribed in the presence of robust contraception.&lt;/p&gt;
&lt;p&gt;If hirstuitism is severe, for example requiring daily shaving, and there has been no response to topical and medical therapies, consider pulsed light therapy or laser hair removal.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Oligomenorrhoea&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Diet and lifestyle advice are essential for all patients with PCOS.&lt;/p&gt;
&lt;p&gt;Metformin should also be considered to improve menstrual regularity.&lt;/p&gt;
&lt;p&gt;The COCP will almost always restore regular withdrawal bleeds, and is generally well tolerated. Where this is contra-indicated, or not well tolerated, consider intermittent progesterone (norethisterone acetate 5mg tds 5/7) to induce endometrial shedding every three months in amenorrhoeic patients.&lt;/p&gt;
&lt;p&gt;Reverse circadian prednisolone was historically widely used and can be highly effective at restoring menses. However, this requires thorough education and counselling of the patient regarding likely side effects, and is now seldom used.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Fertility&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Diet and lifestyle advice are essential for all patients with PCOS. &lt;/p&gt;
&lt;p&gt;Patients whose primary concern is fertility should be reviewed in a formal fertility clinic for counselling, and to investigate both partners for other causes.&lt;/p&gt;
&lt;p&gt;Metformin should be considered to improve menstrual irregularity, though has not been proven to improve pregnancy rates in recent controlled studies.&lt;/p&gt;
&lt;p&gt;Reverse circadian prednisolone may also be considered for anovulatory cycles though is no longer widely used.&lt;/p&gt;
&lt;p&gt;If the patient remains anovulatory, clomiphene acetate should be considered under gynaecological review and with follicular tracking.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, weight, body habitus and BMI 
				</value><value>Olfactory nerves 
				</value><value>Breasts 
				</value><value>Cardiovascular examination 
				</value><value>Body hair 
				</value><value>Gastrointestinal system 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value></CQueExa><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be tested prior to and during testosterone treatment because of the risk of polycythaemia developing. Normocytic normochromic anaemia and eosinophilia may be seen with undiagnosed hypopituitarism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Haemochromotosis may be associated with the development of secondary hypogonadotropic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Liver function test may be surprisingly normal in cirrhosis.&lt;/p&gt;
&lt;p&gt;Albumin levels are required to calculate free androgen index in borderline cases and liver function should also be documented before starting testosterone replacement therapy in all.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypercalcaemia may occur with thyrotoxicosis and, rarely, with hypopituitarism, both of which may be associated with gynaecomastia. Hypercalcaemia may also occur with malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;PSA should be documented before considering testosterone replacement therapy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Testosterone, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to their circadian release, sex hormones should be assessed early morning (typically at 9am), and repeated on more than one occasion.&lt;/p&gt;
&lt;p&gt;Sex hormone binding globulin is necessary to calculate the free androgen index. This is particularly important where testosterone levels are near normal, and the decision to start testosterone replacement is not clear cut.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Where sex hormones are confirmed as low, low or normal luteinising hormone (LH) and follicle stimulating hormone (FSH) indicate pituitary or hypothalamic pathology.&lt;/p&gt;
&lt;p&gt;Elevations in LH and FSH indicate gonadal failure, for example secondary to mumps, testicular trauma, surgery or torsion in males.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia may present with tender gynaecomastia and hypogonadism in male patients.&lt;/p&gt;
&lt;p&gt;Multiple &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hyperprolactinaemia/"&gt;medications&lt;/a&gt; lead to elevations in serum prolactin, and high levels may also occur in non functioning pituitary adenomas.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, free thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyrotoxicosis may cause gynaecomastia in some patients.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Due to the circadian rhythm of ACTH release, cortisol is best assessed early morning (or on waking in patients with irregular hours, for example shift workers).&lt;/p&gt;
&lt;p&gt;Levels above 590nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Patients with possible pituitary disease and levels below this may require formal &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;assessment&lt;/a&gt; for ACTH reserve, depending on clinical suspicion.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Growth hormone, insulin like growth factor I&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;A normal growth hormone (GH) and insulin like growth factor I (IGF-I) taken together form a useful screen for acromegaly.&lt;/p&gt;
&lt;p&gt;Very low IGF-I levels alone are not diagnostic for GH deficiency but are a useful screen indicating potential pituitary dysfunction.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed in all cases with documented hypogonadotropic hypogonadism and urgently if there is visual field loss or optic disc pallor.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;MRI should include the olfactory bulbs in patients with suspected Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients presenting with possible malignancy should have a CXR performed at baseline.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Mammography and further imaging should be considered in patients with unilateral gynaecomastia, breast masses, changes to the overlying skin, or any other suspicious features.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads.&lt;/p&gt;
&lt;p&gt;This is also essential in patients presenting with gynaecomastia with a testicular mass.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Formal visual field testing is mandatory if there is clinical or MRI suspicion of chiasmal impingement in patients with pituitary disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty and gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/insulin-stress-test/"&gt;Insulin tolerance testing&lt;/a&gt; should be performed if GH or ACTH deficiency is suspected but not yet confirmed subject to the usual safety exclusion criteria.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/glucagon-test/"&gt;Glucagon testing&lt;/a&gt; should be performed if GH or ACTH deficiency is suspected but not yet confirmed and the patient is unable to tolerate an insulin stress test.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If insulin stress testing is unavailable or contraindicated, &lt;a href="http://www.endobible.com/investigation/arginine-ghrh-test/" target="_blank"&gt;arginine-GHRH&lt;/a&gt; testing is a suitable alternative test for GH reserve.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be considered in all patients with long standing hypogonadism. It may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Alpha-feto protein and human chorionic gonadotropin should be assessed where testicular or other malignancy is suspected.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Ferritin 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Prostate specific antigen 
				</value><value>Baseline pituitary function 
				</value><value>MRI pituitary 
				</value><value>MRI olfactory bulbs 
				</value><value>Chest radiograph 
				</value><value>Mammography and or breast MRI 
				</value><value>Testicular or pelvic ultrasound scan 
				</value><value>Visual perimetry and acuity 
				</value><value>Karyotype 
				</value><value>Insulin stress test 
				</value><value>Glucagon test 
				</value><value>Arginine-GHRH testing 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value><value>Tumour markers 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/gynaecomastia/examination</CURLExa><CCondName><value>Turner syndrome</value></CCondName><CQueMgt><value>Diagnosis of PCOS should only be considered in patients after ruling out other conditions 
				</value><value>Current diagnostic criteria require the presence of both hyperandrogenism and ovarian dysfunction 
				</value><value>Other diagnoses to be considered in the differential of hirsuitism and irregular menses 
				</value><value>Management of confirmed PCOS should be tailored to the individual's primary complaint 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/examination</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/investigation</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/polycystic-ovarian-syndrome/management</CURLMgt><CURLTop>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</CURLTop><CURLInv>http://www.endobible.com/condition/gynaecomastia/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;To diagnose gynaecomastia a detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Gynaecomastia may be the presenting feature in patients with documented or unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with generalised adiposity may present with non glandular breast swelling. Patients with Cushing’s syndrome have central adiposity, and may have short stature if the disease developed in childhood. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient, and otherwise a diagnosis of Kallmann's syndrome may not be considered.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all cases.&lt;/p&gt;
&lt;p&gt;True gynaecomastia is present when the glandular tissue or breast bud is greater than 0.5cm in diameter.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with suspected hypogonadism to seek evidence of heart failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Examine specifically for stigmata of chronic liver or renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in adult males with gynaecomastia and suspected hypogonadism, and should be documented using an orchidometer.&lt;/p&gt;
&lt;p&gt;Testes should also be examined for abnormalities of texture, masses or lymphadenopathy as testicular tumours may present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyrotoxicosis which may disrupt gonadal function and present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients with possible pituitary disease, and so should be performed unless the diagnosis of Kallmann's, or isolated hypogonadotropic hypogonadism, has already been confirmed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Fine wrinkling of the skin occurs in hypopituitarism.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;
&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Doughy skin with soft tissue swelling also occurs in growth hormone excess.&lt;/p&gt;
&lt;p&gt;Café au lait patches, skin tags and axillary freckling may indicate associated syndromes, for example neurofibromatosis LINK, multiple endocrine neoplasia 2 LINK or McCune Albright syndrome.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Gonadal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Repeat 9am testosterone, SHBG and albumin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Management decisions should not be taken on an isolated testosterone level. Borderline levels (typically between 8-12nmol/l) should be interpreted in the light of SHBG and albumin to calculate a free androgen index.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review baseline pituitary function&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is any doubt, consider dynamic function testing to confirm isolated nature of hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;MRI pituitary&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;With isolated hypogonadotropic hypogonadism, the pituitary is likely to be structurally normal. If the hypogonadism is mild (eg testosterone &amp;gt;6nmo/l), isolated and of late onset eg associated with adiposity and type 2 diabetes mellitus, imaging may not be requried. For more severe cases, a structurally normal pitutiary on MRI scanning is reassuring that no further imaging need be undertaken in the future.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider DEXA scan&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Documented low bone mineral density will inform decision whether to initiate treatment.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss fertility issues&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should be discussed at, or soon after, diagnosis. Semen analysis, counselling, and referral to a fertility clinic for consideration of spermatogenesis induction, should be offered if appropriate.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Testosterone confirmed low with no other abnormalities detected: start treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Discuss whether treatment is actually required in each individual case. The presence of sexual symtpoms - loss of libido and early morning erections are the most specific to androgen deficiency and are likely to improve with treatment. Other symptoms such as fatigue, poor muscle strength and erectile dysfunction are often multifactorial and may respond better to non hormonal treatments.&lt;/p&gt;
&lt;p&gt;If a trial of treatment is indicated, discuss the different testosterone preparations available, for example daily topical gel, patch, or regular or depot injections.&lt;/p&gt;
&lt;p&gt;It is appropriate to start treatment at the usual adult dose in patients with adult onset hypogonadism, and continue for 3 months before determining clinical response.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Optimise dose according to symptoms and serum levels&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Routine monitoring of serum testosterone levels is not necessary until the expected adult dose is reached.&lt;/p&gt;
&lt;p&gt;Peak and trough levels may then be useful to confirm the appropriateness of the final dose in patients taking monthly testosterone undecanoate. Peak 7 days post injection should typically be 25-30nmol/l, with a predose trough level of 8-12nmol/l. Subsequently, the dose should not be altered unless the clinical response is suboptimal, or in the light of changes in serum monitoring of prostate specific antigen, full blood count, liver function, or pre dose testosterone levels.&lt;/p&gt;
&lt;p&gt;In patients taking depot preparations, a random or pre dose level of 15-20nmol/l, and for patients taking daily topical preparations, a level of 15-20nmol/l 4-6 hours post application of the gel is usually suficient.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Annual monitoring and follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;After the dose has been optimised, annual random levels are sufficient in most cases, with pre dose levels also required in patients on testosterone ester injections. Digital rectal examination, prostate specific antigen, full blood count and liver function tests should also be performed annually with dose reduction and or onward referral if abnormalities arise.&lt;/p&gt;
&lt;p&gt;Specialist follow up is not usually required long term.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review baseline pituitary function&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is any doubt that hypogonadotropic hypogonadism may not be isolated, consider dynamic function testing.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;MRI pituitary&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Late onset isolated hypogonadotropic hypogonadism is uncommon in females requiring thorough investigation for other causes.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider DEXA scan&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Documented low bone mineral density will inform decision as whether to initiate treatment, and whether other agents should be considered, for example bisphosphonates and vitamin D.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss fertility issues&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should be discussed at, or soon after, diagnosis and counselling or referral offered if appropriate.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; background-color: rgb(245, 243, 197); "&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; background-color: rgb(245, 243, 197); "&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; background-color: rgb(245, 243, 197); "&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for cardiovascular or thromboembolic disease will also need to be considered. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; background-color: rgb(245, 243, 197); "&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia eg 1x350mcg progesterone only pill daily.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; background-color: rgb(245, 243, 197); "&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;
&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Repeat 9am testosterone, SHBG and albumin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Management decisions should not be taken on an isolated testosterone level. Borderline levels should be interpreted in the light of SHBG and albumin to calculate a free androgen index.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Testicular ultrasound&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is any doubt about the aetiology of gonadal failure, imaging should be performed and further investigation undertaken, for example with tumour markers (alpha feto protein and human chorionic gonadotropin) and urology referral. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid auto-antibody screen&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Primary gonadal failure may be associated with other organ specific auto-immune diseases and so such patients should be screened and monitored for their development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Vitamin B12, coeliac auto-antibody screen&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Primary gonadal failure may be associated with other organ specific auto-immune diseases and so such patients should be screened and monitored for their development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider DEXA scan&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Documented low bone mineral density will inform decision whether to initiate treatment, and whether other agents such as calcium and vitamin D are required.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss fertility issues&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should be discussed at or soon after diagnosis. Semen analysis, counselling and referral to a fertility clinic should be offered if appropriate.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Testosterone confirmed low with no other abnormalities detected: start treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Discuss whether treatment is actually required and the different testosterone preparations available, for example topical gel, patch, regular or depot injections.&lt;/p&gt;
&lt;p&gt;Treatment is usually started at standard adult doses in patients with adult onset hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Optimise dose according to symptoms and serum levels&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Routine monitoring of serum testosterone levels is not necessary until the expected adult dose is reached.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Peak and trough levels may then be useful to confirm the appropriateness of the final dose in patients taking monthly testosterone undecanoate. Peak 7 days post injection should typically be 25-30nmol/l, with a predose trough level of 8-12nmol/l. Subsequently, the dose should not be altered unless the clinical response is suboptimal, or in the light of changes in serum monitoring of prostate specific antigen, full blood count, liver function, or pre dose testosterone levels.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;In patients taking depot preparations, a random or pre dose level of 15-20nmol/l, and for patients taking daily topical preparations, a level of 15-20nmol/l 4-6 hours post application of the gel is usually sufficient.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Annual monitoring and follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;After initial dose optimisation, annual random levels are sufficient in most cases, with pre dose levels for those taking regular injectable preparations.&lt;/p&gt;
&lt;p&gt;Digital rectal examination, prostate specific antigen, full blood count and liver function tests should also be performed annually with dose reduction and or onward referral if abnormalities arise.&lt;/p&gt;
&lt;p&gt;B12, 9am cortisol, TSH and free thyroxine should be assessed annually where the cause is presumed to be auto-immune.&lt;/p&gt;
&lt;p&gt;Specialist follow up is not usually required long term.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid auto-antibody screen&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Primary ovarian failure is associated with other organ specific auto-immune diseases and so such patients should be screened and monitored for their development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Vitamins B12, coeliac auto-antibody screen&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Primary ovarian failure is associated with other organ specific autoimmune diseases and so such patients should be screened and monitored for their development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider DEXA scan&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Documented low bone mineral density will inform decision whether to initiate treatment, and whether other agents should be considered, for example bisphosphonates and vitamin D.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss fertility issues&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This should be discussed at, or soon after, diagnosis and counselling or referral offered if appropriate.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;/p&gt;
&lt;p&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;/p&gt;
&lt;p&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for cardiovascular or thromboembolic disease will also need to be considered. &lt;/p&gt;
&lt;p&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia eg 1x350mcg progesterone only pill daily.&lt;/p&gt;
&lt;p&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Monitoring and follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Estrogen replacement therapy requires no routine monitoring unless the patient is symptomatic, for example menstrual irregularity or hot flushes.&lt;/p&gt;
&lt;p&gt;Annual monitoring of TSH, free thyroxine, 9am cortisol and vitamin B12 level should be initiated to screen for the development of other associated conditions.&lt;/p&gt;
&lt;p&gt;Specialist follow up may not be required long term.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss treatment aims, timescales and outcomes&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Treatment aims to replicate the natural process of puberty and should occur over approximately the same timescale - approximately two to three years.&lt;/p&gt;
&lt;p&gt;Adult patients should be warned that accelerating the process may have adverse long term psychological and physical consequences, for example poor breast development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss fertility issues at, or soon after, diagnosis&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If appropriate, fertility should be discussed early with the patient and their family.&lt;/p&gt;
&lt;p&gt;Patients need to understand that successful pubertal induction will not affect or restore fertility, although appropriate uterine development is necessary prior to possible future pregnancies.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Karyotype analysis&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Adult patients with absent puberty require karyotype analysis to differentiate between different causes, for example Klinefelter's syndrome, androgen insensitivity or Turner's syndrome.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review baseline pituitary function&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is any doubt that hypogonadotropic hypogonadism may not be isolated, consider dynamic function testing.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;MRI pituitary&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If karyotype is normal, and cause of hypogonadotropic hypogonadism is uncertain, thorough investigation for other causes should be performed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider assessing bone age&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Delayed bone age supports the diagnosis of absent puberty.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment: females&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose estrogen replacement therapy.&lt;/p&gt;
&lt;p&gt;An alternative is to use topical estrogen therapy. This may give a better eventual breast shape, and is well tolerated, with the patches often easier to source in the community than low dose ethinylestradiol. A typical start dose is with one quarter of a 25mcg Estradiol patch given either overnight every day, or left on and replaced every 72 hours. The dose should then increase every 3-4 months to half a patch, then a whole 25mcg patch, then a 50mcg patch, then a 75mcg, then a 100mcg patch.  &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider pelvic ultrasound scan to assess uterine size at this stage.&lt;/p&gt;
&lt;p&gt;Once the patient experiences vaginal bleeding or if the patient has tolerated 15mcg orally, or 100mcg transdermally, consider adding cyclical progesterone. Measurement of LH and FSH levels may also be used to help judge whether the final dose of topic estradiol is sufficient, as some girls will require higher doses.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatment regimens&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p class="MsoNormal"&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for cardiovascular or thromboembolic disease will also need to be considered. &lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia eg 1x350mcg progesterone only pill daily.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Duration of treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Continue sex hormone replacement therapy until the time of the natural menopause - typically to age 50.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry and of pituitary function where indicated.&lt;/p&gt;
&lt;p&gt;Patients with Turner’s syndrome, Klinefelter’s, Kallmann’s or underlying pituitary disease will require specific follow up.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment: male patients&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose testosterone therapy, and warn patient of expected psychological and physical effects.&lt;/p&gt;
&lt;p&gt;Typical starting dose in a testosterone naive patient is approximately 20% of the usual adult dose. This has traditionally been given as 50mg testosterone ester as an intramuscular injection, monthly, though an alternative is to use very low dose daily testosterone gel using a metered dose delivery system.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Monthly testosterone treatment is then typically increased by a further 50mg every six months according to clinical response.&lt;/p&gt;
&lt;p&gt;Alternatives include low dose depot testosterone, or topical gel using the same dosing schedule.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Treatment monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Routine monitoring of serum testosterone levels is not necessary until the expected adult dose is reached.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Peak and trough levels may then be useful to confirm the appropriateness of the final dose in patients taking monthly testosterone undecanoate. Peak 7 days post injection should typically be 25-30nmol/l, with a predose trough level of 8-12nmol/l. Subsequently, the dose should not be altered unless the clinical response is suboptimal, or in the light of changes in serum monitoring of prostate specific antigen, full blood count, liver function, or pre dose testosterone levels.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;In patients taking depot preparations, a random or pre dose level of 15-20nmol/l, and for patients taking daily topical preparations, a level of 15-20nmol/l 4-6 hours post application of the gel is usually sufficient.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Once patient is virilised appropriately and established on full adult dose, offer switching to alternative preparation, for example daily gel or depot preparation.&lt;/p&gt;
&lt;p&gt;Optimise final dose according to symptoms and serum levels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Annual monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Annual random levels are sufficient in patients on topical and depot preparations. Annual pre dose levels are required in those on injectable testosterone esters. &lt;/p&gt;
&lt;p&gt;Digital rectal examination, prostate specific antigen, full blood count and liver function tests should also be performed annually with dose reduction and onward referral if abnormalities arise.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry and of pituitary function where indicated.&lt;/p&gt;
&lt;p&gt;Patients with Turner’s syndrome, Klinefelter’s, Kallmann’s or underlying pituitary disease will require specific follow up.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling. Follow protocol according to absent puberty as above.&lt;/p&gt;
&lt;p&gt;Offer life long follow up.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling. Follow the usual protocol for absent puberty.&lt;/p&gt;
&lt;p&gt;Offer life long follow up.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling. Arrange an MRI scan of the pituitary and olfactory bulbs, and a renal ultrasound scan. &lt;/p&gt;
&lt;p&gt;Follow the protocol for absent puberty, and offer life long follow up. For further management see &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/"&gt;Kallmann's&lt;/a&gt; syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling. Follow the treatment pathway for pubertal induction. &lt;/p&gt;
&lt;p&gt;For further management see &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/turners-syndrome/"&gt;Turner's&lt;/a&gt; syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, weight, body habitus and BMI 
				</value><value>Olfactory nerves 
				</value><value>Breasts 
				</value><value>Cardiovascular examination 
				</value><value>Body hair 
				</value><value>Gastrointestinal system 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value></CQueExa><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease. Menorrhagia may cause microcytic anaemia, and exacerbate hair loss.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypokalaemia may raise the possibility of cortisol excess.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Fatty liver is common in both obesity and diabetes. It's also needed as a baseline before starting medical treatments.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Unrecognised hypothyroidism is associated with weight gain and menstrual disturbance.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hyperprolactinaemia of any cause is associated with oligomenorrhoea. &lt;/p&gt;
&lt;p&gt;Mild degrees of hyperprolactinaemia are also seen in PCOS and may not indicate pituitary or other pathology.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Essential for cardiovascular risk stratification.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed early morning, early follicular phase and off the contraceptive pill. &lt;/p&gt;
&lt;p&gt;Sex hormone binding globulin is typically low in PCOS and Cushing’s. Testosterone is typically but not always mildly elevated in PCOS. High levels (&amp;gt;3.5nmol/l in the author's institution) should prompt a search for other causes, for example virilising tumours or Cushing’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Elevated luteinising hormone: follicle stimulating hormone ratio is often seen in PCOS but is not diagnostic and so is not necessarily performed in all cases.&lt;/p&gt;
&lt;p&gt;LH and FSH may both be low in pituitary and hypothalamic causes of oligomenorrhoea, for example associated with low body mass or anorexia or excessive exercise. FSH will be elevated in the secondary amenorrhoea of premature ovarian failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This test needs to be performed early morning, early follicular phase and off the contraceptive pill. &lt;/p&gt;
&lt;p&gt;17OHP is a useful initial screen for congenital adrenal hyperplasia - if elevated above 10nmol/l, the patient will require full evaluation: a short synacthen test.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be taken on day 21 of the menstrual cycle to indicate ovulation in patients with regular menses and diagnostic uncertainty.&lt;/p&gt;
&lt;p&gt;This should also be recorded in patients seeking fertility.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In virilised patients, those with elevated testosterone, or suspected Cushing’s syndrome, or other adrenal pathology, full adrenal androgens should be assessed. These are typically minimally elevated in PCOS, higher in Cushing’s and adrenal tumours. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/urinary-free-cortisol/"&gt;Urinary cortsiols&lt;/a&gt; form a sensitive but not specific initial screen if &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-syndrome/"&gt;Cushing's&lt;/a&gt; syndrome is suspected.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If there is a clinical suspicion of Cushing’s syndrome, a low dose &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/dexamethasone-suppression-test/"&gt;dexamethasone suppression test&lt;/a&gt; (LDDST) should be performed to seek suppressibility of cortisol.&lt;/p&gt;
&lt;p&gt;If androgens are elevated, LDDST should also be performed. Suppressibility of adrenal androgens by more than 40% has been &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://jcem.endojournals.org/cgi/reprint/88/6/2634"&gt;reported&lt;/a&gt; as making virilising tumours highly unlikely.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If the baseline 17 hydroxyprogesterone is elevated &amp;gt;10nmol/l, proceed to a &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/synacthen-test/"&gt;synacthen test&lt;/a&gt; to confirm or exclude late onset congenital adrenal hyperplasia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If adrenal androgens are elevated, and do not suppress after dexamethasone testing, a virilising tumour should be suspected and CT or MRI imaging should be peformed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If androgens are elevated and do not suppress after dexamethasone, imaging of the ovaries and adrenals should be arranged. If no obvious lesion is revealed on imaging, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/selective-venous-sampling/"&gt;selective venous sampling&lt;/a&gt; of the abdomen and pelvis may identify the source of androgens.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This may be useful in cases of diagnostic difficulty where there is evidence of hyperandrogenism but not of ovarian dysfunction.&lt;/p&gt;
&lt;p&gt;Typical polycystic appearance is supportive but not diagnostic of PCOS, as it may also be observed in many other conditions for example acromegaly, Cushing's syndrome and many normal women.&lt;/p&gt;
&lt;p&gt;Ovarian imaging (by ultrasound or MRI) is also mandatory where there is a suspicion of virilising tumour.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;When a virilising tumour is strongly suspected but not visualised on ultrasound scan, MRI pelvis may be helpful and can be combined with adrenal imaging to avoid the abdominal radiation exposure necessary for an adrenal protocol CT scan in a young woman. &lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Thyroid stimulating hormone 
				</value><value>Prolactin 
				</value><value>Fasting glucose and lipids 
				</value><value>Testosterone, sex hormone binding globulin 
				</value><value>Luteinising hormone, follicle stimulating hormone 
				</value><value>170H progesterone 
				</value><value>Progesterone 
				</value><value>Androstenedione, dihydoepiandrosterone 
				</value><value>2x24hr urinary free cortisols 
				</value><value>Low dose dexamethasone suppression test 
				</value><value>Short synacthen test 
				</value><value>CT adrenals 
				</value><value>Selective venous sampling of adrenals and ovaries 
				</value><value>Transvaginal ovarian ultrasound scan 
				</value><value>MRI pelvis and adrenals 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/gynaecomastia/examination</CURLExa><CCondName><value>Turner syndrome</value></CCondName><CQueMgt><value>Male late onset hypogonadotropic hypogonadism 
				</value><value>Female late onset hypogonadotropic hypogonadism 
				</value><value>Male hypergonadotropic hypogonadism 
				</value><value>Female hypergonadotropic hypogonadism 
				</value><value>Absent puberty (any cause) 
				</value><value>Klinefelter's syndrome 
				</value><value>Androgen insensitivity 
				</value><value>Kallmann's syndrome 
				</value><value>Turner's syndrome 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/examination</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/investigation</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/hypogonadism/management</CURLMgt><CURLTop>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</CURLTop><CURLInv>http://www.endobible.com/condition/polycystic-ovarian-syndrome/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;To diagnose gynaecomastia a detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Gynaecomastia may be the presenting feature in patients with documented or unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with generalised adiposity may present with non glandular breast swelling. Patients with Cushing’s syndrome have central adiposity, and may have short stature if the disease developed in childhood. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient, and otherwise a diagnosis of Kallmann's syndrome may not be considered.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all cases.&lt;/p&gt;
&lt;p&gt;True gynaecomastia is present when the glandular tissue or breast bud is greater than 0.5cm in diameter.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with suspected hypogonadism to seek evidence of heart failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Examine specifically for stigmata of chronic liver or renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in adult males with gynaecomastia and suspected hypogonadism, and should be documented using an orchidometer.&lt;/p&gt;
&lt;p&gt;Testes should also be examined for abnormalities of texture, masses or lymphadenopathy as testicular tumours may present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyrotoxicosis which may disrupt gonadal function and present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients with possible pituitary disease, and so should be performed unless the diagnosis of Kallmann's, or isolated hypogonadotropic hypogonadism, has already been confirmed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Fine wrinkling of the skin occurs in hypopituitarism.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;
&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Doughy skin with soft tissue swelling also occurs in growth hormone excess.&lt;/p&gt;
&lt;p&gt;Café au lait patches, skin tags and axillary freckling may indicate associated syndromes, for example neurofibromatosis LINK, multiple endocrine neoplasia 2 LINK or McCune Albright syndrome.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Gonadal</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Many of these diagnoses will come as a shock to patients and their families. Psychological as well as genetic counselling may therefore be helpful. Fertility should also be discussed early with the patient and their family where appropriate.&lt;/p&gt;
&lt;p&gt;Patients need to understand that pubertal induction alone with not affect or restore fertility, although appropriate uterine development is essential prior to possible future pregnancies. Fertility can frequently be acheived with pulsatile gonadotropin therapy or further assisted fertility techniques.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss treatment aims, timescales and outcomes&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Treatment aims to replicate the natural process of puberty and should occur over approximately the same timescale - approximately two to three years.&lt;/p&gt;
&lt;p&gt;Patients need to understand that accelerating the treatment may have adverse psychological and physical consequences, for example poor breast development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment: females&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose estrogen replacement therapy.&lt;/p&gt;
&lt;p&gt;An alternative is to use topical estrogen therapy. This may give a better eventual breast shape, and is well tolerated, with the patches often easier to source in the community than low dose ethinylestradiol. A typical start dose is with one quarter of a 25mcg Estradiol patch given either overnight every day, or left on and replaced every 72 hours. The dose should then increase every 3-4 months to half a patch, then a whole 25mcg patch, then a 50mcg patch, then a 75mcg, then a 100mcg patch.  &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider pelvic ultrasound scan to assess uterine size at this stage.&lt;/p&gt;
&lt;p&gt;Once the patient experiences vaginal bleeding or if the patient has tolerated 15mcg orally, or 100mcg transdermally, consider adding cyclical progesterone. Measurement of LH and FSH levels may also be used to help judge whether the final dose of topic estradiol is sufficient, as some girls will require higher doses.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatment regimens&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for cardiovascular or thromboembolic disease will also need to be considered.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia eg 1x350mcg progesterone only pill daily.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Duration of treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Continue sex hormone replacement therapy until the time of the natural menopause - typically to age 50.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry and of pituitary function where indicated.&lt;/p&gt;
&lt;p&gt;Patients with Turner’s syndrome, Klinefelter’s, Kallmann’s or underlying pituitary disease will require specific follow up.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Initiate treatment: male patients&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose testosterone therapy, and warn patient of expected psychological and physical effects.&lt;/p&gt;
&lt;p&gt;Typical starting dose in a testosterone naive patient is approximately 20% of an adult dose. This has traditionally been given as an intramuscular injection of 50mg testosterone esters, monthly.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Monthly testosterone treatment is then typically increased by a further 50mg every six months according to clinical response.&lt;/p&gt;
&lt;p&gt;Alternatives include low dose depot testosterone, or topical gel using the same dosing schedule.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Treatment monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;
&lt;/p&gt;&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Routine monitoring of serum testosterone levels is not necessary until the expected adult dose is reached.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Peak and trough levels may then be useful to confirm the appropriateness of the final dose in patients taking monthly testosterone undecanoate. Peak 7 days post injection should typically be 25-30nmol/l, with a predose trough level of 8-12nmol/l. Subsequently, the dose should not be altered unless the clinical response is suboptimal, or in the light of changes in serum monitoring of prostate specific antigen, full blood count, liver function, or pre dose testosterone levels.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;In patients taking depot preparations, a random or pre dose level of 15-20nmol/l, and for patients taking daily topical preparations, a level of 15-20nmol/l 4-6 hours post application of the gel is usually sufficient.&lt;/p&gt;
&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Warn patients that testicular volume is not likely to change&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Testicular volume may be enhanced during gonadotropin treatment used in the induction of spermatogenesis, however, this tends to reverse on treatment cessation, and is not expected with testosterone replacement therapy.&lt;/p&gt;
&lt;p&gt;Synthetic implants can be considered to restore testicular volume where required.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Alternative treatments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Once patient is virilised appropriately and established on full adult dose, offer switching to alternative preparation, for example daily gel or depot preparation.&lt;/p&gt;
&lt;p&gt;Optimise final dose according to symptoms and serum levels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Annual monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Annual random testosterone levels are generally sufficient after the dose has been optimised, although trough levels are also assessed in patients on monthly or more frequent testosterone injections.&lt;/p&gt;
&lt;p&gt;Digital rectal examination, prostate specific antigen, full blood count and liver function tests should also be performed annually with dose reduction and/or onward referral if abnormalities arise.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry and of pituitary function where indicated.&lt;/p&gt;
&lt;p&gt;Patients with Turner’s syndrome, Klinefelter’s, Kallmann’s or underlying pituitary disease will require specific follow up.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Osteoporosis is common in patients with hypogonadism of any cause. It is worth ensuring that patients are vitamin D replete and, if not, prescribing vitamin D supplementation where necessary. General life style advice should also be given to patients with confirmed &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/osteoporosis/management"&gt;osteoporosis&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Osteoporosis should respond well to standard sex hormone replacement therapy. However, it may be worth repeating a bone densitometry scan after five years of treatment to determine whether other agents should be considered.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling.&lt;/p&gt;
&lt;p&gt;Ensure that an MRI scan of the pituitary and olfactory bulbs has been performed, and that pituitary function, karyotype and where necessary pelvic ultrasound scan have all been reviewed to exclude other diagnoses.&lt;/p&gt;
&lt;p&gt;Arrange a renal ultrasound scan, as abnormalities of the urogenital tract may be associated with this condition. &lt;/p&gt;
&lt;p&gt;Arrange an echocardiogram and cardiology review where indicated, as multiple congenital heart defects including ventricular and atrial septal defects and rhythm disturbances have been decribed in a small subset of patients with Kallmann's syndrome.&lt;/p&gt;
&lt;p&gt;Arrange neurology review in those patients with other neurological sequellae such as epilepsy.&lt;/p&gt;
&lt;p&gt;Treat with standard pubertal induction and long term testosterone or estrogen replacement therapy.&lt;/p&gt;
&lt;p&gt;Offer life long follow up.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling to all patients diagnosed with this condition. Psychological counselling may also be beneficial in some cases, and other psychological, psychiatric, or learning difficulties should be treated on their own merits.&lt;/p&gt;
&lt;p&gt;Medical treatment is the same as for any other patient presenting with hypogonadism.&lt;/p&gt;
&lt;p&gt;Follow up should be life long.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The diagnosis of androgen insensitivity or 'testicular feminisation' is difficult for many patients and families to understand, and counselling should be offered to all women with this condition.&lt;/p&gt;
&lt;p&gt;Medical treatment is with standard pubertal induction, long term estrogen replacement therapy as with any other form of hypogonadism.&lt;/p&gt;
&lt;p&gt;Offer life long follow up.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling.&lt;/p&gt;
&lt;p&gt;Medical treatment is the same as for other women with hypogonadism or absent puberty, although specific follow up for patients with &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/turners-syndrome/management"&gt;Turner's&lt;/a&gt; syndrome is necessary to detect and treat other complications.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, weight, body habitus and BMI 
				</value><value>Olfactory nerves 
				</value><value>Breasts 
				</value><value>Cardiovascular examination 
				</value><value>Body hair 
				</value><value>Gastrointestinal system 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value></CQueExa><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease. Menorrhagia may cause microcytic anaemia, and exacerbate hair loss.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypokalaemia may raise the possibility of cortisol excess.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Fatty liver is common in both obesity and diabetes. It's also needed as a baseline before starting medical treatments.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Unrecognised hypothyroidism is associated with weight gain and menstrual disturbance.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hyperprolactinaemia of any cause is associated with oligomenorrhoea. &lt;/p&gt;
&lt;p&gt;Mild degrees of hyperprolactinaemia are also seen in PCOS and may not indicate pituitary or other pathology.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Essential for cardiovascular risk stratification.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed early morning, early follicular phase and off the contraceptive pill. &lt;/p&gt;
&lt;p&gt;Sex hormone binding globulin is typically low in PCOS and Cushing’s. Testosterone is typically but not always mildly elevated in PCOS. High levels (&amp;gt;3.5nmol/l in the author's institution) should prompt a search for other causes, for example virilising tumours or Cushing’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Elevated luteinising hormone: follicle stimulating hormone ratio is often seen in PCOS but is not diagnostic and so is not necessarily performed in all cases.&lt;/p&gt;
&lt;p&gt;LH and FSH may both be low in pituitary and hypothalamic causes of oligomenorrhoea, for example associated with low body mass or anorexia or excessive exercise. FSH will be elevated in the secondary amenorrhoea of premature ovarian failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This test needs to be performed early morning, early follicular phase and off the contraceptive pill. &lt;/p&gt;
&lt;p&gt;17OHP is a useful initial screen for congenital adrenal hyperplasia - if elevated above 10nmol/l, the patient will require full evaluation: a short synacthen test.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be taken on day 21 of the menstrual cycle to indicate ovulation in patients with regular menses and diagnostic uncertainty.&lt;/p&gt;
&lt;p&gt;This should also be recorded in patients seeking fertility.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In virilised patients, those with elevated testosterone, or suspected Cushing’s syndrome, or other adrenal pathology, full adrenal androgens should be assessed. These are typically minimally elevated in PCOS, higher in Cushing’s and adrenal tumours. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/urinary-free-cortisol/"&gt;Urinary cortsiols&lt;/a&gt; form a sensitive but not specific initial screen if &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-syndrome/"&gt;Cushing's&lt;/a&gt; syndrome is suspected.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If there is a clinical suspicion of Cushing’s syndrome, a low dose &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/dexamethasone-suppression-test/"&gt;dexamethasone suppression test&lt;/a&gt; (LDDST) should be performed to seek suppressibility of cortisol.&lt;/p&gt;
&lt;p&gt;If androgens are elevated, LDDST should also be performed. Suppressibility of adrenal androgens by more than 40% has been &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://jcem.endojournals.org/cgi/reprint/88/6/2634"&gt;reported&lt;/a&gt; as making virilising tumours highly unlikely.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If the baseline 17 hydroxyprogesterone is elevated &amp;gt;10nmol/l, proceed to a &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/synacthen-test/"&gt;synacthen test&lt;/a&gt; to confirm or exclude late onset congenital adrenal hyperplasia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If adrenal androgens are elevated, and do not suppress after dexamethasone testing, a virilising tumour should be suspected and CT or MRI imaging should be peformed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If androgens are elevated and do not suppress after dexamethasone, imaging of the ovaries and adrenals should be arranged. If no obvious lesion is revealed on imaging, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/selective-venous-sampling/"&gt;selective venous sampling&lt;/a&gt; of the abdomen and pelvis may identify the source of androgens.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This may be useful in cases of diagnostic difficulty where there is evidence of hyperandrogenism but not of ovarian dysfunction.&lt;/p&gt;
&lt;p&gt;Typical polycystic appearance is supportive but not diagnostic of PCOS, as it may also be observed in many other conditions for example acromegaly, Cushing's syndrome and many normal women.&lt;/p&gt;
&lt;p&gt;Ovarian imaging (by ultrasound or MRI) is also mandatory where there is a suspicion of virilising tumour.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;When a virilising tumour is strongly suspected but not visualised on ultrasound scan, MRI pelvis may be helpful and can be combined with adrenal imaging to avoid the abdominal radiation exposure necessary for an adrenal protocol CT scan in a young woman. &lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Thyroid stimulating hormone 
				</value><value>Prolactin 
				</value><value>Fasting glucose and lipids 
				</value><value>Testosterone, sex hormone binding globulin 
				</value><value>Luteinising hormone, follicle stimulating hormone 
				</value><value>170H progesterone 
				</value><value>Progesterone 
				</value><value>Androstenedione, dihydoepiandrosterone 
				</value><value>2x24hr urinary free cortisols 
				</value><value>Low dose dexamethasone suppression test 
				</value><value>Short synacthen test 
				</value><value>CT adrenals 
				</value><value>Selective venous sampling of adrenals and ovaries 
				</value><value>Transvaginal ovarian ultrasound scan 
				</value><value>MRI pelvis and adrenals 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/gynaecomastia/examination</CURLExa><CCondName><value>Turner syndrome</value></CCondName><CQueMgt><value>Discuss diagnosis, offer counselling, and discuss fertility issues 
				</value><value>Pubertal induction and sex hormone replacement therapy 
				</value><value>Osteoporosis 
				</value><value>Kallmann's syndrome 
				</value><value>Klinefelter's syndrome 
				</value><value>Androgen insensitivity 
				</value><value>Turner's syndrome 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/examination</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/investigation</value><value>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/management</CURLMgt><CURLTop>http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/</CURLTop><CURLInv>http://www.endobible.com/condition/polycystic-ovarian-syndrome/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;To diagnose gynaecomastia a detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Gynaecomastia may be the presenting feature in patients with documented or unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with generalised adiposity may present with non glandular breast swelling. Patients with Cushing’s syndrome have central adiposity, and may have short stature if the disease developed in childhood. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient, and otherwise a diagnosis of Kallmann's syndrome may not be considered.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all cases.&lt;/p&gt;
&lt;p&gt;True gynaecomastia is present when the glandular tissue or breast bud is greater than 0.5cm in diameter.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with suspected hypogonadism to seek evidence of heart failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Examine specifically for stigmata of chronic liver or renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in adult males with gynaecomastia and suspected hypogonadism, and should be documented using an orchidometer.&lt;/p&gt;
&lt;p&gt;Testes should also be examined for abnormalities of texture, masses or lymphadenopathy as testicular tumours may present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyrotoxicosis which may disrupt gonadal function and present with gynaecomastia.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients with possible pituitary disease, and so should be performed unless the diagnosis of Kallmann's, or isolated hypogonadotropic hypogonadism, has already been confirmed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Fine wrinkling of the skin occurs in hypopituitarism.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;
&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Doughy skin with soft tissue swelling also occurs in growth hormone excess.&lt;/p&gt;
&lt;p&gt;Café au lait patches, skin tags and axillary freckling may indicate associated syndromes, for example neurofibromatosis LINK, multiple endocrine neoplasia 2 LINK or McCune Albright syndrome.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Others</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Constitutional growth delay is characterised by delayed bone age, normal growth velocity and predicted adult height appropriate to the family pattern. This should be regarded as a normal variant and as such does not usually require treatment, though most children and families benefit from reassurance and counselling.&lt;/p&gt;
&lt;p&gt;However these patients frequently do not reach their parental target, and patients with constitutional growth delay often have a first- or second-degree relative who also had constitutional growth delay.&lt;/p&gt;
&lt;p&gt;In boys aged 10-13 years with mild growth delay, treatment with oxandrolone 1.25-2.5mg daily for 6-12 months can be beneficial. Boys aged over 13 years with more severe delay of growth and puberty usually benefit from androgen therapy, i.e. testosterone depot 50-250mg 2-4 weekly for a limited period, usually 4-6 months.&lt;/p&gt;
&lt;p&gt;Treatment is rarely required in girls.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Short stature is confirmed in a child with a standing height of &amp;lt;-2.0 SD for chronological age, sex and ethnic background. A child with a height velocity below the 5th to 10th percentile for age, with no clear aetiology should also be treated as for confirmed short stature. &lt;/p&gt;
&lt;p&gt;Patients with the phenotype of hypothalamic-pituitary dysfunction (e.g. microphallus, septo-optic dysplasia, tumour in the hypothalamic-pituitary region or history of cranial irradiation) with decelerating growth, and patients with other deficits in their hypothalamic-pituitary hormones require full assessment as for their underlying condition. Their short stature can be treated conventionally depending on their other health issues.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;GH therapy is also used for confirmed short stature associated with other non-GH deficiency causes, with different doses required according to underlying diagnosis and patient response. Excellent guidance is available on &lt;a href="http://www.shortstature-forum.com/" target="_blank"&gt;Short stature forum&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;In Turner syndrome (TS) and Noonan syndrome (not licensed by the EMEA) GH 0.05-0.067mg/kg/day is recommended. In small for gestational age patients GH 0.033 or 0.067mg/kg/day (European dose) may be used.&lt;/p&gt;
&lt;p&gt;In Prader-Willi syndrome the recommended dose is 0.05mg/kg/day. In chronic renal failure the recommended dose is 0.08mg/kg/day.&lt;/p&gt;
&lt;p&gt;In idiopathic short stature (not licensed by the EMEA) a starting dose of 0.05mg/kg/day is recommended.&lt;/p&gt;
&lt;p&gt;Linear growth must be monitored every 6 months during therapy to help with dose titration. Serum IGF-I should also be monitored 6-12 monthly to ensure doses are not excessive, though in paediatrics unlike in adult endocrinology, dose adjustments are not generally guided by IGF-I assessments.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Short stature in GHD tends to have and excellent response to GH therapy. GH therapy in a dose of 0.025-0.035mg/kg/day (UK dose) is given as daily subcutaneous injections in children from the time of diagnosis of GHD until completion of growth after puberty. Some specialists recommend increasing the dose during puberty. &lt;/p&gt;
&lt;p&gt;Recombinant human GH administration increases adult height into the normal range for the population and into the child’s genetic target range provided the treatment is started in early childhood. However, delayed treatment, severity of GHD, IGF-I level, severity of short stature and dose of GH may predict the response in individual patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss treatment aims, timescales and outcomes&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Treatment aims to replicate the natural process of puberty and should occur over approximately the same timescale - approximately two to three years.&lt;/p&gt;
&lt;p&gt;Adult patients should be warned that accelerating the process may have adverse long term psychological and physical consequences, for example poor breast development.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Discuss fertility issues at, or soon after, diagnosis&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If appropriate, fertility should be discussed early with the patient and their family.&lt;/p&gt;
&lt;p&gt;Patients need to understand that successful pubertal induction will not affect or restore fertility, although appropriate uterine development is necessary prior to possible future pregnancies.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Karyotype analysis&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Adult patients with absent puberty require karyotype analysis to differentiate between different causes, for example Klinefelter's syndrome, androgen insensitivity or Turner syndrome.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Review baseline pituitary function&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If there is any doubt that hypogonadotropic hypogonadism may not be isolated, consider dynamic function testing.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;MRI pituitary&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;If karyotype is normal, and cause of hypogonadotropic hypogonadism is uncertain, thorough investigation for other causes should be performed.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Consider assessing bone age&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Delayed bone age supports the diagnosis of absent puberty.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Female patients - Initiate treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose estrogen replacement therapy.&lt;/p&gt;
&lt;p&gt;Typical starting dose in an estrogen naive patient is 1.25mcg ethinylestradiol. Increase dose to 2.5mcg, then by 2.5mcg increments every six months to 10mcg. The dose may then increase to 15mcg.&lt;/p&gt;
&lt;p&gt;An alternative is to use topical estrogen therapy. This may give a better eventual breast shape, and is well tolerated, with the patches often easier to source in the community than low dose ethinylestradiol. A typical start dose is with one quarter of a 25mcg Estradiol patch given either overnight every day, or left on and replaced every 72 hours. The dose should then increase every 3-4 months to half a patch, then a whole 25mcg patch, then a 50mcg patch, then a 75mcg, then a 100mcg patch.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Female patients - Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Consider pelvic ultrasound scan to assess uterine size at this stage.&lt;/p&gt;
&lt;p&gt;Once the patient experiences vaginal bleeding or if the patient has tolerated 15mcg orally, or 100mcg transdermally, consider adding cyclical progesterone. Measurement of LH and FSH levels may also be used to help judge whether the final dose of topic estradiol is sufficient, as some girls will require higher doses.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Female patients - Alternative treatment regimens&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p class="MsoNormal"&gt;Cyclical estrogen and progesterone replacement therapy should be considered in all patients.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;The combined oral contraceptive pill is a convenient preparation and may be more socially acceptable at diagnosis and in young patients. However, there has been some doubt as to whether this offers sufficient bony protection unless taken continuously, with some authorities advising taking this 3 packs at a time. Combined oral contraceptive pills are also contraindicated in patients with a history of migraines with aura. Low dose HRT is more suitable in these cases.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Hormone replacement therapy is more appropriate in the long term, and should be tailored to suit the individual, for example by offering topical, depot or oral preparations. Choice will also depend on the age of the patient, presence or absence of a uterus, and history or family history of breast or endometrial cancer. A history of, or strong risk factors for cardiovascular or thromboembolic disease will also need to be considered. &lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Topical estrogen is particularly useful in patients at high cardiovascular risk, or with abnormalities of liver function. Combined patches are available, or if estrogen gel is used, low dose continuous progesterone will also be required to prevent endometrial hyperplasia e.g. 1x350mcg progesterone only pill daily.&lt;p&gt;&lt;/p&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;Estrogen replacement therapy should be continued until the time of the natural menopause - typically to age 50. Vaginal dryness may be ameliorated by topical estrogen gels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Female patients - Duration of treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Continue sex hormone replacement therapy until the time of the natural menopause - typically to age 50.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Female patients - Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry and of pituitary function where indicated.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Klinefelter’s, Kallmann’s or underlying pituitary disease will require specific follow up.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Male patients - Initiate treatment&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Initiate very low dose testosterone therapy, and warn patient of expected psychological and physical effects.&lt;/p&gt;
&lt;p&gt;Typical starting dose in a testosterone naive patient is approximately 20% of the usual adult dose. This has traditionally been given as 50mg testosterone ester as an intramuscular injection, monthly, though an alternative is to use very low dose daily testosterone gel using a metered dose delivery system.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Male patients - Dose titration&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Monthly testosterone treatment is then typically increased by a further 50mg every six months according to clinical response.&lt;/p&gt;
&lt;p&gt;Alternatives include low dose depot testosterone, or topical gel using the same dosing schedule.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Male patients - Treatment monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Routine monitoring of serum testosterone levels is not necessary until the expected adult dose is reached.&lt;/p&gt;
&lt;p&gt;Peak and trough levels may then be useful to confirm the appropriateness of the final dose in patients taking monthly testosterone undecanoate. Peak 7 days post injection should typically be 25-30nmol/l, with a predose trough level of 8-12nmol/l. Subsequently, the dose should not be altered unless the clinical response is suboptimal, or in the light of changes in serum monitoring of prostate specific antigen, full blood count, liver function, or pre dose testosterone levels.&lt;/p&gt;
&lt;p&gt;In patients taking depot preparations, a random or pre dose level of 15-20nmol/l, and for patients taking daily topical preparations, a level of 15-20nmol/l 4-6 hours post application of the gel is usually sufficient.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Male patients - Alternative treatments&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Once patient is virilised appropriately and established on full adult dose, offer switch to alternative preparation, for example daily gel or depot preparation.&lt;/p&gt;
&lt;p&gt;Optimise final dose according to symptoms and serum levels.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Male patients - Annual monitoring&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Annual random levels are sufficient in patients on topical and depot preparations. Annual pre dose levels are required in those on injectable testosterone esters. &lt;/p&gt;
&lt;p&gt;Digital rectal examination, prostate specific antigen, full blood count and liver function tests should also be performed annually with dose reduction and onward referral if abnormalities arise.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Male patients - Follow up&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Offer life long follow up to all patients.&lt;/p&gt;
&lt;p&gt;Consider periodic monitoring of bone densitometry and of pituitary function where indicated.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Klinefelter’s, Kallmann’s or underlying pituitary disease will require specific follow up.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling. Follow the usual protocol for absent puberty.&lt;/p&gt;
&lt;p&gt;Offer life long follow up.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling. Arrange an MRI scan of the pituitary and olfactory bulbs, and a renal ultrasound scan. &lt;/p&gt;
&lt;p&gt;Follow the protocol for absent puberty, and offer life long follow up. For further management see &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/kallmanns-syndrome-and-hypogonadotropic-hypogonadism/"&gt;Kallmann's&lt;/a&gt; syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Offer genetic counselling. Follow the treatment pathway for pubertal induction. &lt;/p&gt;
&lt;p&gt;For further management see &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/turners-syndrome/"&gt;Turner&lt;/a&gt; syndrome.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Height, sitting height and arm span 
				</value><value>Weight, body composition and BMI 
				</value><value>Arms, carrying angles, hands and feet 
				</value><value>Assess pubertal development 
				</value><value>Examine for mirror movements 
				</value><value>Palate and teeth 
				</value><value>Olfactory and auditory nerves 
				</value><value>Blood pressure 
				</value><value>Cardiovascular examination 
				</value><value>Gastrointestinal system 
				</value><value>Breasts 
				</value><value>Body hair 
				</value><value>External genitalia 
				</value><value>Musculature 
				</value><value>Thyroid and thyroid status 
				</value><value>Pituitary status 
				</value><value>Plot height and weight on a standardised chart 
				</value></CQueExa><CQueMgt><value> Constitutional delay likely 
				</value><value>Short stature also confirmed 
				</value><value>Short stature confirmed without GH deficiency 
				</value><value>GH Deficiency confirmed 
				</value><value>Confirmed pubertal delay (any cause) 
				</value><value>Androgen insensitivity 
				</value><value>Kallmann's syndrome 
				</value><value>Turner syndrome 
				</value></CQueMgt><CQueInv><value>Full blood count 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Glycosylated haemoglobin, fasting glucose and lipids 
				</value><value>Karyotype 
				</value><value>Pituitary function 
				</value><value>Chest radiograph 
				</value><value>Electrocardiogram, echocardiogram 
				</value><value>Renal ultrasound scan 
				</value><value>Pelvic ultrasound scan 
				</value><value>Bone age 
				</value><value>Hearing test 
				</value><value>Auto-antibody screen 
				</value><value>Bone densitometry scan 
				</value><value>Vitamin D 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/short-stature/examination</CURLExa><CCondName><value>Short stature</value></CCondName><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;This is a useful indicator of general health and as a screen for underlying disease including coeliac disease or hypopituitarism in a patient presenting with short stature and abnormal sexual development.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful screen for renal disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Diabetes has an increased incidence in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome also have an increased risk of renal and cardiovascular disease, and so cardiovascular risk modification is essential.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed at presentation in patients with absent puberty, and in all patients with suspected Turner, androgen insensitivity and Klinefelter’s syndrome. XO is the commonest karyotype encountered in Turner syndrome, but mosaics and patients with partial deletions and other chromosomal abnormalities also occur.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Growth hormone, Insulin like growth factor I&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Patients with Turner syndrome and severe short stature may benefit from GH therapy. GH secretion does not need to be assessed following the diagnosis of Turner syndrome. &lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Prolactin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Hyperprolactinaemia may cause pubertal delay and hypogonadotropic hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;9am cortisol&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;This is &lt;u&gt;not&lt;/u&gt; usually assessed in patients with Turner syndrome, though if a diagnosis of &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/cushings-syndrome/"&gt;Cushing's&lt;/a&gt; is being considered, &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/urinary-free-cortisol/"&gt;urinary free cortisols&lt;/a&gt; and a low dose &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/dexamethasone-suppression-test/"&gt;dexamethasone suppression&lt;/a&gt; test should be arranged instead.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Estrodiol, sex hormone binding globulin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Estrodiol is usually low in Turner syndrome.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Luteinising hormone, follicle stimulating hormone&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;LH and FSH should be checked in all patients presenting with hypogonadism.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Thyroid stimulating hormone, thyroxine&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Thyroid dysfunction may lead to pubertal delay. Turner syndrome is also associated with an increased incidence of thyroid disease.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Chest XR should be performed at diagnosis of Turner's as a simple screen for congenital abnormalities and coarctation of the aorta. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;ECG and echocardiogram should be performed to seek coarctation of the aorta or other abnormalities in patients with confirmed Turner syndrome at diagnosis and subsequently three to five yearly.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound of the renal system is performed at diagnosis of Turner and Kallmann’s syndromes as anatomical abnormalities occur more frequently in people with these conditions.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful to perform in most patients presenting with absent or delayed puberty to identify and locate the gonads, and to assess uterine size prior to considering pregnancy in female patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Consider performing plain radiograph to assess bone age in younger patients with delayed puberty.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is performed every five years in people with Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid and coeliac antibodies should be assessed at diagnosis in patients with Turner syndrome, due to an increased incidence of these disorders.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be considered in all patients with long standing hypogonadism. It may be useful to repeat after five years of treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Low serum vitamin D levels strengthen the case for vitamin D replacement therapy in patients with osteoporosis of any cause.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CLiens><value>http://www.endobible.com/condition/hypercalcaemia/</value><value>http://www.endobible.com/condition/hypercalcaemia/examination</value><value>http://www.endobible.com/condition/hypercalcaemia/investigation</value><value>http://www.endobible.com/condition/hypercalcaemia/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/delayed-or-absent-puberty/management</CURLMgt><CURLTop>http://www.endobible.com/condition/hypercalcaemia/</CURLTop><CURLInv>http://www.endobible.com/condition/paediatric-turner-syndrome/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;A detailed and full general examination is mandatory in the initial assessment of all endocrine patients.&lt;/p&gt;
&lt;p&gt;Specifically seek dysmorphic features in the face, trunk and limbs. Abnormalities of pubertal development may be the presenting feature in patients with unrecognised congenital abnormalities which may have other non endocrine manifestations.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In children and young adults it is essential to plot growth against &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised charts&lt;/a&gt;. These allow evaluation of height and weight and put this in the context of pubertal staging. Height should also be converted to standard deviation score in children.&lt;/p&gt;
&lt;p&gt;Patients with Turner syndrome, Noonan syndrome and pseudopseudohypoparathyroidism tend to have short stature. &lt;/p&gt;
&lt;p&gt;Patients with Klinefelter’s tend to have tall stature. &lt;/p&gt;
&lt;p&gt;Patients with Cushing’s syndrome in childhood tend to lose height growth velocity.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Truncal and generalised obesity should be assessed. BMI and BMI standard deviation should be calculated.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Increased carrying angles tend to occur in Turner syndrome and Noonan syndrome.&lt;/p&gt;
&lt;p&gt;Shortened metacarpals and metatarsals may be seen in pseudopseudohypoparathyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;The assessment of pubertal development has recently changed from the previous Tanner staging system. The charts below give an overview of when a child is described as pre-puberty, in puberty or completing puberty.&lt;/p&gt;
&lt;p&gt;Girls:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No signs of nipple or breast development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any breast enlargement as long as nipples also enlarged.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Started periods (menarche)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any pubic or axillary hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Breast, pubic and axillary hair development&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Boys:&lt;/p&gt;
&lt;p&gt;
&lt;/p&gt;&lt;table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
    mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Pre-puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stage 1)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;All of the following:&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;In Puberty &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;(Tanner stages 2-3)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border:solid windowtext 1.0pt;
            border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
            solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Completing Puberty&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt; (Tanner stages 4-5)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Any of the following&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;High voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Slight deepening of the voice&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Voice fully changed (broken)&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No growth of testes or penis&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;&lt;p&gt; &lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Reddening of the scrotum and growth of the testes&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Adult size testes and penis with adult pubic and axillary   hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;tr&gt;&lt;td width="154" valign="top" style="width:115.5pt;border:solid windowtext 1.0pt;
            border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
            padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;No pubic hair&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.5pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early penile enlargement Early pubic or axillary hair   growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
            &lt;td width="154" valign="top" style="width:115.55pt;border-top:none;border-left:
            none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
            mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
            mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"&gt;
            &lt;p class="MsoNormal"&gt;&lt;span style="font-size:9.0pt;
            mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#636155;
            background:white"&gt;Early moustache and facial hair growth&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/td&gt;
        &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Synkinesis or mirror movements occur in some forms of Kallmann's syndrome. Ask the patient to pinch first finger and thumb together repeatedly with one hand and watch to determine whether action is mirrored in other hand.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Dental hypoplasia and mal-alignment may occur with Kallmann’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Anosmia should be assessed formally where possible as this symptom may not be reported by the patient.&lt;/p&gt;
&lt;p&gt;Deafness may occur in various congenital conditions and has an increased incidence in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed in both upper and lower limbs to screen for coarctation of the aorta in Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying cardiovascular problems such as valvular heart disease, to seek evidence of heart failure, and for coarcation of the aorta in possible Turner syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be assessed thoroughly in patients with growth failure or pubertal delay to seek evidence of underlying physical disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Pubertal staging requires breast examination to be performed in all.&lt;/p&gt;
&lt;p&gt;Nipple spacing tends to be increased in Turner syndrome.&lt;/p&gt;
&lt;p&gt;Galactorrhoea should be confirmed and documented as either spontaneous or expressible by gently exerting pressure on both sides of the nipple.&lt;/p&gt;
&lt;p&gt;Breasts and axillae should also be examined for masses particularly in the case of unilateral galactorrhoea.&lt;/p&gt;
&lt;p&gt;Serum prolactin levels may increase after breast examination and so should always be checked before this is performed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual hair should be assessed as part of pubertal staging and in all adults presenting with suspected hypogonadism.&lt;/p&gt;
&lt;p&gt;Fine vellus hair is seen in patients with very low body mass and may be associated with hypothalamic hypogonadism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Secondary sexual characteristics should be assessed as part of pubertal staging.&lt;/p&gt;
&lt;p&gt;Testicular volume is particularly important in assessing puberty and should be documented using an orchidometer. Microphallus should be sought and documented if present.&lt;/p&gt;
&lt;p&gt;Clitoromegaly and ambiguous genitalia should also be assessed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Poor muscle bulk may indicate gonadotropin deficiency.&lt;/p&gt;
&lt;p&gt;Muscle wasting may also occur in glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Proximal myopathy and slow relaxing reflexes may occur with loss of thyroid function.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Specifically seek signs of thyroid dysfunction which may disrupt gonadal function, as part of the general pituitary examination. It may occur in association with Turner’s syndrome.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual acuity and visual fields&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full assessment of acuity and fields is mandatory in all patients suspected of pituitary disease to detect chiasmal compression or other involvement of the optic pathways.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Visual fundoscopy&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Disc pallor is indicative of long term visual loss which may not recover after decompression of the optic pathway.&lt;/p&gt;
&lt;p&gt;Papilloedema is an indicator of raised intracranial pressure requiring urgent investigation.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Cranial nerves III-XII&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Full cranial nerve assessment is important in all patients with suspected pituitary tumours.&lt;/p&gt;
&lt;p&gt;The nerves of the cavernous sinus are most frequently affected, though a VI nerve palsy may be a false localising sign associated with increased intracranial pressure.&lt;/p&gt;&lt;/div&gt;
					&lt;h3 class="question"&gt; 
					&lt;br&gt;&lt;span class="answerHeading"&gt;Skin&lt;/span&gt;
					&lt;img src="http://www.endobible.com/images/more%20button.gif" alt="" width="12" height="12" title="View Details"&gt;&lt;/h3&gt;
	            	&lt;div class="answer"&gt;&lt;p&gt;Bronze pigmentation may be seen in haemochromatosis.&lt;/p&gt;
&lt;p&gt;Pallor may also occur with a normocytic normochromic anaemia with glucocorticoid deficiency.&lt;/p&gt;
&lt;p&gt;Doughy pallid 'myxoedematous' skin may be seen with loss of thyroid function.&lt;/p&gt;&lt;/div&gt;
				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Plot patient’s height and weight and parents’ height centiles on &lt;a href="http://www.rcpch.ac.uk/growthcharts" target="_blank"&gt;standardised local centile chart&lt;/a&gt;. Use 13cm correction to plot gender-appropriate parents’ centiles - (mid parental height +13cm for boys, -13cm for girls).&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Thyroid</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Any patient in whom a solitary &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/thyroid-nodule/"&gt;nodule&lt;/a&gt;, a suspicious or dominant nodule within a multinodular goitre, or lymph nodes are palpated requires urgent ultrasound guided aspiration.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with suspected eye disease require evaluation by an endocrinologist or ophthalmologist experienced in Graves' ophthalmopathy. Simple lubricants, avoidance of smoky environments and avoidance of bright sunlight and strong winds by wearing sunglasses should be advised in all patients with Graves’ ophthalmopathy.&lt;/p&gt;
&lt;p&gt;Detailed guidance on assessment, referral criteria and treatments are given in the section on &lt;a href="http://www.endobible.com/condition/graves-disease/management" target="_blank"&gt;Graves' ophthalmopathy.&lt;/a&gt; An explanatory &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/info-for-patients/Docs/ptinfo-TED.pdf"&gt;leaflet&lt;/a&gt; is also available from the British Thyroid Association.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Smoking increases the risk of developing new ophthalmopathy, increases the severity of existing ophthalmopathy, reduces the efficacy of treatment for ophthalmopathy, and increases the risk of ophthalmopathy deteriorating or developing de novo following radioactive iodine treatment.&lt;/p&gt;
&lt;p&gt;General advice must be given and referral to a formal smoking cessation clinic discussed.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Any patient with severe clinical or biochemical hypothyroidism should be assessed for cardiac disesase and risk factors before starting replacement therapy. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style="font-size: 9pt; "&gt;Usual starting dose is 50mcg thyroxine. The dose can then be increased after two weeks if tolerated to 100mcg. Thyroid stimulating hormone (TSH) should then be reassessed at around six weeks and 12 weeks and dose titrated accordingly, aiming for good improvement in symptoms and a normal TSH.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; "&gt;&lt;span style="font-size: 9pt; "&gt;In patients with mild biochemical hypothyroidism, it may be appropriate to remain on 50mcg and reassess at approximately six weeks, though 100-150mcg are typical adult doses.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; "&gt;&lt;span style="font-size: 9pt; "&gt;Subsequent monitoring of TSH should be at three months and six months, then annually is sufficient. Symptoms do not always completely resolve, leading some patients to consider alternative treatments including combined liothryonine and thyroxine, and natural thyroid extracts. This is not standard practise in the UK.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; "&gt;&lt;span style="font-size: 9pt; "&gt;Patient &lt;a href="http://www.british-thyroid-association.org/info-for-patients/Docs/bta_Armour_T4_T3.pdf"&gt;&lt;span style="mso-bidi-font-size:11.0pt;color:blue"&gt;information sheets&lt;/span&gt;&lt;/a&gt; on this subject are available from the British Thyroid Association.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;25mcg thyroxine is suitable for most patients with severe biochemical disease. However, patients with severe hypothyroidism and unstable cardiac disease, will require very gentle initiation of therapy. Liothyronine is short acting and may be started in extremely low doses in such cases. Tiny doses as low as 1.25mcg may be used in very severe cases, and titrated over a two week period up to 30mcg daily in divided doses. Patients tolerating this with no adverse effects, can be switched to thyroxine 25mcg, which is then uptitrated every six weeks according to symptoms and aiming for a normal serum TSH.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients who are planning or are currently pregnant should be treated with the aim of achieving a TSH of &amp;lt;2.5mU/L according to &lt;a href="http://www.endo-society.org/guidelines/final/upload/Clinical-Guideline-Management-of-Thyroid-Dysfunction-during-Pregnancy-Postpartum.pdf" target="_blank"&gt;latest guidance&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Patients should be advised that thyroxine requirements invariably increase with pregnancy and many services suggest a dose increase of 25mcg as soon as pregnancy is confirmed.&lt;/p&gt;
&lt;p&gt;It is appropriate to monitor TSH every three months during pregnancy and breast feeding, and six weeks after any dose adjustment to ensure that the dose is appropriate. Most patients revert to their prepregnancy dose post partum.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Long term monitoring should be performed by the general physician and may take the form of an annual TSH only.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Body habitus, weight and BMI 
				</value><value>Breast examination 
				</value><value>Cardiovascular system 
				</value><value>Eyes 
				</value><value>Hands and tremor 
				</value><value>Reflexes 
				</value><value>Thyroid gland, neck and nodes 
				</value><value>Pemberton's sign 
				</value></CQueExa><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease, notably malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function should be tested at baseline, and abnormalities should prompt detailed evaluation in case of disseminated malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypercalcaemia may occur with thyrotoxicosis but also occurs in malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A low thyroid stimulating hormone in the presence of a single thyroid nodule is highly suggestive of a toxic nodule.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid stimulating hormone and free thyroxine should be tested together in patients with suspected thyroid disease as the level of thyroxine indicates the severity of thyrotoxicosis and informs treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;ECG should be performed in all patients at baseline to document and confirm any arrhythmias or other changes.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If the entire gland feels like a single hard lump it may be Hashimoto’s thyroiditis rather than a nodule. Thyroid peroxidise antibodies are generally very high in such cases.  &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Free liothyronine levels may be useful if the thyroid stimulating hormone is suppressed, but the thyroxine level is normal, to confirm the suspicion of a toxic nodule.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be tested if medullary cell thyroid cancer is suspected.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;If serum calcium is elevated, it is useful to check PTH to determine the cause.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Bone mineral density should be assessed where there is clinical suspicion of osteoporosis, for example in some older patients with a toxic nodule.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In patients with known or suspected osteoporosis, serum vitamin D levels will guide whether routine calcium and vitamin D supplementation is enough, or whether specific high dose vitamin D replacement is required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This test is not appropriate in patients presenting with a thyroid nodule.&lt;/p&gt;
&lt;p&gt;This should only be assessed in patients with documented thyroid cancer, and only after thyroidectomy and radioactive iodine ablation. In this case it is a useful guide for future monitoring and treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound scan should be performed in all patients presenting with a single palpable nodule.&lt;/p&gt;
&lt;p&gt;The scan may reveal the presence of other nodules within the gland, lymph nodes and may provide useful information about the character of the nodule itself, for example micro-calcification, comet sign or cystic components.&lt;/p&gt;
&lt;p&gt;Ultrasound scanning should also confirm whether fine needle aspiration is necessary and guide this procedure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is essential in the investigation of patients with potential malignancy and is useful if tracheal deviation is suspected clinically.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.aace.com/pub/pdf/guidelines/thyroid_nodules.pdf"&gt;Guidelines&lt;/a&gt; are available recommending when fine needle aspiration should be performed. Fine needle aspiration should always be performed on solitary nodules over 10mm, those under 10mm with suspicious imaging characteristics or on dominant nodules.&lt;/p&gt;
&lt;p&gt;Ultrasound guidance improves the safety of this procedure, increases the yield of this investigation by targeting specific areas of a nodule and allows treatment, for example aspiration of cyst contents at the same time as sampling solid components.&lt;/p&gt;
&lt;p&gt;Ultrasound scanning may also identify patients in whom fine needle aspiration is not necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is not usually required in the assessment of a solitary nodule.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Bone mineral density should be assessed where there is clinical suspicion of osteoporosis, for example in some older patients with biochemical thyrotoxicosis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;In patients with known or suspected osteoporosis, serum vitamin D levels will guide whether routine calcium and vitamin D supplementation is enough, or whether specific high dose vitamin D replacement is required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This may be performed in patients with thyrotoxicosis and a thyroid nodule.&lt;/p&gt;
&lt;p&gt;A hot nodule is more likely to represent a hyperfunctioning follicular adenoma, but this does not obviate the need for a fine needle aspiration if otherwise indicated.&lt;/p&gt;
&lt;p&gt;Isolated cold nodules should always be assessed for malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This should be performed by an experienced surgeon in all patients being considered for thyroid surgery.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>Thyroid stimulating hormone 
				</value><value>Free thyroxine 
				</value><value>Electrocardiogram 
				</value><value>Thyroid auto-antibody screen 
				</value><value>Free liothyronine 
				</value><value>Calcitonin 
				</value><value>Parathyroid hormone 
				</value><value>Bone densitometry 
				</value><value>Vitamin D levels 
				</value><value>Thyroglobulin 
				</value><value>Thyroid ultrasound scan 
				</value><value>Chest radiograph 
				</value><value>Ultrasound guided fine needle aspiration 
				</value><value>Computerised tomography of the neck and chest 
				</value><value>Bone densitometry 
				</value><value>Vitamin D levels 
				</value><value>Thyroid radionucleide uptake scan 
				</value><value>Laryngoscopic examination of the vocal cords 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/thyroid-nodule/examination</CURLExa><CCondName><value>Thyrotoxicosis or hyperthyroidism</value></CCondName><CQueMgt><value>Suspicious nodules 
				</value><value>Suspected eye disease 
				</value><value>All patients with auto-immune thyroid disease should be advised to stop smoking 
				</value><value>Assess cardiac status and risk factors 
				</value><value>Standard replacement therapy 
				</value><value>Low dose treatment initiation 
				</value><value>Pregnancy and fertility plans should be discussed with all patients 
				</value><value>Long term monitoring 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/multinodular-goitre/</value><value>http://www.endobible.com/condition/multinodular-goitre/examination</value><value>http://www.endobible.com/condition/multinodular-goitre/investigation</value><value>http://www.endobible.com/condition/multinodular-goitre/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/hypothyroidism/management</CURLMgt><CURLTop>http://www.endobible.com/condition/multinodular-goitre/</CURLTop><CURLInv>http://www.endobible.com/condition/thyroid-nodule/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;To diagnose thyroid nodule detailed and full general examination is essential in the initial assessment of all patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Weight loss is common with thyrotoxicosis and shouId improve rapidly with treatment, though it may indicate malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;An isolated neck lump may represent a lymph node or thyroid metastasis. Thorough examination is thus essential.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Detailed cardiac assessment is necessary.&lt;/p&gt;
&lt;p&gt;Tachycardia, atrial fibrillation, hypertension and congestive cardiac failure may complicate hyperthyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Lid retraction and lid lag may be seen in any cause of thyrotoxicosis - ask the patient to watch your horizontal finger as you very slowly lower it about 30cm away from their eyes.&lt;/p&gt;
&lt;p&gt;Delay in the upper eye lid following downward gaze will reveal the whites of the eye above the iris in the presence of lid lag.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Examine the palms - hot, red and sweaty hands occur in hyperthyroidism.&lt;/p&gt;
&lt;p&gt;Ask the patient to hold out their hands in front of them. A resting tremor is usually obvious in hyperthyroidism, but may be highlighted by placing a sheet of paper over the hands to demonstrate it shaking.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Brisk reflexes are seen in hyperthyoidism, as is a general increase in resting movement or 'jumpiness' in the patient during examination.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;First inspect the neck from the front and ask the patient to swallow. Diffuse thyroid swelling, nodules, cysts and multinodular goitres may all be obvious as anterior neck masses that move on swallowing.&lt;/p&gt;
&lt;p&gt;Ask the patient to protrude the tongue - this should have no effect on a thyroid swelling.&lt;/p&gt;
&lt;p&gt;Examine the neck thoroughly. This is usually performed from behind the seated patient and in a systematic fashion.&lt;/p&gt;
&lt;p&gt;The texture of the gland, tenderness, and the presence or absence of generalised nodularity or of distinct lumps or lymph nodes must be noted.&lt;/p&gt;
&lt;p&gt;Ask the patient to swallow while palpating any nodules - thyroid nodules should rise and fall with swallowing, and move freely under the skin.&lt;/p&gt;
&lt;p&gt;Examine the patient for lymphadenopathy. Papillary cancer frequently has local lymphadenopathy at presentation. Distant lymph nodes are more likely to occur with follicular, anaplastic or other malignancies.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ask the patient to hold both arms above the head as high as they can. Facial flushing, engorgement of the neck veins, and inspiratory stridor all indicate superior vena cava obstruction.&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item><item><CGlande><value>Thyroid</value></CGlande><CAnsMgt><value>&lt;div class="answer"&gt;
&lt;p&gt;Any patients in whom a solitary &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/thyroid-nodule/investigation"&gt;nodule&lt;/a&gt;, suspicious or dominant nodule within the gland, or with palpable lymph nodes requires urgent ultrasound guided aspiration.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;span style='font-size:9.0pt;font-family:"Calibri","sans-serif";mso-ascii-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-latin'&gt;It is standard practise to use propylthiouracil rather than carbimazole in thyrotoxic patients who may be or are planning &lt;a href="http://It%20is%20standard%20practise%20to%20use%20propylthiouracil%20rather%20than%20carbimazole%20in%20thyrotoxic%20patients%20who%20may%20be%20or%20are%20planning%20pregnancy,%20due%20to%20small%20but%20real%20concerns%20regarding%20teratogenicity%20from%20carbimazole.%20Treatment%20may%20frequently%20be%20stopped%20by%20the%20second%20trimester%20as%20the%20disease%20often%20spontaneously%20improves%20until%20the%20post%20partum%20period.%20Monitoring%20should%20continue%20throughout%20pregnancy%20and%20breastfeeding,%20and%20carbimazole%20substituted%20for%20propylthiouracil%20if%20required%20during%20the%20second%20trimester%20(since%20organogenesis%20is%20complete,%20and%20the%20risk%20of%20liver%20failure%20from%20propyl%20thiouracil%20outweighs%20the%20risks%20of%20carbimazole%20during%20this%20stage%20of%20the%20pregnancy).%20%20Patients%20with%20uncontrolled%20thyrotoxicosis%20should%20be%20advised%20to%20avoid%20pregnancy%20until%20biochemical%20control%20is%20achieved%20due%20to%20the%20risk%20of%20miscarriage.%20Treatment%20during%20pregnancy%20requires%20close%20monitoring%20typically%20every%20six%20weeks.%20Radioactive%20iodine%20is%20contraindicated%20in%20pregnant%20or%20breast%20feeding%20individuals.%20Women%20should%20be%20advised%20to%20avoid%20conception%20for%20six%20months%20and%20men%20should%20avoid%20fathering%20children%20for%20four%20months%20following%20radioactive%20iodine%20treatment.%20" target="_blank"&gt;pregnancy&lt;/a&gt;, due to small but real concerns regarding teratogenicity from carbimazole. Treatment may frequently be stopped by the second trimester as the disease often spontaneously improves until the post partum period. Monitoring should continue throughout pregnancy and breastfeeding, and carbimazole substituted for propylthiouracil if required during the second trimester (since organogenesis is complete, and the risk of liver failure from propyl thiouracil outweighs the risks of carbimazole during this stage of the pregnancy). &lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style='font-size:9.0pt;
font-family:"Calibri","sans-serif";mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:
minor-latin;mso-bidi-theme-font:minor-latin'&gt;Patients with uncontrolled thyrotoxicosis should be advised to avoid pregnancy until biochemical control is achieved due to the risk of miscarriage. Treatment during pregnancy requires close monitoring typically every six weeks.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style='font-size:9.0pt;
font-family:"Calibri","sans-serif";mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:
minor-latin;mso-bidi-theme-font:minor-latin'&gt;Radioactive iodine is contraindicated in pregnant or breast feeding individuals. Women should be advised to avoid conception for six months and men should avoid fathering children for four months following radioactive iodine treatment.&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;All patients with severe thyrotoxicosis should be considered for immediate medical treatment before long term decisions are taken.&lt;/p&gt;
&lt;p&gt;All patients must receive written and verbal &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/carbimazole-warning-sheet/"&gt;warnings&lt;/a&gt; about possible side effects of drug therapy.&lt;/p&gt;
&lt;p&gt;Exact treatment depends on the severity of thyrotoxicosis. Doses as low as 5-10mg carbimazole may be appropriate in asymptomatic patients with mild biochemical disease.  With more severe disease, a typical starting dose is 40mg carbimazole daily. &lt;/p&gt;
&lt;p&gt;All patients should receive instructions as to the timing of dose reduction and firm arrangements made for serial monitoring. Appropriate dose reduction will depend on symptom control, and on the rapidity of the fall in free thyroxine levels in the early stages, as TSH does not tend to respond as quickly to treatment. Typical monitoring intervals are every six weeks, with dose reduction from 40mg, to 20mg, 15mg, 10mg and then to maintenance therapy of 5mg. &lt;/p&gt;
&lt;p&gt;Long term treatment should be monitored with serum TSH, aiming for a level within the normal range with complete resolution of all symptoms.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Some patients with toxic nodular goitres may choose long term medical therapy. Patients need to be warned that this treatment will be lifelong as hyperthyroidism secondary to multinodular goitres does not tend to remit. Antithyroid drugs are thus usually used short term prior to radioactive iodine therapy.  &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Agranulocytosis is an uncommon but important side effect of all anti-thyroid drugs. Patients should receive written and verbal &lt;a href="http://www.endobible.com/investigation/carbimazole-warning-sheet/" target="_blank" style="text-decoration: none; color: rgb(236, 0, 140); "&gt;warnings&lt;/a&gt; to discontinue the drug until they have had a blood count checked if they develop a severe sore throat or mouth ulcers.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Mild neutropaenia &amp;lt;1.5x10*9 is commonly observed in people with Graves disease, some racial groups and with anti-thyroid drugs.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count 1-1.5 - continue drug but institute close monitoring of blood count. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count &amp;lt;1 - stop antithyroid drug and monitor blood count daily.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Neutrophil count &amp;lt;1 with suspected sepsis or in the unwell patient - stop antithyroid drug and arrange urgent admission. Treat as for neutropaenic sepsis, remembering that pseudomonas is a common infective organism in this group. Monitor blood count every 12 hours initially and take haematological advice. Bone marrow biopsy may be helpful to determine response. Granulocyte-colony stimulating factor (GCSF) should be considered after haematology review of the patient's response to drug cessation. DO NOT RECHALLENGE THE PATIENT WITH AN ALTERNATIVE ANTI-THYROID DRUG.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Rash is common and usually controlled by antihistamines. Alternatively switch to alternative anti-thyroid drug.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Arthralgia and arthritis are uncommon with carbimazole but more common with PTU. Stop the drug. Check antibody screen including ANCA for drug induced lupus and discuss wtih rheumatologist. &lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Mild abnormalities of liver function are common with thyrotoxicosis and do not require treatment. Mild transaminitis (&amp;lt;1.6x upper limit of normal) is also common after 3 months therapy with PTU and does not require treatment or monitoring unless baseline liver function was abnormal.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Allergic hepatitis with submassive necrosis occurs in 0.1-0.2% of patients receiving PTU. Stop PTU and involve a hepatologist immediately if this is suspected.&lt;/p&gt;
&lt;p style="color: rgb(51, 51, 51); line-height: 17px; padding: 9px 0px; margin: 0px 22px; font-family: Calibri, 'Trebuchet MS', Trebuchet, Arial, Helvetica, sans-serif; "&gt;Carbimazole is not associated with this condition, but may cause a cholestatic picture of abnormal liver function. Stop the drug and inform hepatology if this is suspected, though complete resolution is normal on drug withdrawal. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;&lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.rcplondon.ac.uk/Pubs/contents/0621b67a-4880-4a1b-9942-57a666efee4a.pdf"&gt;Radioactive iodine&lt;/a&gt; is the treatment of choice for most patients. It will prevent future growth and reduce the size of most goitres by up to 50% and so is particularly suitable for modest sized goitres. Radioactive iodine is also the treatment of choice for toxic nodular goitres which will otherwise require life long anti-thyroid drugs. The dose should be determined in line with local results by the responsible ARSAC officer. Typical doses for a multinodular goitre would be 800MBq, or 400MBq for a small toxic adenoma.&lt;/p&gt;
&lt;p&gt;However, it is usual to start medical treatment at presentation in patients with severe thyrotoxicosis in order to allow them to make an informed decision regarding long term management. &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.british-thyroid-association.org/info-for-patients/Docs/bta_patient_hyperthyroidism.pdf%20"&gt;Written information&lt;/a&gt; should be given to all patients on the different treatments available, and they should be warned specifically about standard radiation safety precautions, the possibility of transient thyroid swelling, the need for long term monitoring and possibile thyroxine requirements.&lt;/p&gt;
&lt;p&gt;Radioactive iodine is contraindicated in pregnant or breast feeding individuals. Women should be advised to avoid conception for six months, and men should avoid fathering children for four months following radioactive iodine treatment.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid function should be assessed at least every three months for the first year after radioactive iodine, and then annually thereafter for emerging hypothyroidism or for recurrent thyrotoxicosis.&lt;/p&gt;
&lt;p&gt;Subsequent &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/condition/hypothyroidism/management"&gt;hypothyroidism&lt;/a&gt; should be treated conventionally.&lt;/p&gt;
&lt;p&gt;Subsequent recurrence of hyperthyroidism may occur, though this is unusual, and should be treated with a repeat application of radioactive iodine.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;With very large goitres, where cosmetic symptoms are severe or where there are definite obstructive symptoms, surgery is the standard treatment, although tracheal deviation or narrowing are not absolute contraindications to radioactive iodine.&lt;/p&gt;
&lt;p&gt;Patients should be warned that surgery cannot prevent future re-growth or hyperthyroidism in all cases.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Most patients with multinodular goitres will receive radioactive iodine treatment and so require annual thyroid stimulating hormone (TSH) measurement to monitor thyroxine replacement only.&lt;/p&gt;
&lt;p&gt;Patients who have not required treatment should also have their TSH monitored on an annual basis. Permanent suppression of their TSH should prompt a review of whether radioactive iodine or other treatments are now indicated. Long term low TSH is associated with osteoporosis and atrial fibrillation. Consider bone densitometry scanning in such cases. &lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Asymptomatic goitres of any size may not necessarily require treatment. Increasing size, TSH suppression, frank thyrotoxicosis, osteoporosis, or atrial fibrillation should all inform the decision whether treatment is indicated in an individual case.&lt;/p&gt;				&lt;/div&gt;</value></CAnsMgt><CQueExa><value>General examination 
				</value><value>Body habitus, weight and BMI 
				</value><value>Breast examination 
				</value><value>Cardiovascular system 
				</value><value>Eyes 
				</value><value>Hands and tremor 
				</value><value>Reflexes 
				</value><value>Thyroid gland, neck and nodes 
				</value><value>Pemberton's sign 
				</value></CQueExa><CAnsInv><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Normocytic normochromic anaemia and eosinophilia may be seen with glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;B12 deficiency may indicate associated pernicious anaemia or coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hyperkalaemia and hyponatraemia may occur in glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Liver function should be tested at baseline and may be abnormal with congestive cardiac failure.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Useful indicator of general health and underlying disease.&lt;/p&gt;
&lt;p&gt;Hypercalcaemia may occur with thyrotoxicosis and glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ensure patients have stopped sex steroid therapy, for example HRT or the combined oral contraceptive pill for six weeks prior to test.&lt;/p&gt;
&lt;p&gt;A &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/synacthen-test/"&gt;synacthen&lt;/a&gt; test is required to formally exclude Addison’s, however a 9am cortisol can be a useful screen. Levels below 250nmol/l demand thorough assessment, levels above 590nmol/l exclude glucocorticoid deficiency.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Elevated thyroid stimulating hormone (TSH) implies hypothyroidism.&lt;/p&gt;
&lt;p&gt;TSH levels within the normal range imply normal thyroid function, except in those with potential pituitary disease, in whom a normal or low TSH may be seen with hypothyroidism.&lt;/p&gt;
&lt;p&gt;Ideal treatment of thyroid disease is reflected by control of symptoms and a serum TSH in the middle of the reference range - approximately 1mU/L.&lt;/p&gt;
&lt;p&gt;Long term monitoring of known thyroid disease relies on serum TSH levels alone.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Thyroid stimulating hormone (TSH) and free thyroxine should be tested together in all patients suspected of having thyroid dysfunction.&lt;/p&gt;
&lt;p&gt;Low thyroxine implies hypothyroidism and is associated with elevated TSH in primary hypothyroidism.&lt;/p&gt;
&lt;p&gt;Low thyroxine occurring with low or normal TSH also requires further investigation as it may suggest pituitary pathology.&lt;/p&gt;
&lt;p&gt;Ideal treatment of pituitary disease is reflected by control of symptoms and a serum thyroxine level in the upper half of the reference range.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;ECG should be performed in all patients at baseline to document and confirm bradycardia or any other changes.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;There are multiple different tests available for thyroid auto-antibodies, with varying levels of sensitivity.&lt;/p&gt;
&lt;p&gt;Thyroid peroxidise (TPO) antibodies are commonly used as an initial screen and may be positive in patients with any auto-immune thyroid condition, with higher titres occurring in patients with Hashimoto’s thyroiditis and hypothyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Free liothyronine levels are not usually necessary for the assessment and treatment of thyroid dysfunction, as long term treatment should be guided by TSH levels.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Hypothyroidism may be associated with hyperlipidaemia, which may normalise with correction of thyroid biochemistry.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with auto-immune thyroid dysfunction are at increased risk of developing diabetes mellitus.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ultrasound scan is rarely performed in hypothyroid patients.&lt;/p&gt;
&lt;p&gt;It is useful when the gland feels hard to assess whether there is a nodule within it or whether the whole gland is inflamed, for example when assessing for lymphoma within a Hashimoto’s gland.&lt;/p&gt;
&lt;p&gt;Ultrasound scan is also essential in the assessment of a palpable thyroid nodule with any suspicious features and to guide how and whether to perform fine needle aspiration.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Fine needle aspiration should be performed in all suspicious or solitary nodules.&lt;/p&gt;
&lt;p&gt;Ultrasound guidance improves the safety of this procedure and increases the yield of this investigation by targeting specific areas of a nodule. Aspiration of cyst contents may also be performed at the same time as the sampling of solid components.&lt;/p&gt;
&lt;p&gt;Ultrasound scanning may also identify patients in whom fine needle aspiration is not necessary.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Patients with coeliac disease may well have low serum vitamin D levels.&lt;/p&gt;
&lt;p&gt;In patients with known or suspected osteoporosis, serum vitamin D levels will guide whether routine calcium and vitamin D supplementation is enough, or whether specific high dose vitamin D replacement is required.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;This is useful in patients with suspected thyroiditis.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Tissue transglutaminase and anti-gliadin antibodies should be checked if there is clinical suspicion of coeliac disease.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;A &lt;a onclick="window.open(this.href,'','resizable=no,location=no,menubar=no,scrollbars=no,status=no,toolbar=no,fullscreen=no,dependent=no,status'); return false" href="http://www.endobible.com/investigation/synacthen-test/"&gt;synacthen test&lt;/a&gt; must be performed if there is clinical or biochemical suspicion of Addison's disease.&lt;/p&gt;				&lt;/div&gt;</value></CAnsInv><CQueInv><value>Full blood count 
				</value><value>Serum B12 
				</value><value>Urea and electrolytes 
				</value><value>Liver function test 
				</value><value>Bone profile 
				</value><value>9am cortisol 
				</value><value>Thyroid stimulating hormone 
				</value><value>Free thyroxine 
				</value><value>Electrocardiogram 
				</value><value>Thyroid auto-antibody screen 
				</value><value>Free liothyronine 
				</value><value>Fasting lipid profile 
				</value><value>HbA1c and fasting glucose 
				</value><value>Thyroid ultrasound scan 
				</value><value>Ultrasound guided fine needle aspiration 
				</value><value>Vitamin D levels 
				</value><value>Thyroid radionucleide uptake scan 
				</value><value>Coeliac auto-antibody screen 
				</value><value>Short synacthen test 
				</value></CQueInv><CURLExa>http://www.endobible.com/condition/thyroid-nodule/examination</CURLExa><CCondName><value>Thyrotoxicosis or hyperthyroidism</value></CCondName><CQueMgt><value>Any suspicious characteristics 
				</value><value>Pregnancy and fertility plans should be discussed with all patients 
				</value><value>Medical treatment for thyrotoxicosis 
				</value><value>Long term medical treatment may be appropriate in some cases 
				</value><value>Common side effects of antithyroid drugs 
				</value><value>Radioactive iodine should be offered to all patients 
				</value><value>Post radioactive iodine monitoring and treatment 
				</value><value>Surgery should be discussed with all patients 
				</value><value>Long term follow up 
				</value><value>Asymptomatic and euthyroid multinodular goitres 
				</value></CQueMgt><CLiens><value>http://www.endobible.com/condition/multinodular-goitre/</value><value>http://www.endobible.com/condition/multinodular-goitre/examination</value><value>http://www.endobible.com/condition/multinodular-goitre/investigation</value><value>http://www.endobible.com/condition/multinodular-goitre/management</value></CLiens><CURLMgt>http://www.endobible.com/condition/multinodular-goitre/management</CURLMgt><CURLTop>http://www.endobible.com/condition/multinodular-goitre/</CURLTop><CURLInv>http://www.endobible.com/condition/hypothyroidism/investigation</CURLInv><CURL>http://www.endobible.com/conditions/</CURL><CAnsExa><value>&lt;div class="answer"&gt;
&lt;p&gt;To diagnose thyroid nodule detailed and full general examination is essential in the initial assessment of all patients.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Weight loss is common with thyrotoxicosis and shouId improve rapidly with treatment, though it may indicate malignancy.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;An isolated neck lump may represent a lymph node or thyroid metastasis. Thorough examination is thus essential.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Detailed cardiac assessment is necessary.&lt;/p&gt;
&lt;p&gt;Tachycardia, atrial fibrillation, hypertension and congestive cardiac failure may complicate hyperthyroidism.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Lid retraction and lid lag may be seen in any cause of thyrotoxicosis - ask the patient to watch your horizontal finger as you very slowly lower it about 30cm away from their eyes.&lt;/p&gt;
&lt;p&gt;Delay in the upper eye lid following downward gaze will reveal the whites of the eye above the iris in the presence of lid lag.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Examine the palms - hot, red and sweaty hands occur in hyperthyroidism.&lt;/p&gt;
&lt;p&gt;Ask the patient to hold out their hands in front of them. A resting tremor is usually obvious in hyperthyroidism, but may be highlighted by placing a sheet of paper over the hands to demonstrate it shaking.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Brisk reflexes are seen in hyperthyoidism, as is a general increase in resting movement or 'jumpiness' in the patient during examination.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;First inspect the neck from the front and ask the patient to swallow. Diffuse thyroid swelling, nodules, cysts and multinodular goitres may all be obvious as anterior neck masses that move on swallowing.&lt;/p&gt;
&lt;p&gt;Ask the patient to protrude the tongue - this should have no effect on a thyroid swelling.&lt;/p&gt;
&lt;p&gt;Examine the neck thoroughly. This is usually performed from behind the seated patient and in a systematic fashion.&lt;/p&gt;
&lt;p&gt;The texture of the gland, tenderness, and the presence or absence of generalised nodularity or of distinct lumps or lymph nodes must be noted.&lt;/p&gt;
&lt;p&gt;Ask the patient to swallow while palpating any nodules - thyroid nodules should rise and fall with swallowing, and move freely under the skin.&lt;/p&gt;
&lt;p&gt;Examine the patient for lymphadenopathy. Papillary cancer frequently has local lymphadenopathy at presentation. Distant lymph nodes are more likely to occur with follicular, anaplastic or other malignancies.&lt;/p&gt;				&lt;/div&gt;</value><value>&lt;div class="answer"&gt;
&lt;p&gt;Ask the patient to hold both arms above the head as high as they can. Facial flushing, engorgement of the neck veins, and inspiratory stridor all indicate superior vena cava obstruction.&lt;/p&gt;				&lt;/div&gt;</value></CAnsExa></item></items>